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Figure 1 • DM1 molecular 
pathogenesis: symptoms and 
locus.
(A) Characteristic symptoms 
of DM1. The frequency of 
symptoms is indicated by a 
sca le from + to +++. Typical 
ske le ta l m uscle fea tures are 
illus tra ted  in the d raw ing 
darkest shading indicates 
most seve re ly  affected s k e l­
eta l m uscle areas. (B) DM1 
locus organization. The 
(CTG)n repeat tract is 
located in a gene-dense re­
gion on human chromosome 
19q13 in exon 15 of the 
DMPK gene, wh ich overlaps 
w ith  the prom oter region of 
the SIX5 gene. Rectangles 
indicate exons (grey, DMWD;
black, DMPK; white, SIX5). 
The s tra igh t line represents 
in trons and inte rgen ic se­
quences. A rrow s denote start 
and d irection of transcrip tion. 
Disease c lassifica tion anc 
correspond ing num ber of 




• 1. Myotonic Dystophy type 1 (DM1)
DM is the most common genetic determined muscular dystrophy in adults
at a prevalence of 1:8000 (101) and was firs t described by Steinert (266), 
and Batten and Gibb (10) about one century ago. We now know that this 
multisystemic neuromuscular disorder can be divided into two subtypes 
with different prevalence: DM type 1 (DM1, also known as Steinert dis­
ease; MIM 160900) and DM type 2 (DM2, also known as proximal myo­
tonic myopathy, MIM 602668). DM symptoms vary in severity and mostly 
manifest themselves as muscle related. Prominent symptoms include 
myotonia, distal and proximal muscle weakness and atrophy, gastroin­
testina l trans it problems, and cardiac aberrations like conduction de­
fects and arrhythm ias. Cardiac problems are generally considered the 
leading cause of death in DM. Furthermore, the central nervous system 
can be affected, and cataract and endocrine problems can be involved, 
i llus t r ating the multisystem ic character of the disease (summarized in 
Fig. 1A). This plethora of symptoms together w ith long asymptomatic
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periods and a variable age of onset make DM a difficu lt to diagnose dis­
order (94). Contrary to DM2, DM1 can also occur as a severe congenital 
form characterized by high neonatal mortality, hypotonia, mental re ta r­
dation and respiratory distress (101).
In the early nineties of the twentieth century the mutation underly­
ing DM1 was discovered by severa l groups on chromosome 19q13 in the 
3'-UTR of the DMPK gene (Fig. 1B) (26, 86, 175). Several years later, a 
(CCTG)n mutation in intron 1 of the zinc finger protein 9 (ZNF9) mapping 
to chromosome 3q21 was identified as the cause of DM2 (167, 225).
For DM1, it has been found that severity of symptoms and length of 
the repeat are correlated (Fig. 1B). An unaffected person carries a short 
repeat composed of 5-35 CTG triplets, while m ildly affected patients 
carry 35-150 CTG units in their affected allele. Patients w ith the classical 
DM1 phenotype have repeats of 100-1000 CTGs and the most severely 
affected individuals carry a repeat of over 1000 CTGs (101, 116). Once 
the (CTG)n repeat crosses a threshold of 35 CTG triplets, it becomes un­
stable, resulting in expansion in somatic tissues (187) and in successive 
generations. Repeat expansion causes anticipation, meaning that severity 
of disease increases between generations and symptoms appear earlie r 
in life (31, 102, 187).
In order to better understand the multisystem ic character of DM1 it is 
of paramount importance to gain extensive knowledge about DMPK mRNA 
and protein functions and expression patterns.
• 2. DM1 molecular pathogenesis
DM1 is now classified as an unstable mini- or m icrosatellite or DNA 
expansion disorder, a heterogeneous family of disorders to which also 
Huntington's disease, FRAXA, various types of spinocerebellar ataxia (94) 
and severa l other neurodegenerative disorders belong. Upon discovery 
that the mutation leading to DM1 is localized in the 3'-UTR of the DMPK 
gene, it was realized that special mechanisms of pathogenesis must be 
operational because formation of abnormal protein structure cannot be 
involved. Hence, severa l hypotheses were postulated to explain the mul- 
tisystem ic nature of DM1 pathology.
• 2.1. RNA pathogenesis
The most prevalent and best supported explanation for the molecular 
pathology of DM1 is an RNA-based toxic gain-of-function mechanism, 
in which newly formed transcription products containing large (CUG)n 
repeats are trapped in the nucleus, where they aggregate w ith nuclear 
proteins to form ribonuclear protein complexes of abnormal nature (75,
111, 129, 181). The end resu lt is global m isregulation of gene expres­
sion (43, 65, 225). Just lately, it was speculated that soluble transcripts 
containing long CUG-repats are also able to bind transcription and splice 
factors, in this way contributing to gene misregulation (132). Length of 
the repeat is correlated w ith binding of nuclear proteins, nuclear reten­
tion and formation of nuclear aggregates (54, 58). Analysis of ribonuclear 
foci in muscle and brain tissue from DM1 patients revealed presence of 
splice factors of the muscleblind family (MBNL 1, 2 and 3) w ith in the
12
ribonucleoprotein (RNP) aggregates. It is therefore commonly believed 
that the amount of MBNL available for proper regulation of splicing is 
reduced. Although not found in nuclear foci but believed to bind soluble,
expanded transcripts, other RNA processing factors able to bind (CUG) 
n repeats are upregulated or are behaving abnormally, like CUG-binding 
protein 1 (CUG-BP1) a member of the CUG-BP and ETR3-like (CELF) 
fam ilies of factors (132, 278) or HnRNP-H (139). Furthermore, several 
other proteins not involved in splicing such as protein kinase R (276), 
transcription factor SP1 (specific protein 1), signal transducers and ac­
tivators of transcription (STAT1 and 3), the retinoic acid receptor gamma 
subunit (58, 65) and Nkx2.5 (306) may also be involved in DM1 via an 
RNA-mediated mechanism.
In DM1 tissues, multiple splice abnormalities have been described 
(58), including in muscle: splicing of the mRNAs for chloride channel 1 
(ClC-1 ) (40, 180), sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2 
(143), cardiac troponin T (110, 219), insulin receptor (IR) (248), and the 
ryanodine receptor (143). In brain, processing of the mRNAs for Tau (164, 
253), and amyloid precursor protein (129) is misregulated. Two of these 
aberrant processing events have been associated w ith typical muscle 
symptoms: myotonia and insulin resistance are associated w ith mis- 
splicing of the ClC-1 and the IR respectively (58). Alterations in splicing 
mostly involve a shift in expression from an adult to an embryonic mode 
of splicing, w ith production of isoform products typ ica l for the immature 
state. Both reduction of available MBNL and increase in CUG-BP1 expres­
sion support this sh ift in splice mode, since MBNL induces adult-type 
splicing whereas CUG-BP1 is known to promote embryonic splice modes 
(58).
• 2.2. Small noncoding RNAs
In recent years it has become clear that the non-coding DNA sequences 
in the genome are not just noncoding or "stuffer” DNA, but that they
contain essential sequences encoding e.g. microRNAs (309), which have 
been found to be important in the regulation of embryogenesis (308), 
protection against cell stress and pathogenic insult and in gene regula­
tion in general (309).
In a paper by Malinina it was hypothesized that the hairpin structure 
of the CTG-repeat in the mutant DMPK gene transcript, when processed 
by the RNAi machinery, could give rise to CUG containing sm all noncod­
ing RNAs (178). In turn, these small noncoding RNAs could serve in 
breakdown or blocking of translation of CUG- or CAG-containing mRNAs. 
Although the CUG containing mRNAs are not fu lly  complementary to the 
CUG containing sm all noncoding RNAs, each U-U mismatch is flanked 
at each side by two C-G pairs providing sufficient stabilization for the 
formation of near complementary double stranded RNA molecules. Pre­
dicted candidates that could be affected are MBNL1 (CUG-repeat) or 
the myosin phosphatase-Rho interacting protein (CAG-repeat), where the 
silencing effect of the CUG containing sm all noncoding RNAs would be 
most effective against the CAG sequence (178). Concrete evidence to 
support that this hypothetical mechanism is in fact active in DM1 was 
provided by Krol et al. (153) who showed that transcripts containing long 




































products generated by Dicer are short CUG repeats that act as siRNAs 
which are used in the RNA interference pathway to downregulate repeat 
containing mRNA. These results provide evidence that sm all noncoding 
RNAs could play a role in the development of DM1 pathogenesis.
• 2.3. Neighboring gene effects
The (CTG)n repeat in the DMPK gene is located within a CpG island, which 
extends to over 3.5 kb (22). When the CpG island is interrupted by an 
expanded repeat this increases nucleosome binding across the area, re­
sulting in a more condensed chromatin structure (22, 83, 147, 152). This 
observation, together w ith the finding of a disruption of a DNase hyper­
sensitive site located just downstream of the repeat led to the hypothesis 
that repeat expansion may be involved in a ltering transcription of DMPK 
and neighboring genes DMWD and SIX5 (77, 125, 147, 153, 247) (Fig. 1B).
Products of the DMWD gene (formerly known as DMR-N9 in mouse 
or gene 59 in human), located just upstream of DMPK, have been found 
in brain (127, 299) and testis (127), tissues implicated in DM1 pathology. 
Comparative expression profiling of DMWD in DM1 patients and unaf­
fected individuals, however, did not reveal a consistent reduction in ex­
pression in the DM1 patient group. Furthermore, no correlation between 
repeat length and DMWD expression levels has been found, dismissing 
DMWD's candidacy for involvement in DM1 disease etiology (4, 71, 83).
The gene encoding homeodomain transcription factor SIX5 is located 
just downstream of DMPK. In fact, the (CTG)n repeat overlaps w ith the 
SIX5 promotor/enhancer region (103, 147). Its expression in eye, heart 
and skeleta l muscle and testis, a ll tissues affected in DM1 pathology, 
implicates SIX5 as an important candidate gene for involvement in DM1 
(107, 213, 245). This idea has been further strengthened by the finding 
that mRNA expression of SIX5 in DM1 patients is reduced by about 50% 
(147, 275). To study the role of SIX5 in DM1 pathology in more detail Six5- 
deficient mice have been generated (146, 243). Homozygous knockout 
mice and, interestingly, also mice that lack only one Six5 allele, devel­
oped cataract at an early age (146, 245, 243). Together, these findings 
seemingly indicate that a decrease in SIX5 expression may be involved 
in cataract formation in DM1. Since the cataracts observed in Six5- 
deficient mice were not of the same type as found in DM1 patients (224), 
however, there is s t il l doubt about the contribution of SIX5-deficiency to 
the ocular pathology in DM1. Moreover, the fact that also patients with 
DM2 develop cataracts on the basis of a completely unrelated genome 
mutation argues against simple causal involvement of abnormal SIX5 ex­
pression (224). Finally, Six5 KO mice showed also impaired male fertility, 
suggesting that SIX5 plays a role in spermatogenesis (144, 245), which 
could be linked to hypogonadism in DM1 patients. Much of this work is 
s t il l in the speculative phase, however, and the true role of neighboring 
genes of DMPK in DM1 disease pathology is therefore s t il l under debate.
• 2.4. Aberrant expression of DMPK protein
Ever since the discovery of the DMPK gene mutation, studies were un­
dertaken to identify DMPK expression levels in patient tissues. Until now, 
controversy on this topic remains. Where some studies report increased 
DMPK expression, others show a decrease (35, 73, 85, 176, 206, 298).
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Figure 2 • DMPK and NDR 
families of serine/threonine 
protein kinases.
Phylogenetic tree of the 
DMPK (DMPK, MRCKa, -ß and 
-y, ROCK-I and II, and CRIK) 
and NDR fam ilies  (NDR1 
and -2 and La ts l and -2) of 
protein kinases. The s truc­
tu re  of the tree is basec 
on homology comparison 
across the serine/threon ine 
protein kinase domain, using 
C lusta lW  (1 84, 274). Mouse 
sequences were used and 
percentage sequence identity 
re la tive  to the DMPK kinase 
domain is given. The tree 
is d rawn to scale. Adapted 
from W ansink et al. (297).
Reduced expression is consistent w ith a haploinsufficiency model, where 
mRNA derived from the DM1 a lle le is retained in the nucleus in nuclear 
foci and unavailable for translation into DMPK protein products (54, 182, 
272).
To investigate the effect of haploinsufficiency and the function of 
DMPK, DMPK KO mouse lines were generated, independently by two labs, 
including ours (126, 227). Replacement of the firs t seven exons of the 
DMPK gene by a neomycin resistance cassette resulted in complete ab­
sence of DMPK protein (298). KO mice were viable and only showed mild 
myopathy in head and neck muscles at an advanced age (126). Skeletal 
muscle cells derived from these mice demonstrated impaired calcium 
homeostasis (13). The DMPK KO mouse generated by Reddy et al. via a 
sim ilar strategy displayed a late onset progressive skeleta l myopathy, 
characterized by a decrease in force generation and increased fiber 
degeneration (227). Upon closer inspection, these mice were shown to 
display cardiac conduction defects including first, second and third de­
gree a trioventricu la r block. The development of third degree heart block 
closely resembles the condition found in DM1 patients, suggesting a 
potential ro le for DMPK haploinsufficiency in DM1 etiology (16). Further­
more, DMPK KO mice showed increased insulin resistance (170) resulting  
in a significantly higher body weight when they were fed a high-fat diet 
(169). Loss of DMPK expression might therefore be involved in the devel­
opment of type II diabetes in DM1 patients (170).
To examine cell biological and physiological consequences of DMPK 
overexpression, a transgenic overexpressor mouse model (Tg26) has 
been generated. Approximately 25 copies of the entire human DMPK 
gene including regulatory flanking segments were tandemly integrated 
into the genome of this model. This resulted in a continuous surplus of 
DMPK transcripts, resulting in 5-10 fold excess of human DMPK pro­
tein over endogenous mouse DMPK protein leve ls (126). Tg26 transgenic 
mice demonstrated hypertrophic cardiomyopathy, reminiscent of human 
cardiac hypertrophy, and neonatal m orta lity indicating a detrimental ef­
fect of DMPK overexpression during pregnancy (126). Additional studies 
revealed cardiac dysrhythmia, myopathy in skeleta l muscle and hypoten­
sion of smooth muscle suggesting a role for DMPK in a dose- or activity-  
dependent manner safeguarding the physiological functioning of skeleta l 
muscle (211). Since DMPK was found to be involved in myogenesis, hav­













































m usc le  maturation (36). Taken together, s e v e ra l  sym ptom s found in DM1 
patients could som ehow  be co rre la ted  to abe rran t  leve ls  of DMPK pro ­
tein. On the other hand, the fu ll  complex ity  of the m u lt isys tem ic  features 
observed  in DM1 patients can ce rta in ly  not be explained by effects  at 
the protein leve l  only.
• 3. DMPK protein
Over time it has become c le a r  that the m u lt isys tem ic  nature of DM1 pa ­
thology is not eas i ly  explained by just  one m ech an is t ic  model. It rem ains  
important to investigate  propert ies  of protein and RNA products of the 
DMPK gene side by side.
• 3.1. DMPK family members
DMPK, an evo lu t ionary  young protein only found in m am m a ls ,  is c l a s ­
sified a s  a ser ine/threon ine  protein k inase belonging to the group of 
AGC (cA M P-dependent  protein k inase/protein  k inase G/protein k inase C) 
k inases  (183). W ith in the group of AGC k inases, DMPK together with its 
c lo ses t  homologs, myotonic  dystrophy k inase-re la ted  Cdc42-binding ki­
nase (M R C K )  a, ß and y (166, 208), rho-assoc ia ted  co i led-co il  contain ing 
kinase (ROCK) I and II (232) and citron k inase (CR IK )  (173) make up the 
DMPK subfamily , for wh ich DMPK itself  is the a rche type  m em ber (Fig. 2) 
(184). DMPK fam ily  m em bers  share  a co m p arab le  s t ru c tu ra l  organization 
with a leucine-rich  N-terminus and a ser ine/threon ine  k inase domain 
fo l lowed by a co i led-co il  region of v a r iab le  length (232, 313). A lthough 
s im i la r  in domain organizat ion, DMPK homologs differ cons ide rab ly  in 
length. The main d if fe rences  are  the v a r iab le  co i led-co il  domain and 
presence  of addit ional  domains like a GTPase-binding domain, plextrin 
homology domain, cys te ine- r ich  domain and citron homology domain 
(297).
More d istant re la t ives  of DMPK a re  m em bers  of the NDR subfam ily  
of k inases  NDR (n u c le a r  Dbf2-re la ted) 1 and 2 and LATS ( la rg e  tumor 
supp resso r )  1 and 2 (Fig. 2) (33, 183). NDR1 and 2 resem b le  DMPK both 
in domain s t ructure  and length. LATS1 and 2, on the other hand, are 
characte r ized  by an N-term ina l ub iqu it in-assoc ia ted  domain, connected 
to the ser ine/theron ine  kinase domain via a long linker (33, 183).
M U SC L E  NON-MUSCULAR








Table 1 • DMPK tissue 
distribution.
Listing  of t is su e s  or organs 
that show  express ion  of 
DMPK. Obtained  from  s tud ­
ies in m ice  and hum ans, 
adap ted  from  W a n s in k  et 
al. (297 ).
Figure 3 • The DMPK gene 
gives rise to different, 
alternatively spliced, serine/ 
threonine protein kinases.
(A ) The D M PK gene cons is ts  
of 15 exons and is s trong ly  
co n served  b etw een  m an and 
m ouse (hu m an  D M PK gene, 
d raw n  to sca le ). R ec ta ng le s  
ind ica te  exons; the stra ight 
line rep re sen ts  introns. 
Exon ic  parts that a re subject 
to a lte rn a t ive  sp lic in g  -i.e., 
a lte rn a t ive  use of 5' and 3' 
s p lic e  s ites-  in exons 8 and 
14 are ind icated  in b lack. 
( B )  D e ta iled  illu s tra tion  of 
a lte rn a t ive  sp lic e  m od es  ir 
the D M PK gene. Inclusion  
of 15 n u c leo tid es  in exon 8 
re su lts  in p re sence  of the 
VSGGG m otif (le ft panel). 
A lte rn a t ive  use  of four 
n u c leo t id es  in exon 14 is 
re sp o n s ib le  for tw o  d ifferent 
open reading fra m es  (O RF), 
defin ing C -term ina l ta il 1 
and ta il 2 (m id d le  panel). 
A s te r isk s  ind ica te  stop 
co d o n s  in the ORFs. Sk ipping 
of exons 13 and 14 is a 
sm o o th - m u sc le  sp ec ific  
event, w h ich  re su lts  in a 
stop codon at the beginning 
of exon 15 and expression  
of a short tw o-am ino-ac id  
C-term inus (ta il 3) (r igh t 
panel). (C ) Dom ain  o rg a n iza ­
tion of the six m ajo r DMPK 
iso fo rm s A through F (d raw n  
to sca le ). A ll iso fo rm s have 
a leu c in e- rich  N -term inus 
fo llo w ed  by a se r in e/th reo ­
nine prote in  k inase  dom ain, 
in c lud ing  an extension 
to the  k inase  dom ain , an 
a - h e lic a l co ile d - co il dom ain  
and d ifferen t C-term inal 
ta ils . A lte rn a t iv e  sp lice  
m od es  show n  under (B )  d e ­
fine the  p re sence  or ab sen ce  
of the  VSGGG m otif and the 
natu re of the C -term ina l tail. 
A dap ted  from  W a n s in k  et 


























• 3.2. Cell type and tiscue distribution of DMPK expression
DMPK prote in is r  xpres s ed ir a wid e range of t iss  ues, with hi gd est 
express ¡0 n in smo o th mus o le, Ske  s tom ach  and hlad de r (Fig. 3) (95, 
2 11, 114 4). In other m usc le  type s like hea rt, sk e le ta l  m u sc l  e, tongue and 
diaphragm, DMPK is a lso  found (Table  1) (95, 126, 174, 244). Further 
specif icat ion ot the exptess ion pn tte r t  in sl<eldtal m usc le  showA tdat 
DMPK is present ie both s low  a n t  feist tw itch  m usc le  f ibers (64, 73, 244). 
In tiso ues like t e s tis a nd tir ain DMP4 has a ls  0 been found, a lbe.t in minor 
am oun ts  (211, 244). A lthough D M PK  protein w a s  found in neurons, the 
antibodies used in this study recognized a 50 kDa protein known to be 
a c ross  reacting protein (see below) (8, 68). Using in situ hybridization 
S a r k a r  and co w orkers  determined DMPK m RNA in neurons in the c e r e ­
bra l  cortex, although the data presented only show  minor expression just 
above background leve l  (244). So the quest ion w hether  DMPK expression 
in brain is confined to neurons or a lso  occurs  in g l ia l  ce l ls ,  has s t i l l  not 
been adequate ly  an sw ered  and further study into this con t rove rs ia l  issue 
is needed. D M PK  m R N A  has  a lso  been identif ied in l iver  (244),  a lthough 
no protein expression w a s  found using W es te rn  blot (95). A lso  for lens 
some stud ies  show  p resence  of DMPK protein and m RN A  (63, 244), while  
o thers  fa i led to detect  D M PK  m R N A  (303).
Multip le  groups have tried to ra ise  antibodies aga inst  va r ious  DMPK 
epitopes, but prote ins identified had seem ing ly  d if ferent m o lecu la r
17
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weights, ranging from 42 to 84 kDa (159, 218, 283, 285). C ross-react ion 
to DMPK-re la ted  proteins explained these findings. Products  of the DMPK 
gene were  predicted to fa l l  in the 65-80 kDa size range, so the 42-55 
kDa proteins recognized by the f irst-generation antibodies soon were  no 
longer considered true products  (95, 159, 218). Reac t iv i ty  tow ards  DMPK 
homologues like M RC Ka  and ß (159) made the production of specif ic  
high-aff in ity  antibodies aga inst  DMPK a tedious and dif f icult  job. Not 
unti l  recently , this si tuation has been improved w ith  the deve lopm ent of 
m onoc lona l  ant ibodies  with true DMPK spec i f ic i ty  (159, 218).
B e ca u se  many ear ly  s tud ies  made use of the f irst-generation an t i ­
bodies, confusion rem a ins  about the su b c e l lu la r  loca l ization of DMPK, 
and ca re  should be taken in interpreting im m une-h is tochem ica l  find­
ings in ear ly  reports. S e v e r a l  groups (11, 174, 301) found DMPK in the 
neu ro m uscu la r  junction of ske le ta l  m uscle ,  near the ace ty lch o l ine  r e ­
ceptor implicat ing a role in s igna l  t ransduction. However,  using a panel 
of m onoc lona l  antibodies aga inst  DMPK no expression of the protein at 
the neu ro m uscu la r  junction w a s  found by Pham  et al. (218). DMPK w as  
detected at the sa r co p la sm ic  ret icu lum (64, 240, 256), near the SerCa  
ATPase  and in the T-tubules of type I ske le ta l  m u sc le  f ibres (283). In ca r  - 
diac muscle ,  DMPK w a s  found in the s a r co p la sm ic  ret icu lum (205, 284), 
next to the in terca la ted  d iscs  (174, 218, 240, 301) where  DMPK w a s  a s ­
sociated to gap junct ions (205, 283). In other ce l l  types like adult  sp inal  
motor neurons in brain, D M PK  loca l ized  in the cy toso l  (68), at  the ER  or 
near dendrit ic  m icro tubu les  (8). O vera l l  it has been dif f icult  to interpret 
these resu lts,  a lso  because  hydrophobic ity  prediction c lass if ied  DMPK as 
a m em brane  bound (64, 205, 240, 256, 284) or cy toso l ic  (68, 218, 284) 
protein. Nowadays, the var iat ion in loca l ization descr ibed  for DMPK can 
be best explained by the existence of mult ip le sp l ice  isoforms as w i l l  
be d iscussed  below (95, 286, 296). Independent ev idence  for va r iab le  
su b c e l lu la r  localization of DMPK cam e from stud ies  with f luorescent 
protein tagged isoforms, expressed  from cDNA vecto rs  in t rans ien t ly  or 
perm anen t ly  t ransfected  ce l l  lines. In these  stud ies  ER, m itochondr ia l  
outer m em brane  (M O M ) and cy toso l  we re  identif ied as the main locations 
for DMPK res idence  as outlined fu rther below (286, 296).
• 4. DMPK sp lice isoforms
• 4.1. Alternative sp lic ing of DMPK isoforms
Transcr ip ts  from the DMPK gene are  subject  to extensive a lte rna t ive  
sp lic ing, in a p rocess  that is la rge ly  conserved  between mouse and 
man. A lte rna t ive  sp lic ing resu lts  in six major isoforms and s e v e ra l  minor 
sp l ice  products (95). The 15 exons of the DMPK gene encode a protein 
with a leucine-rich  N-terminus, a ser ine/threon ine  protein k inase domain 
(exons 2-8), an a - h e l ic a l  co i led-co il  domain (exons 10-12) and s e v ­
e ra l  d if ferent C-termini (Fig. 3) (exons 13-15). In one study, a lte rna t ive  
sp lic ing of DMPK tran scr ip ts  w as  investigated in a t ransgen ic  hDMPK 
ove rexp resso r  mouse model, a l low ing direct com par ison  of human DMPK 
t ransgen ic  and endogenous mouse DMPK gene products. In this study it 
w a s  found that exon 8 contained an a l te rna t ive  5' sp l ice  site, result ing 
in production of DMPK m RN A  w ith  ( iso form s A, C and E )  or without ( i s o ­
fo rm s B, D and F) a 15-nucleotide s tre tch  encoding a VSGGG amino acid 
motif (Fig. 3B and C). A second a l te rna t ive ly  sp l iced  region enco m passes  
exons 12-15, resu lt ing in the use of different ORFs for the production of 
DMPK proteins with different C-termini.  Inc lusion of exons 12-15 resu lts  
in D M PK  iso form s A and B contain ing a hydrophobic C-teminus ( t a i l  1), 
with a m o le cu la r  size of ~70 kDa (Fig. 3B and C). W hen an a l te rna tive  
sp l ice  accep to r  site in exon 14 is used instead of the norm a l  3' sp l ice  
site of intron 13, the fi rst  four nuc leo t ides  of exon 14 are  excluded from 
the mRNA. This use resu lts  in a f ram e  sh if t  in the ORF, wh ich t ran s la te s  
into a less  hydrophobic  ta i l  ( ta i l  2) of near ly  the s am e  size (Fig. 3B and 
C). Fusion of exons 12 and 15, i.e., with sk ipping of exons 13-14, leads  to 
a fram e  sh if t  in the ORF with a stop codon appear ing  at the beginning of 
exon 15. At the protein product leve l  this g ives rise to a truncated  C-ter- 
minus composed  of only two amino ac id s  ( ta i l  3), with a m o le cu la r  size 
of approx imate ly  60 kDa (for both DMPK E and F, see Fig. 3B and C) (95).
A lte rna t ive  sp lic ing is used d if fe ren t ia l ly  in different t issues. Long 
DMPK iso forms A-D are  p redom inant ly  expressed  in sk e le ta l  muscle,  
heart  and brain, w h e re as  short  isoforms E-F  are  main ly  found in smooth 
m u sc le  (95, 211). A l l  the above mentioned mature  t ran sc r ip ts  contain the 
(CUG)n repeat  in the 3'-UTR, e ither of norm a l  length when t ranscr ibed  
from the hea lthy  a l le le  or of increased  length when originating from the 
mutated al le le .
• 4.2. Protein domains
• 4.2.1. Leucine-rich N-terminal domain
The typ ica l  m odu la r  s t ru cture  of DMPK and the different sequence  motifs 
in the va r ious modules is w e l l  p reserved  between m em bers  of the AGC 
subfam ily  of k inases. A leucine-rich  N-term ina l  region of about 70 amino 
ac ids  is com m only  found in MRCKs, ROCKs, CRIK and DMPK (Fig. 3C). 
This domain may se rve  in control l ing the ac t iv i ty  of the ad jacent  ser ine/  
threonine k inase domain in these proteins, e ither by fac i l i ta t ing  linking 
to other s ignal ing proteins, by being a scaffo ld  for interacting proteins, 
or by inducing o ligomerization of the protein. Directly,  or indirectly,  this 
domain may a lso  be involved in directing the su b c e l lu la r  loca l ization of 
the k inase (184). Spec i f ic  ev idence for a role of the leuc ine-r ich  domain 
in modula t ing DMPK ac t iv i ty  has been provided by W ans in k  et al. (297). 
The e lucidation of the c r ys ta l  s tructure  of the DMPK k inase domain ( in ­
cluding the N-term inus) re vea led  that the leuc ine- r ich  N-term ina l  end 
could  a l so  be involved in D M PK  d imerization (67, 89).
• 4.2.2. Serine/threonine protein kinase domain
The k inase domain in DMPK (Fig. 3C) has a l l  the ch a ra c te r is t ic  features 
of ca ta ly t ic  domains in other kinases, e spec ia l ly  the highly abundant 
s u b c la s s  of se r ine-threonine  specif ic  k inases. Typically , a k inase domain 
cons is ts  of 11 major conserved  subdom a ins  separa ted  by insert ions and 
delet ions (100, 297). In an ac t ive  conformation ( "on” state),  the kinase 
domain is folded into two lobes forming the ac t ive  cleft . A g lyc ine-r ich 
sequence  (G X G X 0 G ,  0  is usua l ly  pheny la lan ine  or tyros ine) in the cleft  





























P-loop, ca p a b le  of binding ATP (67, 100, 117, 273). Proper  a l ignm ent  of
ATP for ca ta lys is  is control led  by the main chain n itrogens of the P loop. 
For DMPK this function is se rved  by the highly conserved  lys ine residue 
at posit ion 100, wh ich m akes  contact  with the a  and ß phosphates of 
ATP (117).
Unlike in the "on” state  in wh ich  k inases  adopt a def ined structure, 
protein k inases  in the "o f f ” state  are  not in a ch em ica l ly  constra in t  state 
and therefore  ab le  to adopt va r ious  s tructures .  The most frequent ly  d is ­
cussed  m ech an ism s  of inactivat ion involve e ither major rea r rangem ents  
or d isorder of the act iva t ion loop or aC  helix in the N-term ina l lobe, 
w h ich  resu lts  in d isp lacem en t  of ac t ive  site res idues or in b lockage of 
the ATP subs tra te  binding site (117, 210, 273).
Im m ed iate ly  C-term ina l of the kinase domain, DMPK contains an a d ­
d it ional domain, wh ich  is presumed to be involved in k inase act ivat ion. 
A s im i la r  a r rang em en t  is found in approx imate ly  40 other AGC k inases 
and in s e v e ra l  of these k inases the role of this addit ional  domain has 
been studied extensively. This so-ca l led  C-term ina l  extension of the ki­
nase domain conta ins a conserved  hydrophobic phosphorylat ion motif, 
F X X [F / Y ] [ S / T ] [Y / F ] ,  wh ich  can be ac t iva ted  by phosphorylat ion (17, 84, 
124, 296). For some k inases  it has been shown that when the hydrophobic 
phosphorylat ion motif is phosphorylated  it recru its  phophoinosit ide-de- 
pendent kinase-1, wh ich  can ac t iva te  the k inase by phosphorylat ing  the 
act iva t ion loop (17, 117, 210). The VSGGG motif located in the C-term ina l  
extension of the kinase domain w a s  found to be involved in act iva t ion 
of DMPK in both trans- and autophosphory la t ion (296).  Act iva t ion of the 
k inase can be inhibited by ster ic  h indrance  of the C-term ina l end of the 
different DMPK isoforms, a m echan ism  wh ich  is a lso  used by other DMPK 
fam ily  m em be rs  l ike ROCK II and MRCK a  (165, 270, 296). F ina lly, the 
C -term ina l  extension of the k inase domain is involved in dimerization of 
D M PK  by binding to the leuc ine- r ich  N-term ina l  region (67).
DMPK is a se r ine/theonine  protein k inase that favors  threonine over 
ser ine and prefers p resence  of at leas t  three arg in ines or lys ines among 
the f ive re s idu es  N-term ina l  to the phosphoaccepto r  s ite (296).  Although 
au tophosphory la t ion of DMPK w a s  observed, no site in the protein itself  
m atches  the consensus  sequence. Bes ides  a l l  putative su bs t ra te s  only a 
few na tu ra l  DMPK su bs t ra te s  have been found (see  later  sect ions),  s h o w ­
ing l imited pred ict ive  power of the consensus  sequence.
• 4.2.3. Coiled-coil region
The ser ine/threon ine  protein k inase domain of DMPK is fo l lowed by an 
a - h e l ic a l  co i led-co il  region (Fig. 3C) (26, 95). The co i led-co il  s t ructure  
w a s  fi rst  descr ibed  in 1953 as the main s t ru c tu ra l  e lem ent in a-kerat in  
(49, 50), and w a s  later  found in other proteins like tropomyosin , myosin 
and fibr inogen (28, 96, 188). Coiled-coi l  domains are  often present in 
eukaryot ic  proteins, and more importantly , in a l l  m em bers  of the DMPK 
fam ily  (166, 173, 297). Most m em bers  of the DMPK fam ily  contain long 
co i led-co il  regions of at leas t  600 amino ac ids (297). The co i led-co il  
region of D M PK  itself  is much s m a l le r  and e n c o m p a s se s  only ~ 65  r e s i ­
dues (95).
The co i led  co i l  region of D M PK  is respons ib le  for the formation of m u l ­
t im er ic  com p lexes  (287).  Mult imerizat ion of D M PK  inf luences substra te
Figure 4 • Subcellular 
localization of DMPK splice 
isoforms.
N - term ina l Y FP-D M PK  fusion 
p ro te ins w e re  expressed  in 
DM PK KO m yo b la s ts  and 
v isu a liz ed  by co n fo ca l laser 
scann ing  m icroscopy. ER 
w a s  co un ter-sta ined  using 
a c a lre tic u lin  antibody; m i­
to ch on d ria  w e re  v isu a liz e c  
using M ito tracke rRed . (A, A ') 
Y FP- m D M PK  A is a sso c ia ted  
to the  e n d o p lasm ic  re ticu ­
lum. (B, B ') Y FP -m D M PK  C 
is loca ted  at m ito ch o n ­
dria. (C ) Y FP-m D M PK  E is 
loca ted  in the cytoso l. (D, 
D') Y FP-h D M PK  A and (E )  
Y FP-h D M PK  C a re both a s so ­
c ia ted  to m itochondria . Only 
Y FP-h D M PK  A ind uces  strong 
m ito ch o n d ria l aggregation  
around the nucleus.
B a r  = 10 pm.
binding and in c reases  protein kinase ac t iv i ty  (199, 287, 289). Likewise, 
the a  co i led-co il  reg ions in ROCK II and MRCK influence k inase activity, 
although in these  two fam ily  m em bers  ac t iv i ty  is inhibited by co i led-co il  
interact ions (5, 270). Additionally, co i led-co il  mediated mult imeriz ing is 
involved in anchoring of isoform DMPK C to its spec i f ic  loca l ization at the 
m itochondr ia l  outer m em brane  (286, 287).
• 4.2.4. C-terminal anchor
The six major DMPK iso forms found in mouse and hum ans ca r ry  three
dist inct C-term ina l  ta i l s  (Fig. 3C) (95, 296). Tai ls  1 (D M PK  A and B) and 
2 (D M PK  C and n) are  comprised  of 96 and £3 7 amino ac ids  roscect ive ly ,  
and are  cons ide rab ly  longer than ta i l  3 (D M P P  E and F), wh ich  cons is t  of 
onty twa amino ac id rdaidues. Ac  mentioned earl ier, sevaoa l  s tud ies  have 
shown ttiat ta i l  dom ains of the d iffere  nt DMPK ^ o fo rm s  influence acti  v- 
ity of thn photein Dinase domrin , or its sdbstra td  epec if ic ity  (1S9, °9 6 ) .  
Furthermore, C-term ina l ta i ls  are  involved targeting of DMPK isoforms to 
a specif ic  su b c e l lu la r  localization.
In mouse, DMPK ta i l  1 induces ER  localization, p resence  of ta i l  2 
resu lts  in targeting to the MOM and a cy toso l ic  loca l ization is observed 
for ta i l  3 (Fig. 4A-C) (286, 296). It has been found that a l l  information 
n e c e s s a r y  for targeting to the ER  is present in the ta i l  1, w h e re as  for tai l  
2, add it iona l  p resence  of the co i led-co il  region is a requisite  for proper 
MOM targeting (286). Unlike ta i l  3, wh ich does not contain targeting in­
formation (Fig. 4C), ta i l  1 and 2 anchor  f irmly at their target  m embranes.  
A lthough there is strong homology between m ouse  and human DMPK 
genes,  a spec ie s  d if fe rence  w a s  observed  for iso forms A and B: mouse 
DMPK A and B target  to the ER, the human ortho logues are  loca l ized at 
the MOM (Fig .  4D and E). Fu rthermore, t rans ien t  express ion of hD M PK  A 
induces m itochondr ia l  c luster ing around the nucleus, u lt im ate ly  leading 
to ce l l  death. Express ion  of mouse and human DMPK C and D a lso  resu lts  
in localization to the MOM, but g ives not rise to per inuc lea r  m itochondria l  
c luster ing (286). Computer an a lys is  revea led  hydrophobic regions in tai l 
1 and 2, c lass ify ing  them as m em brane  anchors.  This spec i f ies  long iso ­
form s A-D as ta i l-anchored  (TA) proteins. It is s t i l l  uncerta in  in wh a t  way  
DMPK isoforms are  integrated in the lipid b ilayer (this thes is )  and if they 





























TA proteins are  def ined by a oytosolio  N-term ina l  domain and a stre tch  
of hydrophobic  res idues  in the C-term ina l  region, wh ich a l lo w s  anchoring 
in the phospholip id  b ilayer of m e m b ran e s  (18, 19, 222). TA prote ins occur
at a l l  m em branes  of the ce l l  and play key ro les  in numerous ce l lu la r  
p rocesses  including ve s icu la r  t ranspo r t  (119, 122), protein trans locat ion  
(69, 254) and apoptos is  (137).
W ith  the N-term ina l  bulk of the protein located in the cytosol,  TA 
proteins are  bound to the m em brane  by an anchor  that is usua l ly  located 
within 30 amino ac id s  from the N-terminus. TA proteins do not contain 
a s igna l  sequence, and s ince  the hydrophobic region em erges  from the 
r ibosome upon term ination of t rans la t ion , TA proteins are  not subject  to 
co - trans la t io na l  t rans loca t ion  (18). Som e of these  fea tu res  distinguish 
them from type II t r an sm e m b ra n e  proteins, wh ich  a lso  expose their N- 
te rm inus to the cy toso l  but contain a m em brane  anchor  c lo se r  to their
• 5. Tail-anchored proteins
N-terminus. Fu rtherm ore, type II t r an sm e m bra ne  proteins are  c o t r a n s- 
lat iona l ly  t rans loca ted  w ithout contain ing a c le a va b le  s igna l  sequence. 
Recent pi si pers h a g e sho wn th ag Sh e m a x im a  I n u mb er of hy d rophilie amino 
ac ids  that can lie appended to the m em brane  anchor  without hampgring 
m sm b rae e  t rans loca t ion  can reach up to 85 res idues, a lthough one must 
bear in mind that extending the C-term ina l  po lar  domain w i l l  eventua l ly  
resu lt  in type II t rans loca t ion  (18, 24, 47).
Using truncation an a lys is  it has been shown that targeting in fo rm a­
tion required for t rans loca t ion  of TA protein through their ta rge t  m e m ­
brane is contained within the C-term ina l  region (24, 207, 209). Although 
TA proteins end up in many c e l lu la r  m em branes  they init ia lly  only target 
to a limited number of mem branes .  A few TA proteins are  ab le  to anchor 
in mult ip le  m em branes ;  mitofusin 2 (55 ) and Bc l2  (141), for example, can 
target  to ER  or MOM. To reach  different com p artm en ts  of the secre to ry
Figure 5 • Routing of TA 
proteins in animal cells.
W h en  re leased  from  the 
ribo som e a TA protein 
(s tru c tu re  w ith  b lack  N-end 
and grey C-end) can  insert 
into the ER  (1 ). T ranslocation  
to o ther co m p a rtm en ts  of 
the endo-exocytic  p a th w ay  is 
a ch ie ve d  by v e s ic u la r  tra n s ­
port (do tted  b lack  a rrow ). 
Targeting  to the MOM (2 ) or 
the perox isom a l m em b rane 
(4 ) is  a lso  d irect, a lthough  
an a lte rn a t ive  w a y  for TA 
p ro te ins  to reach  the perox i­
so m e is v ia  insertion  into a 
sp ec ia lized  ER  subdom ain  
(3 ), fo llo w ed  by m aturation  
of th is  subd om a in  into a 
fu lly  d eve loped  perox isom e 
(do tted  grey arro w ). In 
p lants, TA p ro te ins  a lso  d i­
rec tly  target to ch lo ro p las ts . 
A dap ted  from  B o rg ese  et 
a l (1 8 ). ~
Figure 6 • TA features 
determine targeting of TA- 
proteins to the ER, MOM or 
peroxisomes.
O rg ane lle-sp ec ific  targeting  
of TA-proteins, w h ich  d e ­
pends m a in ly  on the length 
of the  h yd rophob ic  stre tch  
and p re sence  of flanking  
cha rg ed  am ino  ac ids. TA 
pro te ins a re d ep ic ted  w ith 
a fo lded  c y to so lic  d o m a ir 
fo llo w ed  by a var iab ly-  
sized hyd ro phob ic  dom ain 
(rounded  grey rectang le ). 
Charged res id ues  flank ing  
the  h yd ro phob ic  dom ain 
a re ind icated  as  + and -. 
(A ) A short hydrophob ic 
d om ain  flan ked  by pos itive ly  
cha rg ed  res id ue s  d rive s  TA 
p ro te ins  to the MOM. (B/C ) 
Lo ss  of e ithe r of these  fe a ­
tu re s  - a  short hyd rophob ic 
dom ain  or flank ing  ch a rg ec  
re s id ue s-  re su lts  in ta rg e t­
ing to the  ER. (D ) C-term ini 
w ith  in te rm ed ia te  fe a ­
tu res  - s lig h t ly  lengthened  
hyd rophob ic  dom ain  and/ 
or reduced  p ositive  ch a rg e-  
induce targeting  to either 
the MOM or ER. (E )  For 
tra n s lo ca t io n  to perox isom es, 
a short h yd ro phob ic  dom ain 
is flan ked  by a m oderate 
p ositive  charge . Seq u en ce-  
sp ec ific  fe a tu re s  like  a 
recogn ition  seq u en ce  (b la ck  
o v a l)  fa c ilita te  d ire ct in se r­
tion into the perox isom e 
(E ). A dap ted  from  Borgese  
et a l (20).
pathway, TA proteins fi rst  insert into the ER  and via v e s icu la r  t ransport  
t ran s loca te  to their f ina l  destination (Fig. 5). How this journey  is e f fe c tu ­
ated is determ ined  by the lipid compos it ion of the d if ferent m e m b ran e s
in de secre to ry  pathw ay  i.e., by the ch o les te ro l  concentra t ion (18, 24)
E R
together with the: length and hydrophobic ity  of the m em brane  anchor  
(20, 27). Overa l l  in an im a l  ce l ls ,  TA proteins e ither insert into the ER 
m em brane ,  MOM, and in soma c a s e s  d irect ly  into Ihe  perox isom a l  m e m ­
brane (F ig .5) (18, 20). In tine fo llowing sect ion poss ib le  m ech an ism s  and 
anchoring requ irements  w i l l  be fu rther d iscussed.
• 5.1. Targeting to the ER membrane
Although ER  targeting requ irements  are  var iab le ,  targeting to the ER is 
control led  by a re la t ive ly  long (>20 amino ac id s )  s t re tch  of hydrophobic 
res idues  with high hydrophobic strength, f lanked by a v a r iab le  amount 
of charged  res idues (Fig. 6) (20). Insert ion of TA proteins into the ER 
m em brane  is d irect and an ATP-dependent process, although the amount 
of ATP required for m em brane  insert ion d iffers between dif ferent TA pro ­
teins. Cytochrome b5 is ab le  to insert into p rotease- treated  m ic rosom es  
in the near ab sence  of ATP, wh i le  addit ion of ATP does not inc rease  inte­
gration into the ER m em brane  s ign if ican t ly  (24, 305). It is hypothesized 
that this ab il i ty  to independently  insert into the ER m em brane  requires 
an ER m em brane  anchor  with a more moderate  hydrophobicity. Such  an 
a r rang em ent  w i l l  give the protein higher so lub il i ty  in the cy toso l  (18). TA 
proteins with a highly hydrophobic tail, like synaptobrev in  2 (Syb2), are 
more prone to form aggregates  in the cy toso l  and therefore  need ATP 
consuming chaperones  to remain so lub le  and to insert  properly  into the 
m em brane  (24, 155). Interestingly , the ER m em brane  has been shown to 
be the most perm iss ive  m em brane  for accepting  TA proteins. TA proteins, 
in vivo targeted to the MOM, a re  ab le  to insert into m ic ro so m es  in v i ­
tro, demonstrat ing  that ER m em brane  is ca p a b le  of taking up many TA 
proteins when it does not need to compete with other m e m branes  (18).
TA proteins that target  to the peroxisome can a lso  t rave l  via the 






























for Pex15p and asco rba te  perox idase (66, 142, 203). A lte rnat ive ly ,  direct 
perox isom a l  targeting w a s  found for Pex26 and hF is  via binding to the 
Pex19 recep tor (Fig. 5) (99, 108). Surpris ingly ,  the ta i l  domain in peroxi­
som e-targeted  TA proteins has only mild hydrophobic ity  and con ta ins a 
posit ive ly  charged  C-terminus (Fig. 6) (18).
The dependence on ATP for ER targeting usua l ly  suggests  a need for 
m o lecu la r  chaperones ,  although for the m ajor ity  of c a s e s  it is not known 
wh ich  chape rones  a re  involved. S e v e r a l  w a ys  of insert ion have been 
investigated and it w a s  shown by High's group, that together with ATP or 
GTP the s igna l  recognition part ic le  ( S R P )  could interact with Syb2 and 
Sec61ß,  and in this way  w a s  involved in insert ion into the ER mem brane  
(1). These resu lts  are  con trovers ia l ,  however, and not supported by other 
groups who showed dependence on ATP but not GTP or the S R P  (155, 264, 
265). Another interaction that fac i l i ta te s  ATP-dependent integration of TA 
proteins invo lves m o le cu la r  chaperones  Hsp40 and Hsc70 (2). Finally, 
the most wel l-def ined  targeting fac tor is the 40 kDa cy toso l ic  protein 
Asna-1/TRC40, a protein with ATPase  activ ity. Asna-1 can interact post- 
t ran s la t io n a l ly  with the m em brane-anchor ing  region of TA proteins and 
thereby de l ive r  the protein to a prote inaceous  recep tor at  the ER  m e m ­
brane (265).  Express ion  of A T Pase-de fec t ive  m utants  of A sna  resulted 
in an inhibitory e ffect  on TA protein insert ion, but did not inf luence other 
trans loca t ion  pathways. This dem onstra tes  that invo lvem ent of ATP hy­
drolysis  is essen tia l .  Based  on these  findings a m echan is t ic  model w as  
proposed, w hereby  a receptor on the ER m em brane  s t im u la te s  Asna-1 
ac tiv ity , a l low ing  re lease  of the TA substra te  and insert ion of the m e m ­
brane anchor  into the m em brane  (265). Recently, a yeast  homologue for 
Asna-1, Get3 w a s  identified wh ich  showed s im i la r  ch a ra c te r i s t ic s  and 
w a s  found to fac i l i ta te  TA protein insert ion via binding to the ER  receptor 
complex Get1/Get2 (114, 189, 251, 268).
Inc reas ing  know ledge  of m em brane  anchoring and underlying ta rg e t ­
ing m ech an ism s  of TA proteins is of great  va lue  in understanding the 
d istribution and ch a ra c te r i s t ic s  of DMPK isoforms. Not much w a s  known 
regard ing DMPK m em brane  anchoring at  the s ta r t  of this thes is  period.
• 5.2. Targeting to the MOM
The genera l  consensus  for MOM targeting is dependent on a m em brane  
anchor  of m oderate  hydrophobic ity , flanked by bas ic  amino ac ids  (Fig. 6). 
Although exceptions exist (7), a B x 0-9Bx0-2-TMD-x0-1Bx0-6B (w h e re  B s tands  
for bas ic  res idues  and x for any amino ac id )  con sensu s  sequence  has 
been proposed (137). Correct  positioning of each residue in this sequence 
is e ssen t ia l  as  it w a s  found that a ltering e ither one residue - f.e. by d e le ­
tion of posit ive cha rges  or increas ing  TMD length - leads  to decreased  
MOM binding or even rerouting to the ER  (18, 61, 113, 119). S t i l l ,  p red ic ­
tions so le ly  based  on hydrophobic ity  and charge  of re le van t  sequences  
may not be a c cu ra te  and add it iona l  s ignals ,  probab ly  in the N-terminus 
of the protein, contribute to targeting (3, 118, 257).
S in ce  t rans loca t ion  to the MOM is d irect and does not occur  via the 
ER  (18) (Fig. 5), the quest ion has been ra ised  w hether  the c la s s i c a l  
m itochondr ia l  t rans loca t ion  m ach ine ry  (i.e., TOM com plex )  is involved 
in insert ing TA protein into the MOM. The an sw e r  cam e  from two recent 
stud ies  in m am m a l ian  and yeas t  ce l ls ,  wh ich  revea led  that targeting of
Figure 7 • DMPK, activators 
and substrates.
Sc h e m e  of know n activa to rs  
and su b s tra te s  of DMPK. 
Su b s tra te s  a re fu n ctio n ­
a lly  ca tego rized  into three 
groups of c le a r ly  d istinct 
b io lo g ica l s ig n ifican ce : i or 
h o m eo sta s is  (lig h t grey), 
actin  cy tosk e le ton  (m ed ium  
grey), and sp lic in g  (dark  
grey). A lso  the  pathogen ic  
pheno types that m ay be 
a s so c ia ted  w ith  DMPK 
su b stra te  d ysregu la tion  are 
dep ic ted . A b b rev ia tio ns : PLM 
= p hospho lem m an , PLN = 
p hospho lam b an , DH PR  = d i­
hyd ropyrid ine  receptor, SkM 1 
= s k e le ta l m u sc le  vo ltage- 
gated  sod ium  ch a n n e l 1, 
S R F  = se ru m  response 
factor, M YPT = m yosin  phos­
p h atase  targeting  subunit, 
CU G -BP  = CUG binding 
protein, M K B P  = DMPK 
b inding protein, H SP25/B1  = 
heat sh o ck  prote in 25/B1, 
a B- C rys t. = a B- C ry s ta llin .
se ve ra l  TA proteins o ccurs  independent of the TOM trans loca t ion  m a ­
chinery . A bsen ce  of m u lt ip le  com ponents  of the TOM com plex  in e ither
system  did not interfere with MOM targeting, suggesting the existence 
of a fu lly  independent m ach ine ry  for MOM t rans loca t ion  (138, 254). In
the m am m a l ian  ce l l  system  MOM targeting w a s  independent of ATP and 
cy toso l ic  m o le cu la r  chaperones,  even though in som e situat ions ch a p e r ­
ones could fac i l i ta te  integration. Presum ab ly ,  this w a s  caused  by folding 
requ irem ents  of the N-term ina l  domain of the TA proteins (254). In yeast  
m em brane  composit ion influenced TA protein integration, s ince  e levat ing  
ergos tero l  le ve ls  inhibited m em brane  insert ion (138). In sum m ary ,  MOM 
targeting is determ ined  by the compos it ion of the TA protein 's C-term inus 
and by m em brane  lipid composit ion. M o lecu la r  chape rones  may f a c i l i ­
















• 6. DMPK substeates and function
DMPK re sea rch  over the oears has provided a limited number of c lues 
for the protein's b io log ica l  s ignif icance. Direct and indirect ev idence is 
a va i lab le  for a role in actin  cytoske leton dyn am ics  and ion homeostas is ,  
as  w i l l  be descr ibed  below.
• 6.1. DMPK and actin-myosin dynamics
DMPK fam ily  m em bers  MRCKs, ROCKs and CRIK play a role in actomyosin 
cytoske leton dynam ics ,  in p rocesses  like ce l l  motil ity, cytok ines is  and 
m usc le  contract ion. In these ac t iv i t ie s  these  enzymes are  under the 
control  of m em bers  of the fam ily  of s m a l l  GTPases, Rho, Cdc42 and Rac 
(74, 92, 173, 232). Based  on these  findings, an ana logous  s ituation was  
pred icted  for DMPK, but based  on sequence  homology, D M PK  does not 
contain a typ ica l  GTPase  binding domain. N ever the less ,  Rac invo lvement 
in phosphorylat ion and act iva t ion of DMPK w a s  reported in one study 































protein ac t iva to r  GTP-y -S, its ac t iv i ty  w a s  inc reased  by about a factor 
two com pared  to that of DMPK iso la ted from non-treated ce l l  (29). Fu r ­
thermore, DMPK can a lso  be phosphoryla ted  and ac t iva ted  by Raf kinase, 
the Ras-ac t iva ted  enzyme in the M A P  kinase pathw ay  (Fig. 7) (255). Thus, 
co l lec t ive ly ,  these  f indings point to invo lvem ent of G-protein s ignal ing  in 
the regulat ion of DMPK activ ity. W h a t  then are  the b io log ica l  functions 
that are  promoted by DMPK ac t iv i t y ?  The a n s w e rs  on this quest ion are 
l ess  c le a r  than for the other k inase fam ily  members.
S tud ies  using DMPK overexpress ion- and knockout mice revea led  
a ro le for DMPK in apoptotic  lens blebbing (130), improper traff icking 
of the insulin recep tor (169, 170) and d ec rem en ta l  synapt ic  long term 
potentiation (252). These e ffects  could a l l  be linked to regulat ion of the 
cytoske leton by DMPK, d irect ly  or indirectly, but fu rther work  is n e c e s ­
s a r y  to c la r i fy  this point.
Independently, there  is a lso  ev idence  to suggest  that e f fects  of DMPK 
on the actin  cytoske leton may be exerted via the myosin phosphatase  
targeting subunit  (M Y PT )  (Fig. 7). MYPT is a subunit  of myosin phospha ­
tase  involved in the phosphorylat ion s ta tus  of the myosin regula tory  light 
chain (M R LC )  (204, 287, 296). In a yeast-two-hybr id  sc reen  both MYPT 
and MRLC w ere  shown to bind DMPK (94), but DMPK only phosphorylated 
MYPT, not MRLC (94, 204, 296). In this manner,  DMPK ac t iv i ty  would  r e ­
su lt  in deact iva t ion of the myosin phosphatase  complex, thereby en h an c ­
ing the phosphorylated  state  of MRLC. In turn, increased  phosphorylat ion 
of MRLC promotes ac t in- f i lam ent  a s s em b ly  and enhances  actomyosin  
interactions, thus influencing m u sc le  contract ion, ce l l  shape  and size, 
s t re ss  fiber formation, cytok ines is  and apoptos is  (74, 232, 282). A role 
for DMPK in a l l  these p rocesses  is thus predicted, but fo l low-up studies 
are  c lea r ly  n e c e s s a r y  to es tab l ish  DMPK 's  ro le in ac to-myosin  based 
dyn am ics  more definitely.
• 6.2. DMPK and ion homeostasis
Altered  modula tion of ske le ta l  m usc le  vo ltage-gated  Na* channe ls  by 
DMPK has been proposed as  a poss ib le  m echan ism  underlying DM1 
pathogenesis  (37, 201). Exper im ents  in Xenopus oocytes have shown that 
coexpress ion of human DMPK together with ske le ta l  vo ltage-gated  Na* 
channe ls  resu lted in a s ign if icant ly  low er  peak Na* current am p l itude  and 
a c ce le ra ted  current decay, in a phosphorylat ion dependent m anner  (37, 
201). Surpris ingly ,  coexpress ion of DMPK and the ca rd iac  vo ltage-gated  
channel,  contain ing an identica l  phosphorylat ion site, did not a lte r  Na* 
cu rrents  (37). In sk e le ta l  m usc le  and ske le ta l  m yocy tes  of homozygous 
and heterozygous DMPK KO mice reduced Na* current am p l itude  and 
increased  Na* channe l  reopening were  found, reproducing Na* channe l 
a b n o rm a l i t ie s  found in DM1 (79, 195, 200, 226). S in ce  com p le te  heart 
b lock and sudden ca rd iac  death a lso  occur in DM1, Na* cu rrents  in 
hea rts  of homozygous and heterozygous DMPK KO mice w ere  investigated 
thoroughly, showing mult ip le  late reopenings of Na* channe ls  s im i la r  to 
those  seen in D MPK-def ic ient  ske le ta l  m u sc le  (162). These data provide 
ev idence  for the invo lvement of DMPK in sym ptom s like myotonia  and 
ca rd iac  abno rm a l i t ie s ,  but m ech an is t ic  deta i ls  in these p ro ce sse s  r e ­
main unsolved.
A nother DMPK target, wh ich  is a cand idate  for being involved in myo-
tonia is phospho lem m an ( P L M )  (Fig. 7), a protein main ly  expressed  in 
heart , ske le ta l  m usc le  and liver. PLM  functions as  a regulator of the Na*/ 
C a2* exchanger and Na*/K* A TPase  (90). Upon expression in Xenopus oo­
cy tes  it induces Cl- currents ,  wh ich are  lowered upon coexpress ion with 
DMPK. This happens in a phosphoryla t ion-dependent m anner  and is the 
resu lt  of a reduced amount of PLM  at the oocyte m em brane  (199). In DM1 
patients, the P L M -D M P K  interaction can be an a l te rna t ive  explanation for 
reduced Cl- conductance  and occurrence  of myotonia. Furthermore, PLM 
is assoc ia ted  with heart fa i lure, suggesting a poss ib le  invo lvement of 
DMPK in DM1 re lated a tr io ven t r icu la r  block (15).
It has fu rthe rm ore  been proposed that DMPK is involved in vo l t ­
age-dependent C a 2* re le a se  in muscle .  In DM1 patient m u sc le  c e l l s  an 
increased  cy top lasm ic  ca lc ium  concentra t ion ( [C a2*]c) w a s  observed, 
caused  by an increased  influx of C a 2* through the vo ltage-operated  
n i fed ip ine-sensit ive  C a 2*, i.e., the dihydropyridine receptor (D H PR )  (Fig. 
7) (121). In m yotubes  der ived from D M PK  KO m ice  a l so  an e levat ion  in 
[Ca2*]i w a s  observed, l ikely due to an a lte red  "open” probab il i ty  of the 
DHPR, rem in iscen t  of the sym ptom s found in DM1 pat ients  (13). In te res t ­
ingly, DMPK KO myotubes we re  found to have a reduced response  upon 
triggering by ace ty lch o l ine  compared  to their wild type counte rpa rts  (13). 
This could  be a d irect e ffect  of D M PK  on the DHPR  s ince  the ß -su bu n it of 
the DHPR might be a phosphorylat ion substra te  (277).
E a r l ie r  s tud ies  in ca rd iac  m usc le  from DM1 patients and DMPK KO 
m ice suggested that DMPK is c r i t i c a l  in the modula t ion of ca rd iac  co n ­
t rac t i l i ty  and m a in tenance  of proper ca rd iac  conduction (16, 101). S u p ­
port for this idea cam e when DMPK w a s  found highly enr iched at the 
sa r co p la sm ic  ret icu lum ( S R )  where  it co lo ca l izes  with the ryanodine 
receptor and phospho lam ban ( P L N )  (Fig. 7). PLN, the m usc le-sp ec i f ic  SR 
C a2* ATPase  ( S E R C A 2 a )  inhibitor, w a s  capab le  of phys ica l ly  interacting 
with DMPK (134). In vitro experiments  have shown that DMPK can use 
PLN as a substra te  for phosphorylat ion, a finding wh ich  is consistent  
with the prediction of a phosphoaccepto r  site in PLN by W ans ink  et a l  
(134, 296). W h e n  hypophosphory la ted , PLN  b inds and inhib its  S E R C A 2 a ,  
thereby impair ing C a2* sequestra t ion  into the SR. Exac t ly  this w a s  found 
in ve n t r icu la r  hom ogenates  of D M PK  KO m ice  (134). Taken together, these 
f indings suggest  that DMPK may be involved in the regulat ion of initial 
events  that govern exc ita t ion-contract ion coupling in ske le ta l  or ca rd iac  
m u sc le s  (13, 134).
• 6.3. A lternative DMPK effectors
An a l te rna t ive  ac t iva to r  of DMPK may be DMPK binding protein (M K BP ) ,  
wh ich is localized in the cy toso l  and a lso  found enriched in the neu ­
r o m u scu la r  junct ions of ske le ta l  m usc le  (Fig. 7) (218, 269). M K B P  is 
thought to be involved in s t r e s s  response  in muscle .  M K B P  binding to 
DMPK and its se le c t ive  upregulat ion in DM1 patients could thus be in­
volved in DM1 pathogenesis  (269, 297).
In a study using m a ss  spectrom etry ,  DMPK interacting proteins were  
found wh ich  comprise  parts  of the con tract i le  and m yof ib r i l la r  m ac h in ­
ery, or are  either m itochondr ia l  proteins, heat shock  proteins or other 
proteins (78). Like MKBP, proteins involved in s t r e s s  response  have been 





























H S PB 1 )  (78). Although it r em a ins  to be determined if these proteins are 
e ffectors  or a c t iva to rs  of DMPK, it can be specu la ted  that they are  ef­
fec to rs  like M K B P  (Fig. 7).
Serum  response  factor (S R F ) ,  a protein known to regulate  a-act in  
gene t ranscr ip t ion w a s  identif ied as  DMPK interacting protein. A lthough 
we know that DMPK is ab le  to phosphory la te  S R F  in vi tro  and in vivo, 
thereby increas ing  its ac t iv i ty  in C2C12 m yob las ts  and non-myogenic  ce l l  
lines, not much is known about the s ign i f icance  of this interaction. A role 
in upregulat ion of c a rd iac  and ske le ta l  a-act in  gene expression has been 
proposed (Fig. 7) (120).
Sp l ice  and p rocess ing  factor CUG-BP1, d iscussed  above as  the factor 
that binds to the expanded (CUG)n repea t  of DMPK t ranscr ip ts ,  may also 
be under the con tro l  of D M PK  (279).  Identif ica tion of CUG-BP1 a s  a d irect 
phosphorylat ion substra te  for DMPK (Fig. 7) (233),  adds another layer of 
comp lex ity  to D M PK  bio logy and to the DM m o le c u la r  pathogenesis .  One 
model w a s  proposed, in wh ich  the leve ls  of DMPK itself  are  decreased ,  
result ing in a hypophosphory la ted  state  of CUG-BP1. In turn, this may 
lead to an accum ula t ion  of CUG-BP1 in the nucleus, thereby affect ing 
proper p rocess ing  of m u lt ip le  m RNAs ,  ult imate ly  leading to inhibition of 
m yogenes is  (157, 233, 248, 280). S in ce  CUG-BP1 protein l e v e ls  in DM1 
patients are  g loba l ly  increased, this could a lso  be an e ffect of a ltered 
phosphorylat ion. On the other hand it has been found that CUGBP1 is 
hyperphosphory la ted  in DM1 by PKC, increas ing  CUGBP1 protein ha lf ­
l ives  (156). S tud ies  with a CUG-BP1 overexpress ing  mouse m odel have 
now demonstrated  m issp lic ing  of the insulin receptor,  ca rd iac  troponin T, 
myotubu la r in-re la ted  1 gene and the m u sc le-sp ec i f i c  ch lor ide channe l  1, 
leading to sk e le ta l  m u sc le  and heart featu res  typ ica l  of DM1 (110, 248). 
Abn o rm a l  CUG-BP1 regulat ion is thus becoming a prominent cand idate  
m echan ism  for explaining DM pathobiology. The question w hether  this 
ab no rm a l  regulat ion is uniquely caused  by repeat RNA-based  toxicity, or 
w hether  ab no rm a l  phosphorylat ion of CUG-BP1 could have an addit ive 
role, is subject  for fu ture studies.
• 7. Aim and outline of this thesis
The d iscove ry  that (CTG)n repeat expansion in the DMPK gene is the root 
cause  of DM1 pathology w a s  the s ta r t  for an intense sea rch  for under ly ­
ing d isease  m ech an ism s  in many labora to r ies  in the world. The aim of 
the study descr ibed  in this PhD thes is  is to concen tra te  on the poss ib il i ty  
that not only toxic expanded D M PK  m R N A  con tr ibutes  to DM1 p a tho ­
genesis  via m e ch an ism s  descr ibed  above (Sect ion  2, this chapter) ,  but 
that there could a lso  be an assoc ia t ion  with ab no rm a l  protein isoform 
production from the m utant and no rm a l  D M PK  genes.  To put this on more 
solid ground than mere speculat ion, the stud ies  in the different chap ters  
focus  on d if ferent a s p e c ts  of D M PK  biology.
First, we needed better insight in the in t race l lu la r  and ce l l-  and 
t issue-type  d is tr ibution of d if ferent D M PK  gene products  (i.e., m R N A  and 
protein). In Chapter 2, we  descr ibe  how we analyzed the expression pro ­
f i les and d istribution of long and short DMPK isoforms in va r ious  m usc le  
types and brain regions, the t issues  that are  most a ffec ted  in DM1. Spe-
cif ica lly, we report on deta iled  studies  on this topic in m usc le  and brain- 
derived ce l l  cu lture  sys tem s.  DMPK is considered  the first ta i l-anchored  
protein kinase. A lte rna t ive  sp lic ing of p recursor  DMPK m RN A  gives r ise to 
mult ip le isoforms, encoding k inases  with different C-term ina l m em brane  
anchors.  Chapter 3 d escr ibes  how s t ru c tu ra l  requ irem ents  for mem brane  
targeting of these  C ta i ls  and the m em brane  anchoring topology and 
dynam ics  of the ent ire protein were  studied. In Chapter 4, we report  
on the finding that overexpress ion of the hDM PK A isoform resu lts  in 
m itochondr ia l  c lustering. The region respons ib le  for this c luster ing w a s  
identified and the phys io log ica l  con sequ ences  assoc ia ted  with this m ito ­
chondr ia l  c luster ing we re  analyzed. In Chapter 5, we provide ev idence  for 
a link between the ac t iv i ty  of ind iv idual  DMPK iso forms and cy toso l ic  and 
m itochondr ia l  C a2* handling in myotubes. In the s am e  chapter, we also 
report on poss ib le  inf luences that D MPK-based  changes  in C a2* handling 
have on the ce l lu la r  energy state. F ina lly , Chapter 6 su m m ar izes  our f ind ­
ings, explaining how resu lts  from our studies  provide more insight in the 
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Myotonic dystrophy type 1 (DM1) is a neu ro m uscu la r  d isorder caused 
by an unstab le  (CTG^CAG)n segm ent in the 3' un trans la ted  region of the 
DM protein kinase (D M P K )  gene. It is com m only  accep ted  that DMPK 
m RN A-based  toxicity is the main contributor to DM1 m anifes ta t ions, 
how ever  not much is known about the s ign i f icance  of the DMPK protein. 
To apprec ia te  its norm a l  and poss ib le  pathob io log ica l  role, we  analyzed 
the pat terns  of DMPK sp l ice  isoform expression in mouse t issues. Long 
m em brane-ancho red  DMPK dominated in heart , d iaphragm and sk e l ­
e ta l  muscle ,  w h e re a s  short cy toso l ic  iso forms were  highly expressed 
in b ladder  and stomach. Both isoform types we re  p resent in d iverse  
brain regions. DMPK protein w a s  a lso  detec tab le  in cultured m yob lasts ,  
myotubes, co r t ica l  a s t ro cy tes  and re lated ce l l  l ines of neura l  or m usc le  
origin, but not in h ippocam pa l  neurons. This work  identifies DMPK as a 
kinase with pronounced expression in d iverse  m usc le  and neu ra l  t is sues  
that a re  a ffected in DM1.
• INTRODUCTION
Myotonic dystrophy type 1 (DM1) is a complex, m u lt isys tem ic  d isorder 
wh ich  a f fec ts  many t issues  including ske le ta l  muscle ,  heart, g a s t ro ­
intest ina l  t rac t  and brain (101). The d isea se  is caused  by ce l l  type- 
spec i f ic  expression of an ab n o rm a l  (CTG^CAG)n segm ent  located in the 
3' un trans la ted  region of the DM protein k inase (D M P K )  gene (94). The 
(CTG^CAG)n segm ent expands over generat ions in DM1 fam i l ie s  and in 
som at ic  t i s sues  during aging. In t i s sues  like m u sc le  and brain, (CUG)n- 
expanded t ran sc r ip ts  become trapped in ce l l  nuclei,  forming abno rm a l  
RNA protein aggregates  (300). The aggregation p rocess  -or ear ly  s teps 
there in- is considered  to be the main contributor to d isease  problems, 
because  it com prom ises  transcr ip t ion  or p rocess ing  of spec i f ic  m R N A s  or 
exerts g loba l  ce l l  s t r e s s  (65, 300). N ever the less ,  it rem a ins  to be seen 
w hether  a l l  d isease  aspects ,  including the se le c t ive  m usc le  wast ing  and 
lo s s  of endocr ine  function, can  be expla ined by the RNA toxicity model. 
There may a lso  be a causa t ive  ro le for an im ba lance  in DMPK protein 
l eve l  or isoform distr ibution as  wel l .
There  is cons ide rab le  con troversy  about the fate and role of DMPK 
protein in t i ssues  of patients with DM1 (sum m arized  by W ans in k  et al. 
(297, 298)). Moreover,  c i r cu m sta n t ia l  ev idence from an im a l  and ce l l  
model s tud ies  connects  DMPK to prob lem s s im i la r  to those in DM1 m an i ­
festation. Lack  of DMPK in knockout (KO) mouse m ode ls  a f fec ts  heart  
physiology (16, 126), v iab i l i ty  and ca lc ium  regulat ion in sk e le ta l  musc le  
ce l ls  (13, 200) and intermediate  m em ory  potentiation in brain (252). In 
addition, our group dem onstra ted  that overexpress ion of hDMPK gene 
products  resu lts  in hypertrophic  cardiomyopathy, c a rd iac  dysrhythmia, 
myotonia  and hypotensic  s t re ss  (126, 211).
DMPK protein occurs  a s  six major sp l ice  isoforms, named A-F, in 
man and mouse (95). Mouse DMPK A and C, the prototype long C-tailed 
isoforms, loca l ize  to the end op lasm ic  re t icu lum  ( E R )  or m itochondr ia l  
outer m em brane  (MOM), respec t ive ly  (296). Strikingly, the human DMPK 
o r tho logues of these  iso form s both loca l ize  to the MOM (286). Forced 
expression of the human DMPK A isoform in different an im a l  and human 
ce l l  types a l te rs  m itochondr ia l  morphology, leading to per inuc lea r  ag g re ­
gation of mitochondria  with poss ib le  consequences  for ce l l  dynam ics  or 
v iab i l i ty  regulat ion (Oude Ophuis et al., m anusc r ip t  in p repara t ion )  (286).
DMPK has been c lass if ied  as  a mem ber of a subfam ily  of the large 
group of AGC protein k inases, to wh ich a lso  ROCK-I/-II, M RC K a/ß /Y  and 
citron k inase belong (135, 232, 297). These k inases  have been implicated 
in smooth m usc le  contract ion, s t re ss  fiber formation, neuri te  retract ion 
and cytok ines is  (232, 260). DMPK has a presumed role in modula t ing 

































































































of myosin phosphatase  (M Y PT )  (204, 296). A lte ra t ions  to the cytoskeleton 
induced by DMPK are  implicated  in traff ick ing of the insulin recep tor to 
the ce l l  membrane ,  indicat ing inc reased  suscep t ib i l i ty  of DM1 patients to 
type II d iabetes (170). In addition, DMPK is engaged in ion homeostas is ,  
regulat ing C a2*, Na* and Cl- currents. Through direct interact ions with 
phospho lam ban and phosphorylat ion of the ß-su bu n it of the d ihydropy­
rimidine receptor,  DMPK is involved in the regulat ion of C a2* t rans ien ts  in 
heart  and ske le ta l  m usc le  (134, 135, 277).
To fu lly  unders tand  DM1 d isease  etio logy at both the RNA and protein 
leve l  it is important to have a deta iled  picture  of t issue  and ce l l-type 
dis tr ibution of a l l  D M PK  gene products. In an in situ hybridization study 
on mouse t issues  by Reddy and co-workers ,  it w a s  shown that DMPK 
m RN A  is expressed  in many, but not a l l  t i s sues  w here  DM1 becomes 
manifes t.  The focus w a s  main ly  on finding co rre la t ions  between t issue- 
spec i f ic  pathogenic e ffects  and the dose of expanded (CUG)n segments,  
p resent in a l l  DMPK sp l ice  va r ian ts  from the mutant a l le le .  Here, using 
a com p lem en ta ry  approach  at the protein level,  we  report on expression 
profi ling of DMPK iso forms in t i ssues  known to be prominently  involved 
in d isease  pathology.
• MATERIALS AND METHODS
• Mice and tissues
T issues  w ere  iso la ted from wild type (WT; 129O la/C57BL6 background),  
DMPK knockout (KO; 129O la/C57BL6 background) and Tg26-hDMPK (TG; 
Fvb background) m ice  generated in our labora to ry  (126). D irect ly  after 
ki lling the a n im a ls  by c e r v ic a l  d is location, the fo l lowing m u sc le - c e l l  
contain ing organ and t issue  sam p le s  w ere  ind iv idual ly  excised and snap 
frozen in liquid nitrogen: ventr ic le  and atr ium from heart , bladder, s to m ­
ach, d iaphragm and tongue, and so leus, gastrocnem ius ,  t ib ia l is  anter ior  
from the hind limb. L ikewise , from the bra ins of each of three mice, the 
cortex, brain stem, ce rebe l lum , hippocampus, str iatum, hypotha lam us 
and o lfactory  bulb regions we re  co l lec ted, snap-frozen and pooled. A lso 
the bra in-connected  p itu itary  gland w a s  iso lated. A l l  p rocedures  invo lv ­
ing an im a ls  we re  approved by the A n im a l  Care Committee  of the Radboud 
Un ivers ity  Nijmegen M e d ica l  Centre and conformed to the Dutch Council  
for A n im a l  Care.
• Primary myoblasts and myotubes
Condit ional ly  immorta l ized myogenic  ce l l  l ines w ere  derived from the 
ca lf  m usc le  complex from W T and KO mice harboring the H-2Kb-tsA58 
a l le le  a s  descr ibed  (197). W T  and KO m yob las ts  we re  ring cloned, and 
se lected  for myotube formation ability.  M yob lasts  w ere  propagated at 
33°C  on ge la t in-coated  d ishes in DMEM (G ibcoBRL ,  Gaithersburg , MD) 
supp lemented  w ith  2 0 %  (v/v) FCS, 50 pg/m l gentamycin  and 20 units 
IFN-Y/ml.  Myotube formation w a s  induced by p lac ing a confluent m yo ­
b las t  cu lture  grown on Matr ige l  (BD B iosc iences ,  the N e ther lands )  at 
37°C in DMEM supp lemented  with 5 %  horse serum (H S )  and 50 pg/ml 
gentamycin  and mainta in ing these condit ions for up to nine days.
• Primary hippocampal neurons and cort ical astrocytes
P r im ary  cu l tures  of co r t ica l  a s t ro cy tes  and h ippocam pa l  neurons were  
es tab l ished  essen t ia l ly  a s  descr ibed  (57, 128), Both ce l l  populat ions 
(>95% pure) d isp layed expected ch a ra c te r is t ic  morphologies. A strocy te  
identity w a s  verified by GFAP immunosta in ing (data  not shown).  P r im ary  
neurons we re  cu ltured w ithout an as t ro cy te  feeder layer and were  m a in ­
ta ined for up to ten days in culture.
• Estab lished cell  lines
Mouse  neuro-2A (N 2 A )  neu rob las tom a ce l ls ,  human SK-N-SH neu ro ­
b las tom a  ce l ls  and mouse C2C12 m yob las ts  we re  grown as  descr ibed 
e lse w h e re  (286, 295). Rat PC12 p heochrom ocytom a ce l ls  w ere  grown on 

































































































at 37°C and harvested  at ~ 7 5 %  confluence. Mouse CCL-131 neu ro b las to ­
ma ce l ls  were  grown for 2 days unti l subconfluent in MEM supplemented 
w ith 10% FCS at 37°C and 5 %  CO2. CCL-131 ce l ls  we re  d if ferentia ted for 
48 hours in MEM supp lem ented  with 2 %  FCS  and 20 pM re tinoic acid 
(S igm a,  the N e th e r land s )  at  37°C and 5 %  CO2. Human U373 g l iob las tom a 
ce l ls  were  cu ltured in DMEM supp lemented  with 10%  FCS at 37°C and 
5 %  CO2 and harvested  at  ~ 7 5 %  confluence. Mouse HL-1 beating and non­
beating ca rd io m yo cytes  we re  cultured for 2 days until near conf luence 
(46, 217 ).
• Ana lysis of DMPK distribution by western blotting
Frozen m usc le  t issues  w ere  homogenized on ice in NP40 lysis  buffer (1%  
NP40, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 25 mM NaF, 1 mM sodium 
pyrophosphate, 0.1 mM vanadate ,  2 pM m icrocyst in ,  1 mM PMSF, 1x 
p ro tease  inhibitor co ck ta i l  (Roche,  Germany),  1 mM EDTA) including 1%
S D S  using a g la s s- g la s s  dounce homogenizer. Bra in t is sues  were  homog­
enized on ice in NP40 lysis  buffer. Lysates  w ere  c lea red  by centrifugation 
for 10 min at 14,000g at 4°C, and the resu lt ing superna tant  frac t ions  
w e re  mixed with S D S - P A G E  sam p le  buffer. M yob las t  and myotube or 
neuron and as trocy te  c e l l s  in cu lture  were  lysed in S D S  sam p le  buf­
fer d irect ly  or NP40 lys is  buffer, respect ive ly .  Lysates  were  c lea red  and 
mixed with sam p le  buffer a s  descr ibed  above.
Protein lysa tes  we re  separa ted  on 8 %  S D S - P A G E  gels and t ransferred  
by w es te rn  blotting to PVD F  m em brane  (M il l ipore , USA).  For im m unode ­
tect ion the fo l lowing antibodies  we re  used: DMPK-spec i f ic  antibody B79 
(95), m onoc lona l  DMPK antibody MANDM1 (159, 218), ß-tubulin antibody 
E7 (D eve lo p m en ta l  S tud ies  Hybr idoma Bank, Un ivers ity  of Iowa, USA), 
pyruvate  k inase antibody (Rock land ,  G i lber tsv i l le ,  USA ),  G FP  antibody 
(52). To d ec rease  the background on blots using the B79 antibody, BSA  
( 3 %  (w /v ) )  and lysate  of DMPK KO m yob las ts  were  added to the block ing 
buffer. As  seco n dary  antibody, HRP-conjugated  I g G ( J a c k s o n  ImmunoRe- 
se a rch  Laborator ies ,  UK) w a s  used, and s igna ls  were  generated by ECL, 
fo l lowed by exposure to fi lm (Kodak X-OMAT AR).
• Immunoprecipitation
W ho le  bra ins from WT, KO and TG mice w ere  homogenized on ice in NP40 
lys is  buffer. Lysates  we re  c lea red  by centr ifugation for 10 min at 14,000g. 
DMPK protein in a sam p le  equa l  to half  the c lea red  homogenate  of one 
brain of pos tna ta l  day 0 (~1.5 mg protein, determined as  descr ibed  (23))  
w a s  immunoprecip itated  using DMPK antibody B79 (95), coupled to pro ­
tein A - Seph aro se  beads. Im m unoprec ip i ta tes  were  w ashed  in NP40 lys is  
buffer, and bound proteins w ere  solubil ized in S D S- P A G E  sam p le  buffer 
and analyzed by S D S- P A G E  and weste rn  blotting.
• Transduction
For trans ien t  expression of Y FP - m D M P K  A, C and E, adenov ira l-vec to r  
mediated gene t ran s fe r  of p r im ary  neurons, p r im ary  as trocy tes ,  m yo ­
b las ts  and myotubes w a s  performed in DMEM for 3 hours at 33°C for 
m yob las ts  and at  37°C for other ce l l  cu ltures. Deta i ls  of the t r a n s d u c ­
tion procedure have been given in van Herpen et al. (286) Three hours 
a fte r  addit ion of recom binan t vi rus, fresh new medium with composit ion
as indicated w a s  added, and cu l tu res  we re  mainta ined for 20-48 hours.
• Immunofluorescence microscopy
C e l ls  were  grown on g la ss  covers l ips ,  coated with gelatin (myob las ts ) ,  
Matr ige l  (m yotubes )  or poly-L-lysine (S igm a; neurons and as trocytes ) .  
Myob lasts ,  neurons and a s t ro cy tes  were  washed  once with phosphate- 
buffered sa l ine  ( P B S )  and fixed in P B S  contain ing 2 %  (w/v) fo rm aldehyde  
20-48 hours a fte r  transduct ion  and perm eabil ized  in P B S  contain ing 0.5% 
(w/v ) NP40. S a m p le s  we re  p rocessed  for im m unof luorescence  m ic ro s ­
copy using s tandard  procedures. M itochondria  we re  v isua lized  either by 
an an t i-cy tochrom e c oxidase antibody (262) or M ito tracker  Red, C M XRO S  
(Inv itrogen , the Nether lands).  The ER  w a s  stained by an an t i- ca lre t icu l in  
antibody (S igm a, the Nether lands) .  Im ages  w ere  obtained with a Bio-Rad 
MRC1024 con foca l  lase r-scann ing  m icroscope  equipped with an argon/ 
krypton laser, using a 60X 1.4 NA oil object ive and Lase rS h a rp 2 0 0 0  a c ­
quisition so ftware .
Myotubes we re  not fixed but stained with M ito tracker  Red, CM XH2RO S  
(Invitrogen, the Nether lands) ,  and wh i le  they were  p laced  at 37°C on a 
tem pera tu re-con tro l led  s tage  of a Zeiss  LSM 510-M eta  con foca l  m ic ro ­
scope  (running so f tw a re  re lease  3.2), im ages  were  acquired using the 
appropria te  argon lase r  l ines and a 63X 1.4 NA oil objective.
• RNA isolation and RT-PCR
RN A  w a s  iso la ted  using the Aurum Total RN A  Mini Kit (B io-Rad ,  Hercules ,
CA, USA ),  accord ing  to the m an ufa c tu re r 's  protocol.  Sem i-quant i ta t ive  
RT-PCR an a lys is  w a s  performed. Approximate ly  0.5 pg RNA se rved  as 
tem plate  for cDNA syn thes is  with random hexam ers  using the Sup erSc r ip t  
fi rs t-s trand  syn thes is  system  ( Inv itrogen )  in a to ta l  vo lum e of 20 pl. One 
pl of the cDNA reaction mixture w a s  used in PCR an a lys is  accord ing  to 
s tandard  procedures. In RT- contro l  experiments, reve rse  t ran sc r ip tase  
w a s  omitted. Cycle number w a s  24 for ß-actin and 26 for DMPK. The 
fo l lowing pr imer pairs  were  used: hum an/m ouse/ra t  beta-actin forward  
pr imer 5'-GCTAYGAGCTGCCTGACGG-3' and reve rse  pr imer 5'-GAGGCCAG- 
GATRGAGCC-3'; human DMPK exon 7 fo rward  pr imer 5 '-ACGGCGGAGA- 
CCTATGGCAA-3' and exon 9 reve rse  pr imer 5'-TCCCGAATGTCCGACAGTGT-3'; 
Mouse/rat  DMPK exon 7 fo rward  pr imer 5 '-AAGAATTCGCCGAGACATATGC- 
CAAGATT-3', exon 9 reve rse  pr imer 5'-AATCTCGAGTCCTGCATGTCTGACAGC- 
GT-3', exon 12 fo rward  pr imer 5'-AAAGAATTCGAGACCTGGAGGCGCATGT-3' 
and exon 15 reve rse  pr imer 5 '-AAACTCGAGCGAACAGGAGCAGGCAAC-3'.  
PCR products were  analyzed on 1.5-2.5% ag a rose  ge ls  and stained by 
ethidium bromide. S ig n a ls  we re  imaged on the Epi Chemi II Darkroom 
(U V P  Bio Imaging system s,  Cambridge, United Kingdom), and images were  
































































































• DMPK protein in muscle tissues
E a r l ie r  work  estab l ished  that m R N A s  encoding long DMPK iso forms ( i s o ­
form s A-D) are  main ly  expressed  in heart  and ske le ta l  muscle ,  and t r a n ­
s c r ip ts  encoding short iso forms ( E  and F) occur  predominant ly  in smooth 
m usc le  (95, 211). To ver ify  w hether  the protein products  are  distributed 
correspondingly ,  we  analyzed different mouse m usc le  types  for presence  
of DMPK protein. For co m p ara t ive  purposes and to obtain re l iab le  s igna ls  
for DMPK, a low -abundance  protein, we  examined expression of the hD- 
M P K  t ransgene  in our Tg26-hDMPK (TG) m ouse  l ineage  next to that of the 
endogenous m D M PK gene in wild type (W T )  mice. Production of hDMPK 
protein in TG mice is driven by its own hDM PK promoter from mult iple 
gene copies and is two to eight-fold higher com pared  to endogenous 
m D M PK ,  depending on the t issue  type (126, 211).
Using our own DMPK-spec i f ic  antibody B79 (95), we  were  ab le  to 
distinguish long and short  DMPK iso forms on immunoblot based on the 
c le a r  d if ference in their m o le cu la r  weight. The human DMPK t ransgene  
product and the endogenous mouse DMPK protein could not be separated,  
so s igna ls  obtained in TG sam p le s  are  composed  of both products. T is ­
sue s am p le s  from the DMPK knockout (KO) mouse se rved  as  negative 
con tro ls  (126). W hen com pared  on the bas is  of to ta l  protein loaded, the 
DMPK s igna l  w a s  c lea r ly  s t rongest  in b ladder and stomach, of in te rm edi ­
ary  strength in heart , d iaphragm and tongue, and - unant ic ipated - r e l a ­
t ive ly  w e a k  in ske le ta l  m usc le  (Fig. 1).
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Figure 1 • DMPK protein ex­
pression in skeletal, cardiac 
and smooth muscle typ es.
Proteins in tissue lysates 
of WT (A) or TG mice (B) 
were resolved by SDS-PAGE 
and analyzed on western 
blot using a DMPK antibody. 
Samples from a KO mouse 
were included as negative 
controls. GPS = Gastroc­
nemius Plantaris Soleus 
muscle complex; L = long 
DMPK isoformsA- D (ap- 
parentmole cp(a rw e ightst 
~7S kD-rS psSort tMPK 
ikoformsD-F (~6 7 (DkO (95, 
--6f7 = -ubulin staining 
used to monitor proteir 
loading.
In WT and TG ventr ic le  and a tr ia l  segm ents  of heart , long and short  
DMPK iso forms were  expressed  in a lm o s t  equa l  am ounts  (Fig. 1A and 
B). Total D M PK  protein expression, i.e. t ransgen ic  and endogenous leve l
combined, in TG heart  w a s  cons ide rab ly  higher than in W T  heart.
In ske le ta l  m usc les ,  in gastrocnem ius ,  fas t  tw itch  t ib ia l is  anterior, 
and a lso  in s low  tw itch  so leus  m usc le  of both W T  and TG mice, long 
DMPK isoforms predominated. W e ak  expression of short DMPK isoforms 
of about 10-40%  of tota l s igna l  intensity w a s  observed  as  we l l ,  at v a r i ­
ab le  long:short s igna l  rat ios for different m usc le  types  in W T  and TG 
(com p are  e.g., t ib ia l is  and so leus).  W hen com pared  to the tubulin contro l  
a lso  to ta l  DMPK s igna l  le ve ls  var ied , with the highest expression in WT 
found in so leus  and in t ib ia l is  an ter io r  in TG.
In d iaphragm of W T  mice, a mixed fiber type m uscle ,  expression of 
long DMPK iso forms predominated. In d iaphragm of TG mice, abso lu te  
DMPK expression w a s  cons iderab ly  increased, and the s igna l  leve l  of 
long and short  isoforms appeared  about equal (Fig. 1A and B). In tongue, 
a lso  a mixed fiber muscle ,  short  and long iso forms were  present at equal 
le ve ls  in both TG and W T mice (Fig. 1A and B). In tongue of W T  mice, a lso  
a fas te r  migrating protein im m unoreact ive  to our an t i-DMPK B79 antibody 
w a s  noted (Fig. 1A).
By far  the highest expression of DMPK, a lm o s t  exc lus ive ly  of the 
short  isof o r m , w a s found in b ladder and s tom ach  of W T  and TG mice, 
both t issues  with a high content of smooth m usc le  c e l l s  (Fig. 1A and B).
Figure 2 • DMPK protein 
expression in brain and 
individual brain regions.
Lysates of brain regions anc 
the pituitary gLanC from one- 
year-old TG mice (A) were 
analyzed by western blotting 
using a DMPK antibody 
(B79).Protern Loading was 
verified by pyruvate kinase 
(PK) immunoreactivity. 
Whole brain extracts from 
one-year-old KO mice (BKO) 
and TG mice (BTG) served 
as controls. (B) Immunopre- 
cipitated DMPK from whole 
brains of KO, WT and TG 
mice isolated at postnatal 
days 0, 21 and 42 detected 
by the MANDM1 DMPK an­
tibody. To better appreciate 
signal intensities, a long and 
a short exposure are shown. 
L = long DMPK isoforms and 
S = short DMPK isoforms 
(95, 296).
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• DM P K protein in brain anO eistinct tihain regions
N o r th e rn b lo t ,  RT-i C R a n d  ISH p trB io s  eem nnstra teb  tOmt RN A  p roducts  
fnoro t i e  it S P K g n n e a r e  ex nnessed a t )ow lene l i n t h e  cen tra l  nervous 
byntnm.(95, 2n 4) S inga dhn htdnc|sooun D M P °  groteio (eve l  in to ta l  WT 
brain lysate  w a s  a lso  ve ry  low and difficult to detect on w es te rn  blot 



























































































DMPK protein distr ibution by examining to ta l  lysa tes  from reg ional brain 
s am p le s  in TG overexpressor  mice.
In a l l  a r e a s  examined -most prominent in o lfacto ry  bulb and p itu itary 
g land- a predominant expression of long iso forms w a s  observed  (Fig. 
2A). A na ly s is  of W T  mice confirmed that the p itu itary gland contained 
a lm o s t  only long DMPK iso forms (data not shown).
To invoke a more sens it ive  a s s a y  for monitoring isoform sh ifts  dur­
ing brain deve lopment,  we  fo l lowed  DMPK profi les by subjecting equal 
am ounts  of protein originating from who le  bra ins of KO, WT and TG mice 
of pos tna ta l  days 0, 21 and 42 to immunoprecip itat ion by DMPK antibody 
B79, fo l lowed by detection on w es te rn  blot with a second DMPK-specif ic  
antibody, MANDM1 (159, 218). In ag reem ent  with prev ious findings, ex- 
p ress io  n o f D M P K w  as s t i l l  bare ly  detec tab le  in W T  brain, but rather 
strong s igna ls  w ere  obtained for TG brain. Long DMPK iso forms were 
predominant,  and there  w a s  a c le a r  inc rease  in s igna l  strength during 
the fi rst  six w eeks  of deve lopment (Fig. 2B).
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• D M PK  protei n in c u l t u r e d  primory meoblayts an t  myotu bes
P t im e ry  m o b l a s te w e r e iso la t e d f eom t h e c a l y m u scle com p lexes  of WT 
a od n0 m ica (1 2 u° l e s  r bo r i ng the H-r y c  -t s A 5 n ol l ele (197) and a l low ed  to 
e l iHetrc t ia t  e i n  r l t r s . l n  ptoU fe ua ti m g m ^ W a y t e a s w  e l l  as  dif ferentia ted 
m hotubuo (F ie . S A ) m u i r e  lorg DM oU isotoums w ere  expressed. S t r ik ­
t e m ,  n o a p t a r e e  C T i f le ren ru  ¡4 exe r rn  smn Imed o u s observed  between 
c r c trng snM to s tm y m r 4 y fu b t n  a se  m r u l b e ^ . W  o d  id observe, however,  
uMoC uac yaosphorn ly r ¡cn  d a t us of b y r l o r o  u M M )  iso forms appeared
Figure 3 • DMPK protein ex­
pression in primary myogenic 
cells.
Conditionally immortalizec 
muobla sts from WT and KO 
mice were cultured anc 
allowed to differentiate into 
myotubes. (A) DMPK protein 
expression in proliferating 
myoblasts (P), a confluent 
myoblast culture (C) a.3d 
myotubes after 1a C, 1, 7 
and 9 days of differentiation 
was assessed by westerr 
blotting. Protein lacda 
ing was related to tubulin 
expression (T). Note that 
DMPK isoforms comigrated 
oith cross-reactingproteins 
(see K0 samplerO tPefrster 
migretmg 3nep 7 tDhtlo bed 
mo aSt^ a^DuecJer S^p presoat 
ic proliferpfihn, i^ t^omf 
differentiation medium. L = 
lane [JMI^issfonms aae S 
= ahort [ M ^ i soforms^e 
2mSa^)aprn i-puptfitahee 
aT-PSSaKalyais wa a par- 
formeh DMRaAeegae0from 
emlifereting e o S a ^ te , )  
confluent myoblast culture 
and myotubes after 1 and 
7 days of differentiation.
The main alternative splice 
products encoding long (L) 
or short (S) DMPK isoforms 
are indicated on the right. 
The asterisks indicate a rare 
DMPK isoform containing a 
premature stop codon as 
a result of incorporation of 
part of intron 13, potentially 
encoding a protein isoform 
with a predicted molecular 
weight of 63 kDa.
T
Figure 4 • DMPK expres­
sion in primary neurons and 
astrocytes.
(A ) Prote in  ly sa te s  of 
p rim ary  neurons and 
a s tro cy te s  w ere  analyzed  on 
w este rn  blot using antibody 
B79 aga ins t D M P K (9 5 ) and 
an an ti-p yruvate  k inase  
an tib od y  (P K ) as  a load ing 
contro l. D M PK protein c o u Ic 
be detected  in W T astrocytes, 
but not neurons. L = long 
D M PK iso fo rm s (~74 kDa) 
and S = short D M PK iso ­
fo rm s (~67 kD a) (95, 296). 
( B )  RT-PCR using RNA from  
p rim ary neurons and a s tro ­
c y tes  d em on stra ted  p resence 
of D M PK  tra n s c r ip ts  in WT 
as tro cy te s  and a lso  neurons. 
The d oub le t s ig n a l rep re ­
sen ts  a lte rn a t ive  sp lic ing  
of 15 nu c leo tid es  encod ing 
the VSGGG seq u en ce  (95 ). 
B e ta-a c tin  se rved  as  con tro l 
for RNA input.
s l ight ly  inc reased  in myotubes at la ter  t ime points of d ifferentiation 
(7-9 days), as  i l lustrated  by the more intense upper band of the doublet 
s igna l  (296).
Ex p ress io n  of short DMPK iso forms w a s  low in differentia ting myo- 
tubes and becam e a lm o s t  undetec tab le  a fte r  nine days of dif ferentia tion 
(Fig. 3A). P re sen ce  of short iso forms in m yob las ts  could not be de te r ­
mined due to a strong cross-reac t ing  s igna l  a lso  observed  in KO ce l ls  
(p robab ly  bovine serum albumin since myotubes cu ltured in the p resence  
of horse serum  did not show a s ignal;  Fig. 3A). To shed more light on the 
reperto ire  of DMPK isoforms in m yob las ts ,  we  a lso  performed an RT-PCR 
an a lys is  of the a l te rna t ive ly  sp liced  exon 12-15 region (Fig. 3B). This 
an a lys is  confirmed that t ran scr ip ts  encoding the short  iso forms were  
present in m yob las ts  and that expression w a s  only just detec tab le  in 
myotubes (Fig. 3B). Ex trapo la t ing  this to the protein level,  our data indi­
ca te that short  iso forms are  present at low leve l  in myob lasts ,  but they 
d isappear  during te rm ina l  d if ferentia tion of myofibers, leaving expression 
of only long DMPK isoforms.
• DMPK protein in cultured primary neurons and astrocytes
DMPK expression w a s  a lso  analyzed in pr im ary  a s t ro cy tes  from brain 
cortex and neurons from the h ippocampus iso la ted from E16.5 WT and 
KO mice and cultured in vitro. DMPK protein w a s  c lea r ly  detec tab le  in 
co r t ica l  a s t ro cy te s  but not in h ippocam pa l  neurons (Fig. 4A). Long iso ­
fo rm s were  predominant, but short  iso forms a lso  occurred  at low s ignal  
strength.
W e wondered w hether  the ab sence  of a DMPK s igna l  in neurons w as  
due to the limited sens it iv i ty  of our weste rn  blotting procedure or to 
complete  ab sence  of t ranscr ip t ion of the DMPK gene in this ce l l  type. 
W e therefore  determined m RNA le ve ls  in the pr im ary  neurons and a s ­
trocy tes  using RT-PCR. This revea led  DMPK m RN A  at low s igna l  intensity
A B
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WT KO WT KO
Neurons Astrocytes





in neurons and much higher intensity in p r im ary  a s t ro cy tes  (Fig. 4B), 
co r robornt mg the w e s te r a b lot find ina s . T a k en com b ined, these res ults 
sugg e s t t n a t D M P K m R S A onb p r o t e i n i s g r e s e n t i n  p r im o ry s e u o o n s  dut
at l o w lo v a t s  compared  to u s t ra r r tn s .
• DMPK preae i a i n  e s ta n i io d e D e e l l l  i n e so f  myog e r ic e r nnupaI origin
To confirm U e rd n g sa n d  o r e v ¡d e ( :urtOer dookgronna for b M k K o t e U ie s  in 
a s e t  h i o l o g i c a l e e U i r ^ w e a l s e  s n a ^ z a S  DM b K gr a t r m expression in a 
numoec of entab U oheh melt l i n e s of m oogen ic nr nep rs lo r ¡o ¡n . l- ILm  c o r ­
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contrast ,  none of the neura l  ce l l  l ines tested (PC12, SK-N-SH, U373, CCL- 
1 3 1 , N 2 A ) s h o w e d c l e a r  DMPK e x p re s s io n ,a l t h o u g h in te rp r e t a t io n  here 
w a s  h a m p e r e d b y  a c r o s s - r e a c t i n g  s igna l  ( c o m p a re b a c k g ro u n d  s igna l  
observed  in KO myotubes).  In PC12 ce l ls  an add it iona l  strong s igna l  
w a s f o u n d j u s t b e l o w  the c r o s s - r e a c t in g p r o t e in ( F ig .  5 A ) . T o s o l v e  this 
c o n f u s io n , D M P K m R N A  expression w a s  again a lso  a s s e s s e d b y  RT-PCR. 
N o P C R p r o d u c t s  were  found for PC12 and N2A ce l ls  ( F i g . 5 B ) ,  strongly 
s u g g e s t i n g t h a t t h e D M P K w e s t e r n b l o t s i g n a l s d i d n o t r e p r e s e n t g e n u i n e  
DMPK p ro te in .To  our surprise ,  U373 ce l ls  showed a strong s igna l  in 
RT-PCR, indicating that the D M PK  gene is t ranscr ibed  in this ce l l  line. 
Although we a ssum e  that the strong s igna l  on w es te rn  blot, based on 
its migration behavior, co rresponds  to a c ross-reac t ing  protein, c lose r  
examination revea led  a second, very  w e a k  s igna l  that migrated s l ightly  
more slowly,  which may represen t DMPK (Fig. 5A).
• Subce l lu la r  local ization of DMPK isoforms in primary cells
Finally, we investigated if ind iv idual DMPK isoforms t rans ien t ly  ex­
p ressed  in the different host  c e l ls  now identif ied we re  targeted to their 
expected locat ions (286). To this end, p r im ary  ske le ta l  m usc le  c e l l s  and 
neura l  c e l ls  from DMPK KO mice were  t ransduced  w ith  ad eno v i ra l  v e c ­
tors encoding YFP- tagged  vers ions  of m D M PK  A (known to anchor  in the 
ER),  m D M PK  C (known to anchor  in the MOM) or m D M PK  E (cy toso l ic )  
(286, 296).
Express ion  in m yob las ts  showed loca l ization of DMPK A, C and E at 
the predicted locat ions (Fig. 6A) (286). In myotubes, m D M PK  A d is tr ibu ­
tion showed a typ ica l  r e t icu la r  ER pattern, c lea r ly  different from the 
m itochondr ia l  d istribution of DMPK C and cy toso l ic  d istribution of m D MPK 
E (s ince  none of the ER  m ark e rs  tested resu lted in a wel l-def ined  ER 
staining in myotubes, a m itochondr ia l  countersta in  w a s  used instead; 
Fig 6B). Y FP - m D M P K  C loca l ization over lapped w ith  mitochondria,  but 
some cy toso l ic  and nu c lea r  staining w a s  a lso  seen. W e attr ibute  this 
to cl ipping of the fusion protein. This resu lts  in re lease  of the re la t ive ly  
res is tan t  Y F P  moiety, wh ich  rem a ins  as  a free-floating, cy toso l ic  and 
nu c lea r  protein (Fig. 6C).
In p r im ary  neurons, Y FP - m D M P K  A co loca l ized  with ER m ark er  cal- 
ret iculin and Y FP - m D M P K  C with m itochondr ia l  m arker  M ito tracker  Red 
(Fig. 7A). Som e cy toso l ic  and nu c lea r  staining, probably  again caused  by 
cl ipping of Y FP- m D M PK  C, w a s  a lso  seen here (Fig. 7A). Y FP - m D M P K  E 
adapted  a cy toso l ic  distr ibution (Fig. 7A). In p r im ary  as trocy tes ,  DMPK 
isoforms exhibited a la rge ly  s im i la r  distr ibution as  seen in neurons, with 
DMPK A, C and E loca l ized to the ER, MOM and cytosol,  respectively ,  
aga inst  some cy toso l ic  and nu c lea r  background staining for Y FP- m D M PK
Figure 5 • DMPK expression 
in established cell lines of 
skeletal muscle, cardiac or 
brain origin.
(A ) Ly sa te s  of c a rd ia c  (HL-1 
B (b eating ), HL-1 NB (n o n ­
beating )), s k e le ta l m u sc le  
(C 2 C 1 2 )o r  brain  o rig ir 
(PC 1 2 , SK-N-SH, U373, 
CCL131 Pro (p ro life ra ting ), 
CCL131 Dif 48h (d iffe ren t i­
ated  for 48 hours), N2A) 
w e re  analyzed  on w estern  
b lot for D M PK  expression .
L = long D M PK iso fo rm s and 
S = short D M PK  isoform s 
(95 , 296). A u then tic  D M PK 
s ig n a ls  a re m arked  by 
as te r isk s . Note that a c ro s s ­
reacting  prote in d e te cted  ^  
K O m y o tu b e s  is a lso  present 
in m any of the  c e ll  lines, 
e sp e c ia lly  U373 and N2A 
(a rrow , CRP). ( B )  A s e m i­
q u an tita tive  RT-PCR spann ing  
exon 7 to 9 w a s  perform ec 
on RNA derived  from  PC12, 
U373, N2A and C2C12 (p o s i­
t ive  co n tro l) ce lls . D M PK 
tra n sc r ip ts  w e re  detected  
in U373 g lio b la s to m a  but 
not in PC12 and N2A 
neu ro b las to m as . The double t 
s ig n a l rep re sen ts  a lte rn a tive  
sp lic in g  of 15 n u c le o ­
t id es  encod ing  the  VSGGG 
seq u en ce  (95 ). P rod uct size 
d iffe ren ces  b etw een  U373 
and C2C12 s a m p le s  reflect 
d iffe ren ces  b etw een  p rim ­
e rs  for the  hum an (U 3 7 3 ) 
and m ouse (C 2 C 1 2 ) DM PK 
am p licons .
Figure 6 • Subcellular local­
ization of individual DMPK 
splice isoforms in myoblasts 
and myotubes.
S p lic e  iso fo rm s m D M PK  A, 
C or E fused  to Y F P  w ere 
exp ressed  in KO m yob las ts  
(A ) and m yo tubes (B )  using 
a d en o v ira l exp ress ion  v e c ­
tors. Confoca l im ages  w ere 
taken  20 hours (m yo b la s ts ) 
or 48 hours (m yo tu b es ) 
a fte r transd uc tion . To identify 
s u b c e llu la r  structu res, c e lls  
w e re  coun te rs ta ined  for 
ER  m arker c a lre tic u lin  or 
m ito ch o n d ria l m arker M ito- 
T racker Red. In m yob lasts, 
Y FP-m D M PK  A, C and E 
w ere  found at the ER, m ito ­
ch on d ria  and in the cytoso l 
re sp e c tiv e ly  (A ). In m yotubes 
Y FP-m D M PK  C, but not YFP-  
m D M PK  A and E, loca lized  
at m itochond ria  (B ). B a rs  ^  
A: 10 pm. B a rs  in B: 25 pm. 
(C ) W este rn  b lotting  w as 
used to verify  in tegrity  of 
exp ressed  fus ion  proteins. 
Reco m b in an t p ro te ins w ere 
v isu a liz ed  using a DM PK and 
a Y F P  antibody. M o le cu la r 
w e ig h ts  of m arker pro te ins 
are ind icated . A s te r isk s  ind i­
c a te  C - term ina lly  truncated  
m D M PK  p roducts  as  a resu lt 
of non-enzym atic  b reakd ow n  
(286 ).
C (Fig. 7B).  A lso  here, som e c l ipping of the Y F P  part  has  occurred  (Fig.
7C).
Overa ll ,  these t re n sient expression studies  dem onstra te  authentic 








































































































Figure 7 • Subcellular local­
ization of individual DMPK 
splice isoforms in brain- 
derived primary cell types.
S p lic e  iso fo rm s m D M PK  A,
C or E fused  to Y F P  w ere  
exp ressed  in KO neurons 
(A ) and a s tro cy te s  (B )  using 
a d e n o v ira l vecto rs. Confocal 
im a g es  w ere  taken  20 hours 
a fte r transd uc tion . To identify 
s u b c e llu la r  s tructu res, ce lls  
w e re  coun te rs ta ined  for 
ER  m arker c a lre ticu lin  
or m ito ch o n d ria l m arker 
cy to ch ro m e  c oxidase. YFP-  
m D M PK  A, C and E loca lized  
to the  ER, m itochond ria  and 
in the  cytoso l, respective ly . 
For Y FP- m D M PK  C, m any 
neurons and a s tro cy tes  
a lso  show ed  n u c lea r and 
c y to so lic  s tain ing. Bars:
10 pm. (C ) W este rn  b lotting 
w a s  used to verify  in tegrity 
of exp ressed  fusion  prote ins. 
R eco m b in an t prote ins 
exp ressed  in as tro cy te s  were 
v isu a liz ed  using a D M PK and 
a Y F P  antibody. M o lecu la r 
w e ig h ts  of m arker prote ins 
a re ind icated . An a rro w  head 
in d ica te s  a cross-reactin g  
prote in  d ete cted  w ith  the 
D M PK  and Y F P  antibody, a lso  
in m ock-treated  astrocytes.
In the  ca se  of YFP-m D M PK  A 
and C som e prote in clipp ing 
occurred , illu s tra ted  by YFP  
s ig n a ls  at 30-40 kDa.
• DISCUSSION
M usc le  and brain a re  prominently  implicated  in DM1. F ISH  a n a ly s es  have 
dem onstrated  p resence  of DMPK t ran sc r ip ts  in these and other t issues, 
how ever  the occurrence  of sp l ice  products  w a s  not addressed  (126, 244). 
Here, we analyzed the d istribution of long and short  DMPK protein iso ­
fo rm s (95, 296) in m u sc le s  of dif ferent fiber type and in d iscre te  regions 
and ce l l  types  of the b ra ins  of mice. S in ce  iso form -spec i f ic  an t ibodies  
are  not a va i lab le  for DMPK, we  have used c lass if ica t ion  of s igna ls  in dif­
ferent m o le cu la r  weight ca tego r ies  to profi le expression. Human DMPK- 
overexpress ing  t ransgen ic  (TG) mice aided in the detection of DMPK 
in t is sues  w ith  low expression, none the less  we rea l ize  that cautious 
interpretat ion is needed. E f fec ts  of t ransgene  integration site, spec ies  
d if fe rences  in promoter spec i f ic i ty  and pos t- trans la t iona l  control  may a f ­
fect express ion le ve l  of d if ferent human and m ouse  D M PK  gene products.
• DMPK protein in muscle t issues and cultured muscle ce lls
A l l  m u sc le  types investigated expressed  long and short DMPK isoforms, 
a lbe i t  at different le ve ls  for dif ferent m usc le  types  from WT and TG origin.
C ard iac  invo lvement in DM1 concerns  conduction defects  leading to 
a r rhy thm ia  and heart  block and has been co rre la ted  with (CTG^CAG) 
n expansion or D M PK  gene product dosage  (16, 101, 211). S tud ie s  in 
t ransgen ic  m ice  demonstra ted  that DMPK is involved in ion hom eostas is  
in heart , influencing C a2+, Na+ and Cl- cu rrents  (16, 134, 211). Combined 
with our current  findings that long and short  DMPK isoforms are  highly 
expressed  in both ventr ic le  and atr ium, this le aves  open the poss ib il i ty  
that both toxicity of (CUG)n-expanded m R N As  and m uta t iona l  e ffects  on 
DMPK protein leve l  or distr ibution contribute to DM pathology. As  we  find 
long and short DMPK fa ithfu l ly  expressed  in HL-1 ca rd iom yocytes ,  we 
consider these c e l l s  a re l iab le  exper im enta l  model for fu rther studies 
into the p a thophys io log ica l  s ign i f icance  of D M PK  m R N A  and protein.
Sm ooth  m u sc le  invo lvement in DM1 is typ ica l ly  noted by m a l fu n c ­
tioning of the gas tro in tes t ina l  t ract  and vacuo l izat ion in the b ladder  of 
patients (101). Smooth m usc le  ab no rm a l i t ie s  have not been reported in 
KO mice, but overexpress ion of hDMPK a f fec ts  a r te r ia l  smooth m usc le  
tone (211). As  we report high expression of v i r tua l ly  only short  DMPK iso ­
fo rm s in both s tom ach  and b ladder here, we propose that fu rther stud ies  
should now be focused pr im ar i ly  on how these pa r t icu la r  iso forms co n ­
trol ce l l  integrity g loba l ly  throughout a l l  smooth m u sc le  cel l-conta in ing  
t issues  in DM1 patients and no rm a l  controls.
W e a k n e s s  and wast ing  of d is ta l  ske le ta l  m u sc le s  and myotonia are  
h a l lm a rk s  of DM1 (101), with type 1 (s lo w  tw i tch )  f ibers being most 

































































































fo rm s coexist, but long isoforms dominate most ly  in ske le ta l  m usc le s  
of a l l  fiber types, including so leus, t ibial is , and g as trocnem ius  muscle, 
t yp ica l  slow, fas t  and mixed m usc les ,  re sp ec t ive ly  (229, 304). A mix­
ture of long and short  DMPK iso forms w a s  a lso  strongly  expressed  in 
d iaphragm and tongue. These t issues  are  of mixed f iber-type and are 
implicated  in resp ira tory  d is t ress  or speech  and sw a l lo w in g  p rob lem s in 
DM1 patients (101).
In con trast  to the pers is tence  of a s ign if icant  percentage  of short 
DMPK iso forms in mature  m u sc le s  in vivo, short DMPK iso forms occurred 
at very  low abundance  in myotubes differentia ted in vitro. M yob las ts  
cultured in vitro usua l ly  lose their com m itm ent imprint and adopt a fast- 
tw itch p recursor  phenotype (158), but neither this fate nor the p rocess  of 
fusion and m aturation to m yotubes a ffected expression of long DMPK iso ­
form s significantly . As  DMPK gene products w ere  reported before  to exist 
a l re ad y  in the myotome region of som ites  (126), we  now think that long 
DMPK isoforms remain expressed  at a l l  s tag es  in the ent ire t ra jecto ry  of 
m usc le  deve lopm ent and aging. Our f indings thus dem onstra te  that our 
im morta lized WT m yob las ts-m yo tubes  or the C2C12 ce l l  line represen t 
fa ithfu l  and a t t rac t iv e  m ode ls  for study of the b io log ica l  s ign i f icance  of 
DMPK, in p a r t icu la r  the long isoforms, during ske le ta l  m u sc le  deve lo p ­
ment. Currently,  we  are  using com plementat ion transfect ion  experiments 
w ith  ind iv idual  DMPK iso forms A-D (286, 296) in KO myotubes to study 
their role in isolation.
• DMPK expression in brain and brain-derived cells
In congen ita l  and adu lt-onset  DM1, invo lvement of the CNS inc ludes  men -
ta l  retardation, cognit ive and em otiona l d is tu rbances  and hypersomnia  
(101, 193). Our resu lts  from TG brain suggest  that both long and short 
DMPK iso forms are  expressed  ac ro s s  a l l  regions,  including brain stem, 
o lfactory  bulb and str iatum. In the p itu itary  gland of both WT and TG 
m ice, long D M PK  iso form s dominated. A poss ib le  exp lanat ion for th is  fact 
is that p itu itary  t issue  (e.g., the anter ior  lobe) d iffers from other brain 
regions,  in that it does not originate from the neura l  tube (145).
An important finding is the identification of DMPK protein in a s t ro ­
cy tes  from the pr im ary  cortex. A lso  U373 g l iob las tom a ce l ls ,  tumor ce l ls  
originating from the as t ro cy t ic  progenitor l ineage, expressed  DMPK at 
low leve l.  It is of note here that we  did not observe  DMPK protein in 
who le  brain until a n im a ls  w ere  3 w eeks  of age. This observa t ion un­
dersco res  that an inc rease  in DMPK expression during te rm ina l  brain 
deve lopment is re levant,  and it is tempting to sp ecu la te  that the d eve lop ­
ment of D M PK-express ing  as trocytes ,  a p rocess  that main ly  takes  p lace 
between pos tna ta l  w e e k s  1-6, contr ibutes most ly  to the ove ra l l  t issue- 
leve l  increase. At this point we  cannot, however, make firm sta tem ents  
about ab sence  or p resence  of DMPK expression in adult neurons. DMPK 
could e ither be not yet expressed  in our p r im ary  h ip pocam pa l  neurons 
derived from E16.5 embryos, and/or the different neurona l ce l l  l ines a n a ­
lyzed may a l l  have reverted  to an non-expressing embryonic  phenotype. 
There  is p resent ly  no other work  to wh ich  our resu lts  can be compared, 
and more e labo ra te  stud ies  are  therefore  necessary .
Currently, most work on brain invo lvement in DM1 is based  on the 
idea that repeat- induced m issp lic ing  of certa in  t ran scr ip ts  in neurons is
the dominant event and is the bas is  of the neuropsych ia tr ic  p rob lem s in 
DM1 (129, 253). DMPK t ran sc r ip ts  aggregated  in RNP foci were  revealed  
in neurons in post-mortem DM1 t issue  (129), but ce l l- type  d if fe rences  in 
accum ula t ion  and aggregat ion behavior of RNAs may contribute to dif­
fe ren t ia l  v is ib i l ity  in neurons and as trocytes .  Given our resu lts ,  we  su g ­
gest  that study of the fate and e f fects  of no rm a l  and mutant DMPK gene 
products in a s t ro cy tes  now a lso m erits  se r ious attention.
As  a prelude to such  studies, we  com pared  the distr ibution fate of 
m D M PK isoforms in t rans ien t ly  t ransduced  p r im ary  brain c e l ls  to that in 
m usc le  c e l l s  and to a l re ad y  known behavior in other ce l l  types  (286). In 
a l l  ce l l  types analyzed, cy toso l ic  or m em brane  loca l ization w a s  exactly 
as  antic ipated for DMPK E or DMPK A/C isoforms, respec t ive ly  (286). 
Hence, our observa t ions  indicate that location of DMPK iso forms does not 
rely on ce l l- type  dependent re a r rang em en ts  in m em brane  composit ion 
(25) or cytoarch itec ture .  B a s e d  on our f indings regard ing the inter- and 
in t race l lu la r  d istribution patterning of DMPK isoforms, more deta iled 
studies  into the no rm a l  and pa thobio log ica l  role of DMPK should now 





















































TOPOLOGY AND SPEC IF IC IT Y  OF M E M B R A N E  INSERTION OF TAIL- 
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Tai l-anchored (TA) proteins are  m em brane  proteins character ized  by a 
single hydrophobic region in their C-terminus.  How spec i f ic i ty  and topol­
ogy of m em brane  insert ion of TA proteins are  determined by amino acid 
sequence  and composit ion of the ta i l  domain is poorly understood. W e  
report on anchoring behaviour of protein-isoform products of the mouse 
and human DMPK genes formed by a l te rna t ive  splicing. Mouse DMPK A 
a s s o c ia te s  via its ta i l  with the endop lasm ic  ret icu lum (ER ) ,  w h e re as  its 
human orthologue binds to the outer m em brane  of mitochondria  (MOM). 
Mutat iona l  an a lys is  demonstra ted  that the nature of the amino ac id at 
one non-conserved  position (hA rg 6 0 0 -m A la6 0 2 )  in the ta i l  determ ines 
this spec ies-spec i f ic  d if fe rence  in m em brane  binding and that o rg an ­
elle  spec i f ic i ty  is re lated to length and hydrophobic ity  of the ent ire tail. 
Charged res idues  f lanking the hydrophobic region only moderate ly  influ - 
ence targeting of DMPK A. Human and mouse DMPK C iso forms ca rry  
a d ist inct ly  d ifferent C-terminus and require p resence  of a co i led-co il  
domain for proper insert ion in the MOM. F R A P  an a lys is  indicated that the 
extent of l a te ra l  m em brane  diffusion d if fers between the DMPK isoforms, 
but that none of the anchored  D M PKs quickly  exchanges  with the cy to ­
so l ic  pool of new ly  t rans la ted  protein. Finally, topology studies  with YFP  
and HA double-tagged fusion proteins revea led  that DMPK A isoforms 
have their C-term inus oriented to w ard s  the o rgane l le  lumen (N -C
■3 '  out ir
orientation), w h e re as  both ends of DMPK C face the cy toso l  (Nout-Cout 
orientation). The unique sequence  com pos it ions of dif ferent ta i l-anchors  
thus determine the location, orientation -and p resum ab ly  ro le-  of d is ­
tinct DMPK isoforms at the ER-MOM interface.
• INTRODUCTION
Tai l-anchored (TA) proteins are  a s t ru c tu ra l ly  and func tiona lly  d iverse  
c la s s  of proteins wh ich a ssoc ia te  with the phospholipid bilayer of o rg an ­
e l le s  l ike end op lasm ic  re t icu lum  (E R ) ,  m itochondria ,  perox isom es and
ch lorop lasts .  For this m em brane  assoc ia t ion ,  TA proteins use a stretch 
of hydrophobic amino ac ids  situated c lose  to their C-terminus (19), wh i le  
their N-term ina l  part fa ce s  the cytosol.  TA proteins are  involved in a wide 
range of ce l lu la r  p rocesses ,  including apoptos is  (228), protein t r a n s lo c a ­
tion (18), ve s ic le  fusion (155) and m itochondr ia l  morphology regulation 
(234, 31 1).
M em brane  targeting of TA proteins occurs  post t rans la t iona l ly ,  a fter  
their hydrophobic  m em brane  region em erges  from the r ibosome upon 
termination of trans la t ion  (19). W hen new ly  synthesized TA proteins use 
this m echan ism  to insert into the ER, they may become redistr ibuted 
via ve s icu la r  t ransport  to other destinat ions within the secre to ry  p a th ­
way  (18, 66, 203). Lipid composit ion of the m em brane  of res idence  is 
then an important p a ram ete r  for retention in spec i f ic  ce l lu la r  o rgane l les  
(25, 138). Targeting of TA proteins to the m itochondr ia l  outer m em brane  
(MOM) or m em branes  of ch lo ro p la s ts  and perox isomes occurs  d irect ly  
from the cy toso l  (18). Generally, m em brane  anchoring depends on ATP, 
and requ ires  chaperone  involvement. Chaperones  that se rve  TA proteins 
as  c l ient-prote ins are  Asna-1 (265) and Hcs70-Hsp40 (2). A lso  the s ig ­
na l  recognition part ic le  may be involved in ta i l  anchoring, although its 
p rec ise  role is not c le a r  (1).
The ta i l  region of TA proteins is thought to contain a l l  n e c e s sa r y  in­
fo rmation for m em brane  spec i f ic i ty  (18). MOM-targeted TA proteins usu ­
a l ly  contain a m em brane  anchor  of at most 20 hydrophobic res idues 
f lanked by bas ic  -i.e. posit ive ly  charged- amino acids. W ith  re la t ive ly  
few exceptions, ER  TA proteins have a longer hydrophobic  region and do 
not require spec i f ic  bas ic  amino acids. P re c is e ly  how these p hys ica l  and 
ch e m ica l  ch a ra c te r i s t ic s  determ ine the se le c t iv it y  of m em brane  a s s o c ia ­
tion rem a ins  u n c le a r
The mode of a ssoc ia t ion  has only been studied for a few TA proteins, 
main ly  with focus on proteins that loca l ize  to the ER  (18). Cytochrome b5, 
for example, conta ins an anchor  that sp ans  the membrane ,  such that its 
C-terminus res ides  in the ER  lumen (25, 154). Even less  is known about 
the t ran sm e m b ra n e  topology of MOM-targeted  TA prote ins (3, 138, 292).
Two recen t ly  identified TA proteins a re  isoform products  of the m yo ­
tonic dystrophy protein k inase  (D M PK )  gene (286), wh ich  c a u se s  m yoton­
ic dystrophy type 1 (DM1) when the (CTG)n repeat in its 3' untransla ted  
region expands beyond a certa in  thresho ld  (26, 176). As  the gene is only 























































































new proteins (286). They are  the a rche type  m em bers  of a subfam ily  of 
ser ine-threonine  k inases, including myotonic dystrophy k inase-re la ted  
Cdc42-binding k inases  (M R C K s )  a, ß, and y , Rho kinase a  and ß, and 
citron k inase  (33). Due to a l te rna t ive  sp lic ing, two long DMPK isoforms 
(A  and C) exist that ca r ry  d ifferent types of extended C termini,  both 
serv ing  as  m em brane  binding domains. Interestingly , o rgane l le  sp e c i f ic ­
ity of m em brane  anchoring d if fers between these DMPK types and is 
even spec ies-spec i f ic .  W h i le  mouse and human DMPK C both target to 
the MOM, mouse DMPK A (m D M P K  A) a s s o c ia te s  w ith  the ER, w h e re as  
its orthologue in hum ans  (hD M PK  A) loca l izes  to the MOM. Ectop ic  ex­
press ion of DMPK A in vitro, in t ransfected  ce l ls ,  can cause  formation 
of organized smooth ER  (O S E R )  s t ru c tu res  or per inuc lea r  c luster ing  of 
mitochondria  (216, 286).
Here, we  study the s t ru c tu ra l  requ irem ents  of the ta i l-dom ains  that 
determ ine  d if fe ren t ia l  m odes  of m em brane  anchoring  of DMPK. Using 
trunca t ion-m uta tion ana lyses ,  we  report  how amino ac id composit ion, 
ta i l  length and hydrophobic ity  distr ibution ac ro s s  ta i l  regions determine 
DMPK 's  aff in ity for m em brane  type, its insert ion topology, a s  w e l l  as  its 
effect on m em brane  behaviour.
• MATERIALS AND METHODS
• Cell culture and DNA transfect ion
C2C12 m yob las ts  and N2A ce l ls  w ere  grown to subconf luency  in Dulbec- 
co's m in im al  e ssen t ia l  medium supp lemented  with 10 %  (v/v) foeta l  ca lf  
serum and mainta ined  at 37oC under a 5 %  CO2 atmosphere. Ce l ls  were  
trans ien t ly  transfected  with var ious  expression p lasm ids  in p resence  of 
L ipofectam ine  (p rotoco l  as  specif ied  by the manufacturer ,  Invi trogen, the 
N e ther lands  and mainta ined  in cu lture  for an addit ional  20 hours prior 
to analys is .
• DNA vectors
E Y F P - D M P K  express ion vec to rs  and mutation and delet ion co n s t ruc ts
w ere  obtained by cloning appropria te  PCR fragm en ts  into p E Y F P - C 1 
(C lontech; see Sup p lem en ta ry  Ex per im enta l  for deta ils ) .  Next to the ORFs 
for d if ferent mouse and human DMPK A or C isoforms, expression p la s ­
m ids  a lso  conta ined  the co rrespond ing 3'-UTR reg ions of m ouse  or hu­
man DMPK mRNAs. P lasm id  inserts  were  verified by DNA sequencing. For 
v isua lizat ion of the ER, we  used vecto r  pDsRed2-ER ,  encoding Discosoma 
sp. red f luo rescen t  protein with a ca lre t icu l in-de r ived  ER  targeting s ig ­
na l  at its N-terminus and a KD EL  ER  retention s igna l  at its C-terminus 
(C lontech ) (191).
• Immunofluorescence analys is  of intrace llu lar  protein distribution
C2C12 m yob las ts  and N2A ce l ls  we re  grown and t ransfected  on g lass  
cover s l ips, fixed in P B S  contain ing 2 %  (w/v) fo rm a ldehyde  and per- 
meabil ized in P B S  contain ing 0 .5%  (w/v) Nonidet P-40. S a m p le s  were  
p rocessed  for im m unof luorescence  m icroscopy  using s tandard  p roce ­
dures. A rabbit an t i-cy tochrom e c oxidase antibody w a s  used to v isua lize  
mitochondria  (262).  S u b ce l lu la r  localization of Y F P - D M P K  fusion proteins 
w a s  scored  independently  by two exam iners  blinded to sam p le  identity, 
whereby  location w a s  categorized as  either ( i )  cy toso lic ,  ( ii)  ER (w ith or 
without O S ER  s t ructures ) ,  (iii) m itochondr ia l  (w ith  or without per inuc lear  
c luster ing of mitochondria ) .
• Immunofluorescence analys is  of membrane topology by se lect ive  mem­
brane permeabil ization
Insert ion topology w a s  investigated by se le c t ive  perm eabil izat ion of the 
p la s m a  m em brane  wh ich  w a s  done as  fo l lows: C2C12 m yob las ts  and N2A 
ce l ls  grown on cover s l ips  w ere  incubated with 3 pg/ml (C2C12) or 6 
pg/ml (N 2A )  digitonin ( S ig m a )  in cytomix buffer (120 mM KCl, 0.15 mM 
C aC l2, 25 mM Hepes/KOH pH 7.6, 2 mM EGTA and 5 mM MgC l2) contain ing 























































































m em branes ,  c e l ls  were  incubated with 0 .3%  (w/v ) Triton X-100 ( S e r v a )  
in P B S  for 25 m inutes at 4oC. Subsequently ,  c e l ls  were  washed  with P B S  
and incubated for 1 hour at  room tem pera tu re  in 10% (v/v) foeta l  ca lf  
serum  in PBS .  Then they were  incubated for 1 hour at room tem pera tu re  
with one of the fo l lowing antibodies: an t i-hemagglut in in  (anti-HA; 12CA5), 
an t i-cy tochrom e c oxidase, anti-protein disulfide isom erase  (S t re s sg e n )  
or anti-high tem pera tu re  requ irement protein-2 (H trA2/Om i)  (R&D S y s ­
tems).  After  a 30 m inutes w ash  with P B S  c e l l s  w ere  incubated for 1 hour 
w ith a f luo rescen t  seco n dary  antibody. Im ages  w ere  obtained with a 
B ioRad (B io rad )  MRC1024 con foca l  la se r-scann ing  m icroscope  equipped 
w ith an argon/krypton laser, using a 60x 1.4 NA oil object ive and Laser-  
S harp2000  acquis it ion so ftware .
• Fluorescence recovery after photobleaching analysis
D M PK-YFP  t ransfected  C2C12 m yob las ts  w ere  grown on g lass-bottom  
d ishes (W i l c o  w e l ls ) .  Ce l ls  were  imaged in phenol red-free Dulbecco 's 
m in im a l  e ssen t ia l  medium supp lem ented  with 10% (v/v) foeta l  ca lf  s e ­
rum while  p laced  at  37oC on a tem pera tu re-con tro l led  stage of a Zeiss 
LSM 510-M eta  con foca l  m icroscope  (running so f tw a re  re lease  3.2) using 
a 488 nm argon la se r  l ines and a 63x 1.4 NA oil object ive. A 3.5 pm x 
3.5 pm region w a s  photob leached  at fu l l  la se r  power and f luo rescence  
re cove ry  w a s  monitored by scann ing  who le  c e l ls  at low la se r  power (1%). 
F lu o re sce n ce  re cove ry  w a s  recorded as  a t ime se r ies  (1 s per frame).  
C u rves  were  fitted using GraphPad  Pr ism  4 and T1/2 v a lu es  and mobile 
frac t ions  determined.
• Immunoelectron microscopy
N2A ce l ls  t ransfected  with p E Y F P - h D M P K (R 6 0 0 A )  were  fixed for 1 hour 
in PH EM  buffer (60 mM P IP E S ,  25 mM H E P E S ,  10 mM EGTA, and 2 mM 
M gC l2, pH 6.9) contain ing 1%  (w/v ) fo rm a ldehyde  and 0.01% (w/v ) glu- 
ta ra ldehyde  and p rocessed  for immunogold detection and e lectron m i­
croscopy  as  descr ibed  (286).
• SDS-polyacry lamide gel electrophoresis and western blotting
Transfected  C2C12 and N2A ce l ls  were  lysed in NP-40 lys isbuffer  (50 
mM Tris-HCl, 150 mM NaCl, 1%  (w/v ) NP-40, 25 mM NaF, 1 mM s o ­
dium pyrophosphate, 0.1 mM vanadate ,  1 x protease inhibitor cock ta i l  
(Roche )  and 1 mM P M S F )  for 5 m inutes at 4oC. Crude lysa tes  w ere  c e n ­
tr ifuged for 10 m inutes at 14.000g at 4oC. Sup erna tan ts  w ere  co l lected, 
separa ted  by SD S- p o lya c ry la m id e  gel e lec trophores is  and t ransfe rred  
to PV D F  m e m b ran e s  (M i l l ip o re )  for immunodetection using an an t i- G FP  
antibody, fo l lowed by ho rse rad ish  peroxidase-conjugated  seco n dary  a n ­
tibodies ( J a c k s o n  Im m un oR esea rch  Laborator ies ) .  Immunodetect ion w as  
performed by enhanced  ch em i lu m in escen ce  and exposure to film (Kodak 
X-OMAT AR).
• Bioinformatics
Hydrophobic ity  w a s  ca lcu la ted  for each residue a s  an ave rage  hydropho- 
bic ity using the G ES  hydrophobic ity  s c a le  (70) and a w indow of seven 
amino ac ids. DMPK protein sequences  from var ious  spec ie s  we re  co l ­
lected as  descr ibed  in Sup p lem en ta ry  Experimenta l .
• S tat is tics
A l l  v a lu es  are  presented as  m ean ± SEM . S ta t is t i c a l  s ign i f icance  of T1/2 
and mobile  f rac t ions  in F R A P  an a lys is  w a s  a s s e s s e d  by a student 's  t- 
test, taking Y FP - m D M P K  E as  a re ference. A Chi-square  test w a s  used to 

























































































A hydrophobic  region in its ta i l  anchor  and the co i led-co il  domain are 
required for m itochondr ia l  targeting of human DMPK C.
A
577 583 HR 630
P g s l g l a y r r R f p c s c s p l f c l v p p p w a a l g w w pt p a n s p q s g a a q e p p a l p e P
YFP-hDMPK C M
YFP-hDMPK CO1' 583) C
YFP ^ ------- ) YFP-hDMPK C-534-630) C
YFP-W W W K]=^ YFP-hDMPK ci421'630) M
YFP
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1 m /  1
YFP-hD M PK C ___ mto merge
Figure 1 • Human DMPK C re­
quires the hydrophobic region 
in the C-terminus plus coiled 
coil domain for mitochondrial 
targeting.
(A ) P r im ary  seq u en ce  of 
hD M PK  C's C-term inus and 
s c h e m a tic  rep resenta tio n  of 
d ifferen t hD M PK  C-reLated 
Y F P  fus ion  p ro te ins and 
th e ir  subceLLuLar Loca l­
ization. HR = hyd rophob ic 
region (boxed seq uence),
M = m itochond ria , C=cytosoL. 
The subceLLuLar LocaLiza­
tion w a s  d ete rm ined  using 
confocaL m icro sco p y  after 
express ion  of fusion  pro te ins 
in C2C12 m yobLasts. CeLLs 
w e re  co-sta ined  for m ito ­
chondriaL m arker cytoch rom e 
c oxidase. (B -D ) Y FP-hD M PK  
C LocaLized to m itochondria. 
(E - G ) M utant YFP-h D M PK  
C(1 -583), w h ich  Lacks the HR, 
Located in the cytosoL. (H - J )  
Hum an D M PK C taiL 2 aLone 
(m u tan t Y FP-h D M PK  C(5 34-630)) 
did not ta rge t to m ito ch o n ­
dria, but resided  in the c y ­
tosoL. (K -M ) IncLusion of the 
coiLed coiL dom ain  bes ides 
the C-term inaL taiL resuLted 
in m itochondriaL LocaLization. 
Bars, 10 pm.
Memtirane a n ch o r ing Di' hDMPK iso forms a n d t r u n c a t e d  der iva t ives  
expres s e d a s Y F P fu s ion p^re^^ins w a s  exv m íse d in ( ^2C ie  m yobla s ts , u 
na t n a l tsne hf dost c e l l fc^ i‘ S)Z r^5W ( F i g. 1A). Fclb^fäi^^tS Y FS -^^ li lDM P ^ S; 
lonaUzsd ul ) hs M ^ M .a n  ck h e n t iF d csr othec c e ^ ^ e s f 2 f | S  ( F ^ . I B - ID1. 
A C-te rm in a l. ey e raf^Irrt^is i'vs ¡on ( H )i f .r^^^rr^titoun^t; ra ir x (i^5)) w as 
n e c s s se ay fuo th in a n s h o r m g .F i s s e  F p  h eM ^ aC  r e s 8 l t e d i c a  cyrohel ic  
lonaUeat ion ( dit]. 1E-G), h FU somnd^tox le s r  o) eo lusslizbtidn witd fCe 
m F oc doa d r ía l  m arno t  nyloeaHoesF si axiease. e c m n a n so n  g e lw sen  t tie
loca l ization of Y F P  fusion proteins with only the HR sequence  in the tail  
segm ent  (m utant  Y FP- h D M PK  C(534-630), Fig. 1 H - J )  or a ta i l  segm ent  plus 
coiled coil  domain immediate ly  upstream  (m utant  Y FP- h D M PK  C(421-630), 
Fig 1K-M) revea led  that both e lem ents  are  n e c e s sa r y  for proper m ito ­
chondr ia l  targeting. Of note, we had d if f icu lt ies  in defining the precise 
location of the Y FP- h D M PK  C(534-630) mutant because  in ce l ls  t ransfected  
with the vecto r  for this mutant a lso  some free  Y F P  tag w a s  produced 
( S u p p lem en ta ry  Fig. S1). Probably, the Y FP- h D M PK  C(534-630) product is 
more suscep t ib le  to proteoly t ic cl ipping, explaining a lso  the nuc lear  
staining in som e cells.
Figure 2 • A 12-amino- 
acid hydrophobic region in 
its C-terminal anchor is 
responsible for association of 
hDMPK A with mitochondria.
(A ) P r im ary  seq u en ce  of 
hD M PK  A 's C-term inus and 
s ch e m a tic  rep resenta tio n  of 
d ifferen t hD M PK  A-reLated 
Y FP  fusion  p ro te ins anc 
the ir subceLLuLar LocaL­
ization. HR = hyd rophob ic 
region (boxed s e ­
quences ), M = m itochondria, 
CM = cLustered m ito ch o n ­
dria, C=cytosoL, N = nucLeus, 
PA=protein agg regate s. The 
subceLLuLar LocaLization w as 
d ete rm ined  using con fo ca l 
m icro sco p y  a fte r expression  
of fus ion  p ro te ins in C2C12 
m yobLasts. CeLLs were 
co-sta ined  for m ito ch o n ­
driaL m arker cy to ch ro m e  c 
oxidase. (B -D ) Y FP-hD M PK  
A LocaLized to m itochond ria  
and cau sed  cLustering of 
m itoch on d ria  around the 
nucLeus. (E - G ) TaiL 1 aLone 
(m u tan t Y FP-h D M PK  a (534-629)) 
w a s  su ffic ien t for targeting  
to m itochond ria . (H - J )  
DeLetion of the ten uLtim ate 
C-term inaL am ino  acids, 
incLuding th ree  arg in ines, 
did not a ffect m itochondriaL 
LocaLization. (K-M ) DeLetion 
of HR2 pLus additionaL 
uLtim ate C-term inaL res id ues  
stiLL resuLted in a m ito ­
chondriaL LocaLization. (N -P ) 
Fused  to YFP, the uLtim ate 
30 am ino  ac ids, i ncLuding 
HR2, LocaLized to the  cytosoL 
and nucLeus. (Q -S ) IncLusion 
of aLso HR1 did not restore 
m itochondriaL LocaLiza­
tion, but induced  cytosoLic 
protein a g g reg a te s  (a rrow s).
Bars, 10 pm.
577 587 HR1 600 HR2 619 629
p a r v p r p g l s E a l s l l l f a v v l s T r A a a l g c i g l v a h a g o l t a v w R r p g a a r a p  
1----------------------------------------------------------------------------1 I------------------1
Y F P ^ ^ »  YFP-hDMPK A(534-629) M/CM
Y F P * ^ ------WMAMKW YFP-hDMPK AC1'600) M/CM
Y F P *  YFP-hDMPK A(600-629) C/N 























































































• Human DMPK A's tai l  requires HR1 but not HR 2 for mitochondrial  targeting
In a s im i la r  way, we examined wh ich  part of hDM PK A, the isoform with 
C-term ina l  ta i l  1 (see  (95 ) for ref)  w a s  responsib le  for su b c e l lu la r  t a r ­
geting. Fu ll- length hD M PK  A ta rg e ts  to the MOM in around 5 0 %  of the
C2C12 ce l ls ,  wh i le  the other ha lf  of the ce l l  population sh ow s  a cy toso lic  
distr ibution. In the major ity  of ca ses ,  m itochondr ia l  anchoring leads  to 
c luster ing of mitochondria  in the per inuc lea r  a rea  (216, 286) (Fig. 2A-D). 
S im i la r  d istribution behaviour w a s  observed  for the tai l-only  segment 
Y FP- h D M PK  A (534-629) demonstrat ing  that a l l  MOM targeting information is 
inc luded in the ta i l  1 segm ent  (F ig .  2E-G). S eq ue n ce  com par ison  of tai l  
1 segm ents  a c ro ss  mult ip le  spec ie s  indicated that cow, pig and sheep 
lack  the ten ult imate C-term ina l  am ino ac id s  found in other spec ies  
(S u p p lem en ta ry  Fig. S2). This decapept ide  segm ent  is p a r t icu la r ly  rich in 
arg in ines and prolines, res idues  known to be important in ta i l  anchoring 
(18). Yet, when we  removed this s t re tch  of amino ac ids  from the sequence 
of Y FP- h D M PK  A (Y FP - h D M P K  A (1-619)), no change in localization becam e 
apparent,  indicat ing that these res idues  do not contribute targeting in­
formation (Fig. 2 H- J ) .
Tail 1 conta ins two regions with high hydrophobic ity  (HRs),  separated  
by a s ingle arg in ine residue (Fig. 2A). D if ferent ia l  an a lys is  using a t run ­
cation mutant lack ing HR2 (Y F P - h D M P K  A (1-600)) or a Y FP  fusion protein 
ca rry ing  the HR2 motif only (Y F P - h D M P K  A (600-629)) showed that the first 
fusion product w a s  s t i l l  ab le  to anchor  to mitochondria  (Fig. 2K-M), wh i le  
the la tte r  did no longer a ssoc ia te  and distr ibuted throughout the cytoso l 
and nucleus (Fig. 2N-P). Targeting information of ta i l  1 thus res ides  
p redom inant ly  in HR1. In contrast ,  a Y F P  fusion protein ca rry ing  only HR1 
and HR2 (Y F P - h D M P K  A (587-629)) did not a ssoc ia te  with mitochondria,  but 
adopted a cy toso l ic  loca l ization (Fig. 2Q-S). There  it occurred  main ly  in 
am orphous complexes, probably large protein agg regates  formed as a 
resu lt  of the strong hydrophobic ity  of HR1.
• Length and hydrophobicity of the HR determine ta i l  anchor character ist ics
The observa t ion that spec i f ic  anchoring of hDM PK A a lso  has a m orpho ­
log ica l  effect , i.e., leads  to c luster ing of mitochondria  in the per inuc lear  
region (216), suggests  that there must be a re lat ionship  between tai l 
anchor  s tructure  and function. In fact, we know from e ar l ie r  work  that 
expression of the murine counterpart  of DMPK A a s s o c ia te s  spec i f ica l ly  
w ith  the ER  and induces anom a lous  m em brane  a r rangem ents ,  known 
as  O SER  s t ru c tu res  (286). Here  we  analyzed the coupling between TA 
s t ructure  and function in more deta il  in a compar ison  between effects  
of lengths and hydrophobic  propert ies  of m em brane  anchors  in DMPK A 
iso forms of human and mouse. A hydrophobic ity  an a lys is  of the re levant 
segm ents  of both ortho logues  is given in Fig. 3A-B (a ccord ing  to the GES  
sc a le  (70 ))  and e ffects  of d ist inct point mutat ions are  shown in Fig. 3C-D 
and Sup p lem en ta ry  Fig. S3.
A str ik ing d if fe rence  between mouse and human DMPK A is the p res ­
ence of R600 separat ing  HR1 and HR2 in hDMPK A and rep lac ing  an 
a lan ine  residue (A 602 )  at the equ iva lent  position in the centre  of the 
long HR in m D M P K  A (F ig .  3B). W e  pred icted  that introduction of a R600A 
mutation in hD M PK  A wou ld  in fac t  fuse HR1 and HR2 to one long HR 
with increased  hydrophobic ity  (Fig. 3A-B). Indeed, testing of this muta-
Figure 3 • Point mutations 
in the C-termini of DMPK A 
isoforms modulate organelle 
specificity and membrane 
clustering effects. 
Y FP-D M PK  A fusion  p ro te ins 
m utated  in th e ir  C-term ini 
w ere  exp ressed  in C2C12 
m yobLasts and anaLyzed for 
the ir targeting  c h a ra c te r is ­
t ic s  by confocaL m icroscopy. 
(A ) ALignm ent of am ino  acid 
se q u en ces  of D M PK A C- 
term inaL m utan ts  exam ined . 
R es id ue  num bering  is ind i­
ca ted  sep ara teLy for m ouse 
(top ) and hum an (b o ttom ) 
form s. H ydrophob ic  reg ions 
(H R s ) a re boxed, positiveLy 
cha rg ed  res id ues  a re boLd, 
point m u tations are in red.
A verag e  hyd rophob icity  
s co re s  (G E S  scaLe (7 0 ))  of 
the H Rs are ind icated  at 
the right, incLuding the size 
of the var io u s  hydrophob ic 
reg ions in itaLic, b e tw ee r 
brackets . (B )  H yd rop ho b ic ­
ity pLots of the  C-term ini 
of the p ro te ins Listed m 
(A ) i LLustrate e ffec ts  of 
point m utations  on LocaL 
hyd rophob icity. (C ) TypicaL 
exam pLes of five ca te g o ries  
of subceLLuLar LocaLization 
w h ich  w e re  scored  fo r wt 
and m utan t p ro te ins  Listed 
in (A ): MOM (w ith  or w ithou t 
cLustered  m itochond ria ), ER 
(w ith  our w ithou t O S E R s ) or 
cytosoL. Fifty  C2C12 ceLLs 
w ere  anaLyzed for each  
protein (n = 2) (D).
A
mDMPK A(R591L) R IP R PG LSEA l C l L l FAAA l AAa ATLGCTGLVAYTGGLTPVWCFPGATFAP 2.03(24) 
mDMPK A(L595R) RIPRPGLSEARCl Lr If A A A l Aa AATLGCTGLVAYTGGLTPVWCFPGATFAP 1.88(18) 
mDMPK AaA602R) R IPRPG LSEa RC l L l Fa A ALARAATLGCTGLVAYTGGLTPVwCFPGATFAP  2.33ai0)/1.5ia20)
591 595 602
mDMPK A RIPRPGLSEARC L L l FAAALAAAATLGCTGLVAYTGGLTPVWCFPGATFAP 2.01a22)
hDMPKA RVPRPGLSEA l S l L l F AVVLSrAAALGCIGLVAHAGQLTAVwIRRPGAARAP 2.28ai2)/1.37a20)
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To ad d re ss  influence of HR s t ructure  in a d if ferent way, we c r e ­
ated a m D M PK  m utant that c a r r ie s  a shorte r  H R  w i th  lower  a ve rage  
hydrophobic ity  and an extra posit ive charge  in the N-term inal flanking 
sequence  (Y F P - m D M P K  A (L595R)). The major ity  of c e l ls  expressing this m u ­
tant showed  a stain ing of the MOM, aga in  w ith  hard ly  any m itochondr ia l  
c luster ing  (Fig. 3D, Supp lem en ta ry  Fig. S3). In an a ttem pt to e longate the 
HR, we rep laced  R591 in m D M PK  for a leucine (the corresponding r e s i ­
due at the equ iva len t  posit ion in hD M PK ).  P r e se n ce  of this  e longated HR 
■ now with a negative  charge  ( E5 8 9 )  flanking the N-term inal  side, like in 
the hDM PK sequence  - did, however, not change the assoc ia t ion  with the 
























































































S im i la r  a n a ly s es  were  performed for hDM PK A's HR1 segm ent  of 
12 amino ac ids, wh ich  specif ied  MOM assoc ia t ion  and mito-cluster ing  
abil ity. Shortening of the hydrophobic region and exchange of the N- 
te rm ina l  f lanking negat ive  charge  for a posit ive one via introduction 
of a L589R mutation strongly  reduced m itochondr ia l  a ssoc ia t ion  and 
drove the protein into a cy toso l ic  loca l ization (Fig. 3D, Sup p lem en ta ry  Fig. 
S3; p<0.001). Rem arkab ly ,  introduct ion of mutation L593R, wh ich  sp li ts  
HR1 in two even s m a l le r  hydrophobic s t re tches ,  resu lted in a s ignif icant 
inc rease  in MOM assoc ia t ion , with reduced c luster ing ab il i ty  (Fig. 3D 
and Supp lem en ta ry  Fig. S3; p<0.001). Collect ive ly,  our findings imply that 
hDM PK- induced  m itochondr ia l  c luster ing  indeed depends on the high hy- 
drophobic ity  of the HR1 segment.  Furthermore, the data show  that subtle  
changes  in am ino ac id composit ion can strongly inf luence mem brane  
assoc ia t ion  chara c te r is t ic s .
A
YFP-mDMPK A # #
•
,/ i
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T1/2 (s) ± sem Mobile fraction ±  sem
YFP-mDMPK A 16.0 + 2.3 0.79 ±  0.10
YFP-mDMPK C 15.2 ±  3.6 0.32 ±  0.01
YFP-mDMPK E 2.4 ±  1.1 0.97 ±  0.09
YFP-hDMPK A 10.8 ±  2.4 0.17 ±  0.02
YFP-hDMPK C 16.9 ±  4.3 0.37 ±  0.06
Figure 4 • Tail-anchored 
DMPK isoforms show lateral 
diffusion but no quick ex­
change with a cytosolic pool.
Y FP-D M PK  p ro te ins w ere  ex ­
p ressed  in C2C12 m yo b las ts  
and su b jected  to FRA P  
an a lys is . (A ) A rep resen ta tive  
s e r ie s  of im ag es  show ing  a 
C2C12 m yob las t ex p ress ­
ing YFP-m D M PK  A during 
FR A P  ana lys is . B leach ed  
a rea  is 3.5 pm x 3.5 pm.
(B )  F lu o rescen t in tensities, 
norm alized  to p re-b leach  
va lu es , p lotted  aga ins t tim e 
from  FR A P  a n a ly se s  of five 
d ifferen t Y FP-D M PK  isofo rm s.
(C ) R eco ve ry  h a lf t im e  (T1/2) 
and m ob ile  fraction  for 
d iffe ren tia lly  lo ca liz ed  YFP-  
D M PK  iso fo rm s show n  in B. 
A ll v a lu e s  d iffe r s ig n ifican tly  
from  that ob tained  fo r YFP- 
m D M PK  E, except the  m ob ile  
fra c tio n  of Y FP- m D M PK  A
(n = 3; tw o  or th ree  c e lls  per 
experim ent).
• Membrane-anchored DMPK isoforms show lateral diffusion, but no rapid 
exchange with a cytosolic pool
B io c h e m ica l  extract ion exper im ents  dem onstra ted  that m D M P K  m e m ­
brane anchoring is robust and can only be disrupted by t rea tm ent  with 
detergents  (286). To examine m em brane  assoc ia t ion  dyn am ics  in another 
manner,  we  subjected Y FP- D M PK  fusion proteins to F R A P  an a lys is  (Fig. 
4A). Y FP- m D M PK  E, a cy toso l ic  sp l ice  isoform (296),  w a s  used as  re fe r ­
ence and showed a rapid re cove ry  with a T1/2 of 2.4 s, w ithout any a p ­
p rec iab le  immobile  f ract ion (F ig. 4B-C). ER-res iden t  Y F P - m D M P K  A d is ­
p layed a much s lo w e r  recovery  (Fig. 4A-C) and a mobile frac t ion of 0.79, 
implicat ing hardly  any exchange with a cy toso l ic  pool of new ly  s yn th e ­
sized protein but ra ther re cove ry  via la te ra l  diffusion in the m em brane  
(239). Recove ry  of MOM isoforms Y FP- h D M PK  A and C and Y FP - m D M P K  C 
w a s  even lower. Both Y FP- D M PK  C iso forms showed s im i la r  mobile  f r a c ­
tions of 0.32 and 0.37 and T1/2 of 15.2 and 16.9 seconds, respect ive ly  
(Fig. 4 B  and C). Y F P - h D M P K  A’s mobile  f rac t ion w a s  only 0.17, implicat ing 
a very  sta t ic  nature of the protein, when present on c lustered  m itochon­
dria. These resu lts  indicate that TA DMPK isoforms are  f irmly a ttached  to 
the m em brane  and show  only migration through la te ra l  diffusion.
• Membrane topology of DMPK tai l  anchors
Finally, we  performed a topology study on a l l  ta i l-anchored  mouse and 
human DMPK isoforms. To d isc r im inate  between s i tuat ions in wh ich  the 
C-terminus t ra ve rse s  the o rg ane l la r  m em brane  (N out- C )  or is a s s o c i ­
ated with the outer lea f le t  of the lipid b ilayer (N out-Cout), we generated 
Y FP-D M PK -H A  fusion construc ts ,  w ith DMPK flanked by an N-term inal 
Y FP-m o ie ty  and a C-term ina l  HA-tag. By w es te rn  blotting an a lys is  of ce l l  
f rac t ions  and im m unof luorescence  m icroscopy, we  first demonstrated  
that tagging with the HA moiety did not a lte r  DMPK's  m em brane  an ch o r ­
ing ab i l i ty  (S u p p lem en ta ry  Fig. S1 and S4). Topology of D M PK  proteins 
w a s  then analyzed using digitonin-induced se le c t ive  permeabi l izat ion of 
the p lasm a  m em brane  in combination with complete  perm eabil izat ion by 
Triton X-100 (see Sup p lem en ta ry  Fig. S5). Conspicuously, anti-HA im m u­
no f luo rescence  revea led  that the HA-tag at the C-terminus of YFP-m D - 
MPK  A-HA did not produce any spec i f ic  s igna l  in d ig iton in-permeabil ized 
ce l ls ,  indicating that the C-end w a s  loca l ized at the lum ina l  side of the 
ER  in C2C12 ce l ls  (Fig. 5A).
In contrast ,  under the condition of se le c t ive  permeabil izat ion with 
digitonin (F ig. 5B and C), the HA tag at the C-termini of mouse and hu­
man Y FP- D M PK  C y ie lded c le a r  s igna ls  and therefore  must be exposed 
( in )to  the cytoso l.  In the m ajor ity  of c e l l s  express ing  Y FP- h D M PK  A-HA, 
no HA-tag s igna l  w a s  detec tab le  a fte r  se le c t ive  perm eabi l izat ion of the 
ce l l  m embrane ,  suggest ive  of an N -C topology (F ig. 5D).
'  cytosol intermembrane space “  o j   ^ o  '
W e  know that in a minority  of c e l ls  the MOM had become leaky  due to 
the initiation of apoptosis , explaining the p resence  of ant i-HA s igna l  in 
some d igitonin-treated ce l ls  (216). G loba l  m em brane  permeabi l izat ion 
with Triton X-100 resu lted  in co loca l izat ion of Y F P  f luo rescen ce  and 
HA-immunosta in ing  in a l l  ce l ls .  E s se n t ia l  s im i la r  topology findings were  
obtained for t ransfected  N2A ce l ls ,  a neu rob las tom a ce l l  line, thus co n ­






























































































YFP 1 . HA x merge
Figure 5 • Topology of 
membrane-anchored DMPK 
isoforms.
Using  a d ig iton in-based , 
s e le c t iv e  p e rm eab iliz a t io r 
p ro toco l (see  Figu re  S5), 
m em b ran e  insertion  topology 
of Y FP-D M PK -H A  fusion 
p ro te ins  w a s  investiga ted  
in tra n s ie n t ly  transfected  
C2C12 m yob las ts . T rans ­
fected  c e lls  w ere  recogn ized  
by the ir Y F P  flu o rescen ce .
An anti-H A  an tib od y  w a s  
used  to d etect the  HA-tag 
at the  C-term inus of fusion 
prote ins. (A ) In d ig iton in- 
perm eab iliz ed  ce lls , the 
H A - ta g o fY F P - m D M P K  A-HA 
w a s  not a c c e s s ib le  in d ica t­
ing that the C-term inus w a s  
lo ca liz ed  at the  lu m in a l side 
of the ER  m em b ran e  (see  
illu s tra tion ). (B  and C) For 
both D M PK  C fusion  prote ins 
the HA-tag w a s  a c c e s ­
s ib le  a fte r m ild  d ig ito n ^  
perm eab ilization , ind icating  
that the C-term inus w a s  
loca ted  at the  cy toso lic  
s id e  of the  MOM. (D ) In the 
m ajo rity  of Y FP-h D M PK  A-HA 
tran sfec ted  c e lls  the  HA tag 
w a s  a cce ss ib le . A fter Triton 
X - 1 0 0 p e rm e a b il iz a t io n  a ll 
Y FP- p o s it ive  c e lls  d isp layed  
a c l e a r s i g n a l w i t h t h e  
a n ti- H A a n tib o d y .C = cy to so l,
I = in te rm e m b ra n e s p a c e , 
L= lum en. Bars, 10 pm.
• DISCUSSION
The m o le cu la r  p r inc ip les  that govern m em brane  insert ion and organe l le  
se le c t iv i t y  of C-termini of ta i l-anchored  proteins are  s t i l l  ra ther poorly 
understood. Here, we used long DMPK isoforms, wh ich  show  both sp lice-  
form and spec ies-dependent  var iat ion in in t race l lu la r  locat ion, as  m od ­
els to learn more about sequence  ch a ra c te r i s t ic s  that contro l  anchoring 
of proteins in the ER  or the MOM. E a r l i e r  s tud ies  of our group had a lready  
c lass if ied  DMPK as a m em ber of the func t iona l ly  highly v a r iab le  group 
of TA prote ins and identified D M P K s  of d if ferent sp ec ie s  a s  proteins 
w ith a p a r t icu la r  va r iab le  anchoring behaviour. In te rspec ies  difference 
in protein targeting as  noted for D M PK  A has been descr ibed  for at least  
one other protein, i.e., the equ i l ibra t ive  nucleos ide  t ranspo r te r  1 (161). 
E x am p les  of d if fe ren t ia l  location of sp l ice  va r ian ts  of TA proteins are 
a lso  known, e.g. the VAMP-1A protein targets  to the endom em brane  s y s ­
tem, w h e re a s  the VAMP-1B protein, a product of the s am e  VAMP-1 gene, 
loca tes  at  the MOM (119). A lso  SLMAP-TA1 locates  to the ER, w h e re as  its 
sp l ice-coun te rpa r t  SLAM P-TA2  loca tes  to the ER  and MOM (32).
Our study of human D M PK  C anchoring  presented  here, together with 
study of mouse DMPK C anchoring e a r l ie r  (286),  now def in it ive ly  e s ­
tab l ish es  that p resence  of a coiled coil  domain next to the ta i l  domain 
is required for proper insert ion. This suggests  that, in addit ion to the 
m oderate ly  hydrophobic ta i l  anchor  (a ve rage  score  of 1.54, G ES  sca le) ,  
some form of coopera t ive  binding in m u lt im er ic  complexes, assoc ia t ion  
w ith other m em brane  proteins,  or d irect binding of the co i led  co i l  domain 
to the m em brane  is c ru c ia l  (221). A lternat ive ly ,  p resence  of the coiled 
coil  domain may help to drive DMPK C's ta i l  in a m em brane- recep t ive  
conformation, even though protein s t ructure  so f tw a re  p red icts  that the 
ta i l  region has ch a ra c te r i s t ic s  of an unstructured  random coil. A co n ­
sensus  for MO M-anchored  proteins sh ow s  that their TAs are  of moderate  
hydrophobic ity , flanked by bas ic  res idues  (18). Human DMPK C conta ins 
bas ic  amino ac ids  only at the N-term ina l border of its HR. The c o r re ­
sponding res idues  have been shown to be important in anchoring of the 
mouse orthologue (286). A prominent and consp icuous  ch a ra c te r i s t ic  of 
DMPK C from both spec ie s  is the high (2 5 - 3 0 % )  proline content in and 
C -term ina l  of the HR. Pro l ine  res idues  in HRs have been im plicated  in 
sorting of inner m em brane  proteins in mitochondria  (192). In addition, 
proline res idues  have a strong impact  on the formation of a- h e l ic e s  and 
the e f f ic iency  of m em brane  insert ion (109). Hel ix-breaking proline re s i ­
dues in DMPK C's HR may thus prevent formation of long, t ran sm e m b ra ne  
a- h e l ic e s  and be responsib le  for the unique Nout-Cout topology in the MOM.
To our best knowledge, DMPK C iso forms are  the fi rst  TA proteins 























































































the m em brane  anchor  is embedded in the mem brane ,  ra ther than c r o s s ­
ing it. The very  large immobile  fract ion observed  during F R A P  ana lys is  
suggests  that rapid exchange with a cy toso l ic  pool of newly t rans la ted  
protein (220) w i l l  not occur. W e  propose that DMPK 's  tail, once inserted 
in the m embrane ,  may be engaged in mult imerization, in teract ions with 
other MOM-loca lized proteins (286) or adopts a conformation wh ich a l ­
lows a very  strong anchoring in the lipid bilayer (109).
Our an a lys is  of DMPK A confirmed that long, highly hydrophobic, r e ­
gions a s  p resent in this isoform, are  more prone to loca l ize  a protein 
to the ER, like mouse DMPK A (18, 137). This tendency  w a s  nicely il ­
lustra ted  by the behaviour of m D M PK  A(A602R) and hDM PK A(R600A). S w a p ­
ping of one s ingle charged  (A 6 0 2 R / R 6 0 0 A )  residue in the TA segm ent  of 
these mutants  induced a sh if t  in m em brane  locat ion. Others have shown 
that a charged  res idue may be to lerated within the TA when flanked by 
su ff ic ient  hydrophobic res idues  (109). B a s ic  re s idu es  flanking the HR 
appeared  less  important in the ca se  of DMPK A, a lthough for some point 
m utants  it w a s  d iff icult  to d isc r im inate  between e ffects  of loss  or gain 
of charge, or a l te ra t ions  in length and to ta l  hydrophobic ity  of the region. 
Surpris ingly ,  and not in a c co rd an ce  with p red ict ions from the consensus  
for MOM-targeted  TA proteins,  posit ive ly  charged  res idues C-term ina l  of 
HR2 appeared  not to be important for proper MOM targeting of hDM PK 
A (20). Taken together, these resu lts  show  that human DMPK isoforms 
A and C do not fu lly obey cu rrent ly  postu la ted  genera l  con sensu s  ru les  
for MOM-targeted TA proteins. W e do propose, however, that this sp e ­
cif ic  anchoring behaviour is entirely determ ined  by intr insic propert ies  
of DM PK 's  C-term ina l domain  based  on the observat ion that su b c e l lu la r  
part it ioning behaviour w a s  identica l  for each mutant in a l l  murine and 
human ce l l  types tested. E f fec ts  of extr ins ic  factors,  like d if fe rences  in 
lipid or protein composit ion of ta rget  m e m branes  in d ifferent c e l l  types 
(25, 138) can thus be excluded.
As  for a l l  ER-res ident  TA proteins for wh ich m em brane  topology w a s  
published, we found an Nout-Cin orientation for m D M PK A (18, 230, 154, 
305). W h e th e r  the s m a l l  C-term ina l region exposed in the ER  lumen has 
any func tiona l  in teract ions with so lub le  ER  proteins rem a ins  to be inves ­
tigated. Com parison to pub lished  data for m em brane  mobil ity  indicated 
that the mobil ity  of m D M PK  A is co m p arab le  to that of other regu la r  ER  
m em brane  proteins (239).
The few MOM-res ident TA proteins for which m em brane  topology w a s  
determ ined  a l l  showed exposure of their C-terminus in the in te rm em ­
brane space  (3, 138, 141, 292), s im i la r  to wh a t  we  observed  here  for 
hD M PK  A. B a se d  on est im at ions  of segm ent  length of l inear  amino ac id 
sequences ,  we a ssu m e  that it is the HR2 of hDM PK A that sp ans  the lipid 
bilayer, s ince the HR1 is probably  too short  to act  as  a t ran sm em brane  
domain (118, 302). The finding that separat ion  of HR1 in two hydrophobic 
segm ents  ( l ike  in mutant hDM PK A (L593R)) enhances  ra ther than impairs 
m itochondr ia l  localization, co rrobora tes  this conclusion. If not by direct 
m em brane  spanning, how then could  the com plete  HR1 sequence  be r e ­
quired for eff ic ient MOM targeting (co m p are  mutant hD M PK  A (1-600)) ?  We 
suggest  that HR1 con tr ibutes by becoming embedded in the outer leaf let  
of the MOM, much like is p roposed for hydrophobic  domain 1 in GDAP1 
(292), but exper im enta l  ev idence  for this idea is s t i l l  needed.
Apparently ,  s tas is  of D M PK  A production and m em brane  anchoring 
is essen tia l .  W e  observed  here and e a r l ie r  that m itochondr ia l  c lu s t e r ­
ing (and to a le sse r  extent O S ER  form ation )  can a l read y  be induced at 
moderate  le ve ls  of ectopic DMPK A expression (see  a lso  (216)). Taken 
together with f indings reported here, we  thus a ssu m e  that induction of 
o rgane l le  c luster ing  and protein aggregation is an intr insic capac i ty  of 
the hDM PK A ta i l  itself, and not a s im ple  e ffect of expression leve ls  that 
go far  beyond the phys io log ica l  threshold . Our m uta t iona l  an a lys is  d em ­
onstrated that only the HR1 in hDMPK A's ta i l  anchor  region w a s  a l read y  
su ff ic ient  for induction of aggregates .  Interruption of HR1 in fu ll  length 
hD M PK  A by mutating a leucine to an arginine residue (m u tan t  hDMPK 
A (L593R)) s trongly  reduced  its m itochondr ia l  c lus ter ing  ability. HR1's high 
hydrophobic ity  may induce formation of agg regates  when proper ta rg e t ­
ing and timing of anchoring fai ls. Ev idence  has been provided that a n ­
choring of highly hydrophobic TA proteins should be sw if t  (spontaneous 
insert ion (138))  or guided by chape rones  in order to p revent aggregation 
in the cy toso l  (18, 221). Possib ly , p resence  of an ad jacent  co iled coil 
domain a f fec ts  the eff ic iency or order of s teps  that help the protein 
domain tow ards  co rrec t  s t ru c tu ra l  assem bly ,  w ith or in o rgane l le  m e m ­
branes. For mitofusin 2 (234) it has been shown that p resence  of a coi led 
coil  domain a f fec ts  tethering behaviour of opposing m em branes .  Induced 
dense packing of m itochondr ia l  m em brane  s t ru c tu res  (216) may further 
potentiate ab no rm a l  in te rac t ion-assem b ly-anchor ing  of hDM PK A, thus 
explaining the strongly impaired F R A P  mobil ity  of hDM PK A.
In summary ,  our data support that length and hydrophobic ity  of the 
m em brane  anchor  is the dominant fac tor determining organe l le  sp e c i f ic ­
ity of D M PK  sp l ice  isoforms. Evo lut ionary  adaptat ion of the m em brane  
anchor  leading to a l te red  m em brane  location between spec ie s  may im ­
p lica te  d ifferent functions for mouse and human D M PK  A isoforms. A l t e r ­
natively, d if ferent ia l  m em brane  local ization may be of minor importance 
if D M PK  functions at ER-M OM con tac t  s i tes  (91). Future  study is needed 
to r e ve a l  deta i ls  about the re lat ion between in t race l lu la r  m em brane  
























































































• DMPK cDNA cloning and site-directed mutagenesis 
Y F P - h D M P K  C(1-583). A PCR  fragm ent w a s  am plif ied  by s ite-d irected  m u ­
tagenes is  using Pfu po lym erase  from tem plate  p E Y F P - h D M P K  C (286 ) 
w ith fo rward  pr imer 5'-CCTAGGCCTGGCCTAGCGGAGGCGCTTTCC-3' and r e ­
ve rse  p r im er 5 '-GGAAAGCGCCTCCGCTAGGCCAGGCCTAGG-3' (g ene ra tes  a 
Tyr584Stop mutation). The PCR product obtained w a s  digested with XhoI 
and the resu lt ing 1.7 kb f ragm ent contain ing the mutation w a s  l igated 
into the XhoI site of p E Y F P - h D M P K  C.
Y FP- h D M PK  C(534-630). A fragm ent encom pass ing  human ta i l  2 inc lud ­
ing the 3'-UTR w a s  PCR-am pl i f ied  from tem plate  p E Y F P - h D M P K  C with 
fo rward  pr imer 5'-GGAAGATCTGCTGTCACGGGGGTCCC-3' adding a BglII  
s ite and reve rse  p r im er 5 '-TGCAATAAACAAGTTAACAACAAC-3' located  in 
the mult ip le c loning site of the pEYFP-C1 backbone. The resu lt ing DNA 
w a s  tr immed with BglII ,  gel purified and subc loned  into the BglII  si te of 
pEYFP-C1.
Y FP- h D M PK  C(421-630). A f ragm ent encom pass ing  human ta i l  2 inc luding 
the 3 '-UTR w a s  PCR-am pl i f ied  from template  p E Y F P - h D M P K  C with fo r ­
w ard  pr imer 5'-GTCAGATCTATGGAAGTGGAGGCCGAGCAG-3' adding a BglII 
s ite and reve rse  p r im er 5 '-TGCAATAAACAAGTTAACAACAAC-3' located  in 
the mult ip le c loning site of the pEYFP-C1 backbone. The resu lt ing DNA 
w a s  tr immed with BglII ,  gel purified and subc loned  into the BglII  si te of 
pEYFP-C1.
Y FP- h D M PK  A (600-629). A fragm ent encom pass ing  hydrophobic  region 
1 (HR1 ) of human ta i l  1 including the 3'-UTR w a s  PCR-am pl i f ied  from
template  p E Y F P - h D M P K  A with fo rward  pr imer 5'-GTCAGATCTCGTGCCGC- 
CGCCCTG-3' adding a BglII  si te and reve rse  pr imer 5 '-TGCAATAAACAAGT- 
TAACAACAAC-3 ' located in the mult ip le cloning site of the p E Y F P - C 1 
backbone. The resu lt ing DNA w a s  tr immed with BglII ,  gel purified and 
subc loned  into the Bgl I I  s ite of pEYFP-C1 .
Y FP- h D M PK  A (587-629). A fragm ent encom pass ing  HR1 and 2 of human 
ta i l  1 inc luding the 3'-UTR w a s  PCR-am pl i f ied  from tem plate  p EYFP-hD -  
M PK  A with fo rward  pr imer 5'-GTGAGATCTGAGGCGCTTTCCCTGCTC-3' ad d ­
ing a BglII  si te and reve rse  pr imer 5 '-TGCAATAAACAAGTTAACAACAAC-3' 
located  in the m u lt ip le  c loning site of the pEYFP-C1  backbone. The r e ­
su lt ing DNA w a s  tr immed with BglII ,  gel purified and subc loned  into the 
BglII  si te of pEYFP-C1.
Y F P - m D M P K  A-HA. A fragm ent encom pass ing  the fina l  3' 900 bp of 
the coding region of m D M PK  A w a s  PCR-am pl i f ied  from template  p E Y F P -  
m D M PK  A with fo rw a rd  p r imer 5'-GCCGCTGGCAGACACAGTT-3' and r e ­
ve rse  pr imer 5'-GGCGGTACCTAAGCGTAATCTGGAACATCGTATGGGTAGGGGGC- 
GAAGGTGGCTC-3' adding an HA-tag and KpnI site. This fragm ent w a s
tr immed with XbaI and KpnI result ing in a 250 bp fragment.  Another 
f ragm ent  of about 1.1 kb encom pass ing  the 3'-UTR of m D M PK  A w a s  
PCR-am pl i f ied  with fo rward  pr imer 5 '-GCCGGTACCTGAACCCTAAGACTC- 
CAAGC-3’ adding a KpnI s ite and r e ve rse  p r imer 5'-TGCAATAAACAAGT-
TAACAACAAC-3 ' located in the mult iple cloning site of pEYFP-C1. The 
resu lt ing DNA w a s  tr immed with KpnI and Sa l I  resu lt ing in a 800 bp 
fragment. The f ragm en ts  were  subc loned  into p E Y F P - m D M P K  A digested 
with XbaI and Sa l I .
Y F P - m D M P K  C-HA. A f ragm ent encom pass ing  the f ina l 3’ 900 bp 
of the coding region of m D M PK  C w a s  PCR-am pl i f ied  from tem plate  
p E Y F P - m D M P K  C with fo rward  pr imer 5'-GCCGCTGGCAGACACAGTT-3' 
and reve rse  pr imer 5'-GGCGGTACCTAAGCGTAATCTGGAACATCGTATGGG- 
TAGGGTTCAGGGGGCGAAGG-3' adding an HA-tag and KpnI site. This f r a g ­
ment w a s  tr immed with XmnI and KpnI resu lt ing in a 450 bp fragment. 
Another f ragm ent of about 1.1 kb encom pass ing  the 3’-UTR of m D M PK  
C w a s  PCR-am pl i f ied  with fo rw ard  p r imer 5’-GCCGGTACCTGAACCCTA- 
AGACTCCAAGC-3' adding a KpnI site and reve rse  pr imer 5'-GCCGG- 
TACCTAAGACTCCAAGCCATCTTTC-3’ located in the mult ip le c loning site of 
p E Y F P- C 1 . The resu lt ing DNA w a s  tr immed with KpnI and S a l I  result ing 
in a 800 bp fragment.  The f ragm en ts  were  subc loned  into p E Y F P - m D M P K  
C digested with XmnI and SalI.
Y F P - h D M P K  A-HA. A f ragm ent encom pass ing  the fina l  3’ 900 bp of 
the coding region of hDM PK A w a s  PCR-am pl i f ied  from template  p E Y F P -  
hD M PK  A with fo rw ard  p r im er 5’-GCCGCTGGTGGACGAAGGG-3’ and r e ­
ve rse  pr imer 5'-GGCGGTACCTAAGCGTAATCTGGAACATCGTATGGGTAGGGAGC- 
GCGGGCGGCTC-3' adding an HA-tag and KpnI site. This f ragm ent w a s  
tr immed with Sst I  and KpnI resu lt ing in a 500 bp fragment.  Another 
f ragm ent  of about 1.1 kb encom pass ing  the 3 ’-UTR of hD M PK  A w a s  
PCR-am pl i f ied  with fo rw a rd  p r imer 5’-GCCGGTACCTGAACCCTAGAACT- 
GTCTTCG-3’ adding a KpnI site  and r e ve rse  p r imer 5-TGCAATAAACAAGT- 
TAACAACAAC-3 ' located in the mult iple cloning site of pEYFP-C1. The 
resu lt ing DNA w a s  tr immed with KpnI and Sa l I  resu lt ing in a 800 bp 
fragment. The f ragm ents  w ere  subc loned  into p E Y F P - h D M P K  A digested 
with Sst I  and SalI.
Y F P - h D M P K  A (1-619). A PCR  fragm ent w a s  am plif ied  by s ite-d irected  
m u tagenes is  from template  p E Y F P - h D M P K  A with fo rw ard  p r imer 5’-CT- 
CACCGCAGTCTGACGCCGCCCAGGAG-3’ and reve rse  p r im er 5’-CTCCTGGGC- 
GGCGTCAGACTGCGGTGAG-3' (g e ne ra tes  a Trp620Stop mutation).  The r e ­
su lt ing product w a s  digested with XbaI and EcoR I and the 1 kb fragment 
contain ing the mutation w a s  l igated into p EY F P - h D M P K  A digested with 
XbaI and EcoRI.
Y FP- h D M PK  A (1-600). A PCR fragm ent w a s  amplif ied  by s ite-directed 
m u tagenes is  from tem plate  p E Y F P - h D M P K  A with fo rw ard  p r imer 5’-GTT- 
GTTCTGTCTCGTTGAGCCGCCCTGGG-3' and reve rse  pr imer 5'-CCCAGGGCG- 
GCTCAACGAGACAGAACAAC-3 ' (g ene ra tes  an Ala601 Stop mutation). The 
resu lt ing product w a s  digested with XbaI and EcoRI and the 1 kb f r a g ­
ment contain ing the mutation w a s  ligated into p E Y F P - h D M P K  A digested 
with XbaI and EcoRI.
Y F P - h D M P K  A (R600A). A PCR  fragm ent w a s  amplif ied  by s ite-d irected  
m u tagenes is  from tem plate  p E Y F P - h D M P K  A with fo rw ard  p r imer 5’-CC- 























































































GCGGCAGCAGACAGAACAACGG-3 ’ (g ene ra tes  an A rg 6 00 A la  mutation). The 
resu lt ing product w a s  digested with XbaI and EcoR I and the 1 kb f r a g ­
ment contain ing the mutation w a s  ligated into p E Y F P - h D M P K  A digested 
w ith XbaI and EcoRI.
Y FP- h D M PK  A (L589R). A PCR fragm ent w a s  am plif ied  by s i te-d irec t ­
ed m utagenes is  from tem plate  p E Y F P - h D M P K  A with fo rward  pr imer 
5'-CTATCGGAGGCGCGTTCCCTGCTCCTGTTC-3' and reve rse  pr imer 5'-GAA- 
CAGGAGCAGGGAACGCGCCTCCGATAG-3’ (g e n e ra te s  a Leu589A rg  m u ta ­
tion). The resu lt ing product w a s  digested with XbaI and EcoRI and the 1 
kb f ragm ent contain ing the mutation w a s  ligated into p E Y F P - h D M P K  A 
digested with XbaI and EcoRI.
Y F P - h D M P K  A (L593R). A PCR  fragm ent w a s  amplif ied  by s i te-d irec t ­
ed m u tagenes is  from tem plate  p E Y F P - h D M P K  A with fo rw a rd  p r im ­
er 5’-CGCTTTCCCTGCTCCGATTCGCCGTTGTTCTG-3’ and reve rse  p r im ­
er 5’-CAG AACAACGGCGAATCGGAGCAGGGAAAGCG-3 ’ (g ene ra tes  a 
Leu593Arg mutation).  The resu lt ing product w a s  digested with XbaI and 
EcoR I and the 1 kb f ragm ent contain ing the mutation w a s  l igated into 
p E Y F P - h D M P K  A digested with XbaI and EcoRI.
Y FP - m D M P K  A (R591L). A PCR f ragm ent w a s  amplif ied  by s i te-d irec t ­
ed m u tagenes is  from template  p E Y F P - m D M P K  A with fo rw ard  pr imer 
5'-CTATCCGAGGCGCTTTGCCTGCTCCTGTTC-3' and reve rse  pr imer 5'-GAA- 
CAGGAGCAGGCAAAGCGCCTCGGATAG-3' (g e ne ra tes  an Arg591 Leu m u ta ­
tion). The resu lt ing product w a s  digested with XbaI and HindIII and the 
1 kb fragm ent contain ing the mutation w a s  ligated into p E Y F P - m D M P K  A 
digested with XbaI and HindIII.
Y FP - m D M P K  A (A602R). A PCR fragm ent w a s  amplif ied  by s i te-d irec t ­
ed m u tagenes is  from template  p E Y F P - m D M P K  A p lasm id  with fo rward  
p r imer 5’-CGCTGCTCTGGCTCGGGCCGCCACACTGG-3’ and reve rse  pr imer 
5'-CCAGTGTGGCGGCCCGAGCCAGAGCAGCG-3' (g ene ra tes  an A la602Arg  
mutation). The result ing product w a s  digested with XbaI and HindIII and 
the 1 kb f ragm ent contain ing the mutation w a s  ligated into p E Y F P -  
m D M P K  A digested w ith  XbaI and HindIII.
Y F P - m D M P K  A (L595R). A PC R  fragm ent w a s  am plif ied  by s i te-d irec t ­
ed m u tagenes is  from template  p E Y F P - m D M P K  A p lasm id  with fo rward  
p r imer 5’-CGTTGCCTGCTCCGGTTCGCCGCTGCTCTG-3’ and reve rse  pr imer 
5 ’-CAG AGCAGCGGCGAACCGGAGCAGGCAACG-3 ’ (g ene ra tes  an Leu595Arg 
mutation). The result ing product w a s  digested with XbaI and HindIII and 
the 1 kb f ragm ent contain ing the mutation w a s  ligated into p E Y F P -  
m D M P K  A digested w ith  XbaI and HindIII.
Cloning of Y FP- h D M PK  A (534-629) and Y FP- h D M PK  C-HA w a s  descr ibed 
e ar l ie r  (216).
• Bioinformatics
Mouse (N M_032418) and human (N M _ 0 0 4 4 0 9 )  DMPK nucleotide s e ­
quences (and protein sequences  derived from these )  we re  used as  query 
in B L A S T  s e a r c h e s  (b last .ncb i.n lm .n ih .gov/b las t .cg i)  in EST, protein, t r a n ­
sc r ip t  and genome d a tabases .  D M PK  protein sequences  we re  deduced 
from the fo l lowing nucleotide d a tabase  a ccess io ns ,  a ssum ing  that the 
a l te rna t ive  3' sp l ice  accep to r  site at the border of exon 14 w a s  used in 
each  sp ec ie s  (95):  Ochotona pr inceps, AAYZ01229401; Myot is  lucifugus, 
A A P E 0 1 124197; Spe rm o ph i lu s  t r idecem linea tus ,  AAQQ01017148; Ra t tus
norvegicus, X M _ 2 1 8411; Pan trog lodytes, X M _ 5 1 2759; M a ca c a  mulatta ,  
XM_001111220; M ic rocebus  murinus, ABDC01131798; Oto lemur garnett i i ,
AAQR01015434; Canis  fam i l ia r is ,  X M _ 5 4 1 551; Fe l is  catus, AANG01678636; 
Bos taurus, XR_028836 ; Sus  scrofa , CF791315, DT333544, and BE233962, 
Ovis ar ies ,  EE772416. No true D M PK  o rtho logues  could  be found in G a l lu s
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Supplementary Figure 1 • 
Assessment of proper expres­
sion of DMPK fusion proteins 
via western blotting.
(A ) P ro te ins  used in lo c a l­
ization s tud ies  in C2C12 
m yo b la s ts  (a n ti- G FP  po ly ­
c lo n a l antibody). M o le cu la r 
w e ig h ts  of m a rke r p rote ins 
are ind icated  w ith  a rrow  
heads (kD a). (B )  P rote ins 
used to study m em b rane 
topology in C2C12 (le f t) anc 
N2A (rig h t) c e lls  (an ti-G FP  
p o lyc lo n a l an tibody and 
anti-HA m o n o c lo n a l a n ti­
body). B la c k  a rro w s  ind icate 
s ig n a ls  rep resenting  YFP- 
DM PK-HA fusion  proteins. 
M o le cu la r w e ig h ts  of m arker 
p ro te ins are ind icated  w ith 
a rro w  heads (kDa).
C2C12B N2A
Supplementary Figure 2 • 
Sequence alignment of C- 
termini of DMPK isoforms A 
and C from different species.
DM PK protein seq u en ces  
w ere  d educed  from  the fo l­
low ing  nuc leo tid e  d a tabase  
a ccess io n s , a ssu m in g  that 
the a lte rn a t ive  3' sp lic e  a c ­
cep to r s ite  at the b order of 
exon 14 w a s  used in each  
sp ec ie s  [24] (O chotona  p rin ­
ceps, AAYZ0 1 22940 1; M yotis 
lucifugus, A A PE0  1 1 24 1 97;
S p e rm o p h ilu s  trid ecem -  
linea tus, A A Q Q 0 1 0 1 7 14 8 ;
Rattu s norveg icus, 
X M _ 2 1 8 4 1 1 ; M us m uscu lu s, 
N M _0  324 1 8; Hom o sapiens, 
N M _0  0440 9; Pan trog lodytes, 
X M _5  1 2759; M a ca ca  
m ula tta , X M _0 0  1 1 1 1 220;
M ic ro ceb us  m urinus, 
ABDC0 1 1 3 1 798; O to lem ur 
garnettii, AAQR0 1 0 1 5434;
Canis fam ilia ris , 
X M _5 4  1 55 1; Fe lis  catus, 
AANG0 1 678636 ; Bos  taurus, 
X R _0 2 8 8 3 6 ; Su s  scrofa, 
C F79 1 3 1 5 , DT333544, 
and B E2 3 3 9 6 2 ; Ovis a r ­
ies, EE7 7 2 4  1 6). No DM PK 
ortho logs  cou ld  be found 
in G a llu s  g a llu s  (ch ick ) 
or Danio rerio (zeb raf-  
ish). Num bering re fers  tc 
am ino ac id  seq u en ce  in man. 
Id en tica l am ino  a c id s  are 
show n  in w h ite  on a b lack  
b ackground . X = seq uence  























































































































m D M PKA
h D M P K A
Supplementary Figure 3 • 
Targeting of DMPK A point 
mutants.
Y FP-D M PK  A fus ion  pro te ins 
carry ing  s in g le  point m u ta ­
t ions  in the ir C-term inus 
w e re  tra n s ien t ly  expressed  
in C2C12 ce lls . D isp layed  
a re rep re se n ta tive  im ages 
of the lo ca liz a tion  of these 
m utan t prote ins. An a n ti­
COX an tib od y  w a s  used  to 
v isu a liz e  m itochondria. Co­
express ion  of a D sRed -ER  
m a rke r prote in w a s u s e d  to 
v isu a liz e  the ER. (A-C ) YFP-  
m D M PK  A (R591L) w a s lo c a l iz e d  
to the  ER  and induced  OSER 
s tru ctu res. (D -F ) Fusion pro­
te in  YFP-m D M PK  A (L595R) w a s  
found at m itochond ria  w ith ­
out any c y to so lic  stain ing. 
(G - I) An A 6 0 2 R  m utation  in 
m D M PK  A resu lted  in a shift 
in lo ca liz a tion  to the MOM 
and cytoso l. ( J- K )  A L589R  
m utation  in hD M PK  A re­
su lted  m a in ly  in a cy toso lic  
loca lization . In a m inority of 
c e lls  a m ito ch o n d ria l s ta in ­
ing w a s  ob served . (M -O) 
Y FP-h D M PK  A (L593R) lo c a l ­
ized to m itochond ria  and 
m ito ch o n d ria l c lu s te rin g  w as  
m a rk ed ly  reduced. (P - R ) 
M utant Y FP-h D M PK  A (R600A) 
targeted  to the  ER. The 
insert sh o w s  an en la rgem en t 
of the p erip h era l ER  net­
work. Bars, 10 pm. (S-T ) ER 
lo ca liz a tio n  of Y FP-hD M PK  
A (R600a> w a s  con firm ed  by 





Supplementary Figure 4 • 
Proper subcellular targeting 
of YFP-DMPK-HA fusion 
proteins.
C2C12 (A -H ) and N2A 
(I- P ) c e lls  w ere  tra n s ien t ly  
tran sfec ted  w ith  construc ts  
encod ing  YFP-D M PK -H A  
fusion  prote ins. Y FP-D M PK  
co n s tru c ts  w ithou t an HA- 
tag  w e re  used  as  control. 
S u b c e llu la r  lo ca lization  
of D M PK  fusion  prote ins 
w a s  a sse sse d  v ia  YFP  
flu o rescen ce . (A, B, I and 
J )  Y FP - m D M PK  A-HA and 
YFP-m D M PK  A lo ca liz ed  at 
the  ER. (C, D, G, H, K, L, C 
and P ) Y FP-D M PK  C-HA, like 
Y FP-D M PK  C, lo ca liz ed  at 
m itoch on d ria  and show ed  no 
im paired  anchoring  ca p a c ity  
in e ither c e ll  type. (E, F, M 
and N) Y FP-h D M PK  A-HA 
loca ted  at m itoch on d ria  and 
induced  the sa m e  c lu s te ring  
phenotype as  YFP-h D M PK  A.
Bars, 10 pm.
C2C12 N2A
YFP-m D M PK^
E
YFP-hDM PK A
G  % , YFP-hDM PK A-HAH























































































3 and 6 ^g/ml digitonin 0.3% TritonX-100
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Supplemental Figure 5 • 
Selective permeabilization 
of the cell membrane by 
digitonin treatment.
(A ) S c h e m e  dep ic ting  the 
s e le c t iv e  p e rm eab ilization  
p rinc ip le . Low  d igitonin 
co n cen tra tio n s  w e re  used 
to p e rm eab iliz e  the p lasm a  
m em b ran e  only. Triton X-100 
w a s  used to pe rm eab ilize  
a ll c e llu la r  m em b ranes. Thus 
p ro toco l w a s  su cce s s fu lly  
app lied  to C2C12 c e lls  (3 
m g/m l d ig ito n in ) (B )  anc 
N2A c e lls  (6 m g/m l d ig ito ­
n in ) (C). A c c e s s ib ility  of the 
cy to so l w a s  d em onstra ted  by 
an an tib od y  d irected  aga inst 
tubu lin . The ER  lum en  w as 
sta ined  w ith  an ti-PD I. The 
m ito ch o n d ria l inner m e m ­
brane and in te rm em brane  
sp a ce  w a s  sta ined  w ith 
anti-COX or anti-HtrA2/Om i 
rep ective ly . Bars , 10 pm.
A
Supplementary Figure 6 • To­
pology of tail-anchored DMPK 
isoforms in N2A cells.
Using  a s e le c t ive , d ig itonin- 
based  p e rm eab iliz a tio r 
p rotocol, m em b ran e  topology 
of Y FP-D M PK -H A  fusion 
pro te ins w a s  investiga ted  m 
tra n s ien t ly  tran sfected  N2A 
n eu ro b las to m a  ce lls . T ran s ­
fected  c e lls  w e re  recognized 
by the ir Y F P  flu o rescen ce . 
An anti-H A  an tibody w a s  
used  to de te ct the C-term i­
nus of fusion  proteins. (A ) In 
d ig ito n in- perm eab ilized  c e lls  
the HA-tag of Y FP-m D M PK  
A-HA w a s  not a c c e s ­
s ib le  ind icating  that the 
C -term inus w a s  lo ca lized  at 
the  lu m en a l s id e  of the ER 
m em b ran e  (see  sch em a tic  
rep resenta tion  of the protein 
in the m em b rane). (B  and 
C) For both DM PK C fusion 
p ro te ins the  HA-tag w a s  a c ­
c e s s ib le  a fte r m ild  d ig ito n ^  
p erm eab ilization , ind icating  
that the C-term inus w a s  
lo ca ted  at the c y to so lic  s ide 
of the MOM. (D ) A m ixed 
population  w a s  ob served  
a fte r Y FP-h D M PK  A-HA 
trans fec tion : in one-th ird  of 
d ig iton in- trea ted  c e lls  the 
HA tag w a s  a c c e s s ib le  tc 
the  HA-antibody, w h e re a s  in 
the  other tw o-th ird  no s ig ­
na l w a s  d etected . C=cytosol,
I = in n erm em b ran e  space, 
L= lum en. Bars, 10 pm..
A
YFP-m D M PK A-HA
YFP-m D M PK C-HA
C
YFP-hD M PK  C-HA
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Background: Studies on the myotonic dystrophy protein kinase (DMPK) 
gene and gene products have thus far main ly  concentrated on the fate of 
length mutation in the (CTG)n repeat at the DNA level and consequences 
of repeat expansion at the RNA leve l in DM1 patients and disease models. 
Surpr is ing ly l i t t le  is known about the function of DMPK protein products.
Methodology/Principal Findings: We demonstrate here that t rans ient ex­
pression of one major protein product of the human gene, the hDMPK A
isoform with a long ta i l  anchor, resu l ts  in m itochondr ia l f ragmenta tion 
and cluster ing in the per inuc lear region. Cluster ing occurred in a va r ie ty  
of ce l l  types and was enhanced by an intact tubulin cytoskeleton. In 
addition to morphomechan ica l changes, hDMPK A expression induces 
physiolog ical changes like loss of m itochondr ia l membrane potential, 
increased autophagy activ i ty  and leakage of cytochrome c from the m i­
tochondria l in termembrane space accompanied by apoptosis. Truncation 
analys is using YFP-hDMPK A fusion constructs revealed that the protein's 
ta i l  domain was necessary and suffic ient to evoke mitochondria l c lu s te r­
ing behavior.
Conclusion/Significance: Our data suggest that the expression leve l of the 
DMPK A isoform needs to be t ight ly  control led in ce l ls  where the hDMPK 
gene is expressed. We speculate that abe rran t splice isoform expression 
might be a codetermining factor in manifestation of specific DM1 features 
in patients.
• INTRODUCTION
The myotonic dystrophy protein kinase (DMPK) gene is involved in myo­
tonic dystrophy type I (DM1) when it is mutant and contains an unstable 
(CTG)n segment in its 3' te rm ina l exon (176). DMPK encodes seve ra l  se r­
ine/th reonine protein kinases, bel ieved to be involved in ion homeostasis  
and remodeling of the actin cytoskeleton (13, 95, 199, 296). Up t i l l  now, 
emphasis in most DM1 studies was on the pathobiological signif icance 
of toxic RNA products from the mutant DMPK gene. Only re la t ive ly  few 
studies have addressed indiv idual protein products from the DMPK gene, 
including the ir  no rma l st ruc tu re  function re la t ionship  (135, 297).
Consti tutive and regula ted modes of a l te rna t ive  splic ing exist for 
DMPK pre-mRNA and resu l t  in the expression of six majo r DMPK splice 
isoforms, conserved between mouse and man. Ind iv idual isoforms are 
characterized by presence of e ither one of two types of long C-termini 
( ta i l  versions 1 or 2; DMPK isoforms A to D) or a ra the r shor t C-terminus 
( ta i l  3; isoforms E and F), combined with absence or presence of an 
in terna l VSGGG-motif (A vs B, C vs D, E vs F) (95). DMPK isoforms A-D 
are typ ica l tail-anchored proteins w ith a membrane segment in the ir  C- 
terminus. These isoforms are main ly  expressed in heart, ske le ta l  muscle 
and brain. Isoforms E and F are cytosolic proteins, p redominant ly  found 
in smooth muscle ce l ls  (95, 215, 296).
Previously, we demonstra ted that ta i l  anchors in DMPK A/B and 
DMPK C/D drive binding to specific o rgane l la r  membranes (259). In 
mouse, this resu l ts  in binding of mDMPK A and B to the endoplasmic 
re t icu lum (ER) and in binding of mDMPK C (and D) to the m itochondria l 
outer membrane (MOM). In humans, hDMPK A/B and C/D have also d is­
tinct tails, but these isoforms a l l  anchor to the MOM. Isoform hDMPK A 
is unique in that its t rans ient expression causes mitochondria l mo rpho l­
ogy to become abnormal, eventua l ly  leading to ce l l  death via an as yet 
unidentified mechanism (286).
Mitochondria form an elaborate network  with va r iab le  morphology 
and spat ia l distribution, t ightly control led by the physiological state of 
the ce l l  and dependent on ce l l  type and metabolic needs (12). Organel la r 
fo rm and function in this ne twork are regula ted by fission and fusion 
w ith important bearing on the in terna l d is tr ibution of energy metabolites, 
the mode of sequestrat ion of in t race l lu la r  Ca2+ ions (261) and perhaps 
even apoptosis signaling (312). MOM-associated proteins like mitofus ins
1 and 2 (Mfn1 and 2) and OPA1 or hFis control m itochondria l f ragm en ta­
tion or per inuc lear localization (115, 234, 246, 311).
Various diseases, e ither coupled to acquired or inherited defects in 
bioenergetic c ircu its or to abno rma l i t ies  in the fission-fusion machinery 













































































































































































































patients, abno rma l m itochondr ia l fo rm and mitochondr ia l dysfunction 
have been described (258, 284). Furthermore, overexpression of RNA and 
protein products from a hDMPK (CTG)11 transgene in a DM1 mouse model
induced accumulat ion of m itochondr ia  in the subsa rco lem m a l space and 
formation of abe rran t cr is tae and caused a reduced work load tolerance 
in mice (211).
Quantitat ive and qual i ta t ive aspects of DMPK biology -via m ito ­
chondr ia l involvement- could thus contr ibute to typ ica l features of DM1 
disease manifestation, including defect ive Ca2+ ion homeostasis, insulin 
resistance and loss of ce l l  v iab i l i ty  in muscle, brain and other organs 
(135). Here we report on one aspect, consequences of expression of 
the hDMPK A isoform, in pa r t icu la r  its binding to the MOM. By use 
of transfect ion-complementation exper iments in cu ltured cells , w ith  or 
without DMPK deficiency, we analyze hDMPK A's ro le in determining m i­
tochondria l fate and function and the funct ional in tegri ty of the cell. We 
demonstrate that the protein's C-terminal ta i l  is sufficient for induction 
of per inuc lear cluster ing. Microscopy and biochemical ana lys is  revealed 
that m itochondr ia l cluster ing was associated w ith increased autophagic 
activity. Ultimately, decoration of m itochondr ia  w ith hDMPK A resu l ts  in 
loss of cell-funct ional in tegri ty and in the in itiat ion of apoptosis.
• MATERIALS AND METHODS
• Antibodies and chemicals
Staining with anti-cytochrome c oxidase antibody (262) was used to v is u ­
alize mitochondria  and monitor apoptosis. Monoclonal ß-tubulin antibody 
E7 (Deve lopmenta l Studies Hybridoma Bank, Univers ity  of Iowa, Iowa City, 
Iowa) was used to stain the tubulin  cytoskeleton. TexasRed-conjugated- 
phallo id in stain ing (Mo lecu la r Probes, Breda, The Nether lands) was used 
to v isua l ize  F-actin. Manipula tion of the cytoskele ton was performed 
by incubating ce l ls  for 18 hours in ce l l  cu ltu re  medium supplemented 
w ith 3 |j M  nocodazole (Sigma, Zwijndrecht, The Nether lands) or 0.6 pM 
cytochalasin D (Sigma). Mouse monoclonal antibody 12CA5 was used to 
detect the HA epitope tag. For western blotting DMPK-specific antibody 
B79 (95), ß-tubulin antibody E7 and LC3b polyc lonal antibody (Cell S ig­
nall ing, Beverly, Massachusetts) were used. Apoptosis was inhibited by 
addit ion of 100 j M  of the pan-caspase inhibitor z-vad-fmk (R&D systems, 
Abingdon, UK) to the cu ltu re  medium for 16-72 hours.
• Cell culture and DNA transfection
C2C12 myoblasts (ATCC #CRL-1772), N2A neurob lastoma cells (ATCC 
#CCL-131 ) and HeLa ce lls  (ATCC #CCL-2) were grown subconfluent in 
DMEM supplemented with 10% FCS and main tained at 37oC under a 5% 
CO2 atmosphere. C2C12 and N2A ce lls  were t rans ien t ly  transfected with 
expression p lasmids (specified below) using Lipofectamine (Invi trogen, 
Breda, the Nether lands) as specified by the manufacturer. HeLa cells 
were t rans ien t ly  t ransfected using polyethyleneimine. Afte r transfection 
cells were main tained in cu ltu re for an add it ional 8-72 h prio r to ana ly­
sis. A lte rnat ive ly , we used adenovira l vector-based DNA transduction for 
expression of single hDMPK isoforms in DMPK knockout (KO) myoblasts 
(286), since transfection with lipofectamine or polyethyleneimine does 
not achieve sufficient efficiency.
To force C2C12 myoblasts to use mitochondr ia l oxidat ive phosphory­
lat ion for the production of ATP, ce l ls  were cultu red in DMEM without 
glucose, supplemented with 10 mM galactose, 1 mM sodium pyruvate, 2 
mM g lu tamine and 10% dialyzed FCS. Cells were main tained at 37°C un­
der a 5% CO2 atmosphere. To m ax im a l ly  s t imu la te  glycolyt ic metabolism, 
C2C12 myoblasts were cu ltured in DMEM, 10% FCS with 10 mM glucose 
and 1 pM of the m itochondr ia l uncoupler FCCP (Sigma, Zwijndrecht, The 
Nether lands) and main tained at 37°C under a 2% O2 atmosphere. Cells 
were a llowed to adapt to these cu ltu re conditions for 5 days, transfected 
w ith equal amounts of p lasmid DNA encoding YFP-hDMPK A or C and 
then main tained in cu ltu re  for an addit ional 20 hours before the number 







































































































Autophagy was induced by placing ce l ls  in nutr ient-starvation m e­
dium Ear le's Balanced Salt Solution (EBSS) for two hours.
• Plasmids and adenoviral vectors for DMPK expression
EYFP-DMPK expression vectors were obtained by cloning appropria te
DMPK cDNA segments into pEYFP-C1 (Clontech, Saint-Germain-en-Laye
France) and pSG8AEco vectors (286, 296). Inserts of a l l  expression 
p lasm ids were composed of re levant domains from the open reading 
frames plus the adjacent 3'-UTR of DMPK cDNAs. A l l  segments obtained 
via PCR were verif ied by DNA sequencing.
MonoYFP-hDMPK A. To introduce a L221K mutat ion into YFP, pEYFP- 
C1 vector was PCR-amplif ied w ith fo rward p r imer 5'-GATCACATGGTCCT- 
TAAGGAGTTCGTGACC-3' and reverse p r imer 5'- GGTCACGAACTCCTIA- 
AGGACCATGTGATC-3' (mutation underlined). The resulting fragment was 
digested w ith  BsrGI and NheI, gel puri fied and subcloned into pEYFP-C1. 
A BglII excised hDMPK A fragment was introduced into the BglII site.
YFP-hDMPK A(K100A). A PCR fragment was amplif ied by site-directed 
mutagenesis  from a templa te pEYFP-hDMPK A p lasmid w ith fo rward 
p r imer 5'-GGCCAGGTGTATGCCATGGCAATCATGAACAAGTGGGAC-3' and re ­
verse p r imer 5'-GTCCCACTTGTTCATGATTGCCATGGCATACACCTGGCC-3' (m u­
tation underlined). The result ing PCR product was digested w ith BspEI 
and the fragment containing the mutation was subcloned between two 
BspEI sites of pEYFP-hDMPK A.
YFP-hDMPK A (534-6l9). A fragment encompassing human ta i l  1 inc lud­
ing the 3'-UTR was PCR-amplif ied from pEYFP-hDMPK A with fo rward 
p r imer 5'-GGAAGATCTGCTGTCACGGGGGTCCC-3' adding a BglII site (under­
l ined) and reverse p r imer 5'-TGCAATAAACAAGTTAACAACAAC-3' located 
in the mult ip le  cloning site of the pEYFP-C1 backbone. The resulting DNA 
was tr immed with BglII, gel purified and subcloned into the poly l inker of 
vector pEYFP-C1.
YFP-hDMPK a ®34-62®*3'-™. A fragment encompassing human ta i l  1 
excluding the 3'-UTR was PCR-amplif ied from pEYFP-hDMPK A with fo r­
ward p r imer 5'-GGAAGATCTGCTGTCACGGGGGTCCC-3' adding a BglII site 
(underlined) and reverse p r imer 5'-CGAATTCTCAGGGAGCGCGGGCGG-3' 
located at the stop codon containing an EcoRI site (underlined). The 
result ing DNA was tr immed w ith  BglII and EcoRI, gel puri fied and sub­
cloned between the BglII and EcoRI restr ic t ion sites in the po ly l inker of 
pEYFP-C1.
YFP-3'-UTR. A fragment encompassing the hDMPK A 3'-UTR was PCR-
ampli f ied from pEYFP-hDMPK A, with fo rward p r imer 5'-GGAAGATCTT- 
GAACCCTAGAACTGTCTTC-3’ adding a BglII si te (underlined) and reverse
pr imer 5'-TGCAATAAACAAGTTAACAACAAC-3' located in the mult ip le  c lon­
ing site of the p EYFP-C1 backbone. The result ing DNA was t r immed with 
BglII, gel pur if ied and subcloned into the po ly l inke r in vector pEYFP-C1.
hDMPK C-HA. A fragment encompassing the f ina l 900 bp of the cod­
ing region of hDMPK C was ampli f ied by PCR from pEYFP-hDMPK C with 
fo rward p r imer 5'-GCCGCTGGTGGACGAAGGG-3' and reverse p r imer 5'-GC- 
C G G T A C C T A A G C G T A A T C T G G A A C A T C G T A T G G G T A G G G T T C A G G G A G C G C G G - 3 '  
adding an HA tag ( i ta l ics) and KpnI site (underlined). The PCR fragment 
was t r immed w ith SstI and KpnI result ing in a 500 bp fragment. A f rag ­
ment of about 1.1 kb encompassing the 3'-UTR of hDMPK C was PCR a m ­
82
plified with forward p r imer 5-GCCGGTACCTGAACCCTAGAACTGTCTTCG-3' 
adding a KpnI site (underlined) and reve rse  p r imer 5'-TGCAATAAACAAGT-
TAACAACAAC-3' located in the mult ip le cloning site of pEYFP-C1. The 
PCR product was tr immed with KpnI and SalI result ing in a 800 bp f rag ­
ment. The two fragments were subcloned into pEYFP-hDMPK C digested 
w ith SstI and SalI. The pEYFP-hDMPK C-HA construct was digested with 
BglII  and ligated into the BglII si tes of pSG8AEco resu l t ing in pSG8AEco- 
hDMPK C-HA.
E1/E3-deleted serotype 5 adenov ira l vectors encoding YFP-hDMPK 
isoforms A and C under the control of a CMV IE-promoter were generated 
using the AdEasy Vector System (106), as described (41). In brief, cD- 
NAs encoding YFP-hDMPK isoforms includ ing the ir  3'-UTR, were obtained
from pEYFP-hDMPK A or C and cloned into t ransfe r  vector pShuttle-CMV. 
In a second step, pShutt le-YFP-hDMPK plasmid was recombined with 
the v i r a l  DNA plasmid pAdEasy-1 in E. Coli stra in BJ5183. Next, v i ra l  
part ic les were generated in N52.E6 (249) v i r a l  packaging ce lls  (93). A d ­
enovira l vectors were purified using CsCl gradient puri fication and stored 
at -80oC. The v i ra l  t i te r and plaque forming units were determined (41).
• Immunofluorescence microscopy
Cells were grown on g lass coverslips, fixed in PBS containing 2% (w/v) 
fo rmaldehyde ~20 h af ter t ransfect ion and permeabi lized in PBS contain­
ing 0.5% (w/v) Nonidet P-40 substitute. Samples were processed for im ­
munofluorescence microscopy using standard procedures. Images were 
obtained with a Bio-Rad MRC1024 confocal laser scanning microscope 
(Biorad, Hercules, Cal iforn ia ) equipped w ith  an argon/krypton laser, us­
ing a 60x 1.4 NA oil object ive and LaserSharp2000 acquisition software.
• Time lapse imaging
Transfected KO myoblasts or N2A ce l ls  were stained for 30 minutes using
1 pM MitoTracker Red (CM-H2XROS; Invitrogen). Afte r washing with acqui­
sition medium (DMEM w ithou t phenol red supplemented w ith  10% (N2A)
or 20% FCS (KO myoblasts)), dishes were mounted into a temperature- 
controlled incubation chamber on the stage of an inverted microscope 
(Ax iover t  200 M; Car l Zeiss, Jena, Germany) equipped with a 63x, 1.25 NA 
Plan NeoFluar oil- immersion objective. Images were acquired every three 
minutes in three Z-directions at 33°C for myoblasts and 37°C for N2A 
ce l ls  during which ce l ls  were main tained in standard cu ltu re medium 
w ithout phenol red. YFP was excited at 510 nm w ith  an acqu is i t ion / i l­
luminat ion t ime of 200 ms and f luorescence light was directed through a 
545AF35 emission f i l te r (Omega Optical, Bratt leboro, VT). MitoTrackerRed 
was excited at 568 nm (Polychrome IV) with an acqu is i t ion / i l lum ina­
tion time of 200 ms and f luorescence light was directed by a 525DRLP 
dichroic m ir ro r  (Omega) through a 564AF65 emission f i l te r (Omega). A 
CoolSNAP HQ monochrome CCD-camera (Roper Scientif ic Photometrics, 
Vianen, The Nether lands) was used and no bleed through was detected. 
Hardware was control led by and images were analyzed using Metamorph 
6.2 software for mean fluorescence in tensity of the mitochondr ia l area.
• Western blotting













































































































































































































pH 7.5, 150 mM NaCl, 25 mM NaF, 1 mM sodium pyrophosphate, 0.1 mM 
vanadate, 1 mM PMSF, 1x protease inhibitor cockta i l (Roche, Mannheim, 
Germany), 1 mM EDTA). Lysates were cleared by centr ifugation for 10 
min at 14,000g at 4°C and supernatant fract ions were mixed w ith SDS- 
PAGE sample buffer. Lysates were separated on 8% SDS-PAGE gels and 
t ransfe rred  by western blotting to PVDF membrane. As secondary an t i­
body, HRP-conjugated IgG (Jackson ImmunoResearch Laboratories, UK) 
was used, and signals  were generated by ECL, fo l lowed by exposure to 
f i lm  (Kodak X-OMAT AR).
• Mitochondrial membrane potential (MMP)
HeLa ce lls  were cu ltured in W i l lco dishes (W il lco  w e l ls  B.V., Amsterdam, 
The Nether lands) and transfected with pEYFP-hDMPK A and pEYFP-hD- 
MPK C. A f te r ~20 h, ce lls  were stained for 30 minutes using te t ram e th­
y lrhodam ine methy l ester TMRM (Invitrogen) at 100 nM in DMEM supp le­
mented with 10% FCS. Wilco dishes were mounted on the stage of the 
inverted microscope. Experiments were performed at room temperature  
during which ce l ls  were main tained in phenol red-free DMEM supp le­
mented w ith 10% FCS. TMRM was excited at 555 nm with an acquisit ion/ 
il lum ina tion time of 100 ms using a monochromator (Polychrome IV, TILL 
Photonics, Gräfelfing, Germany) and f luorescence light was directed by 
a 560DRLP dichroic m ir ro r  (Omega) through a 565ALP emission f i l te r 
(Omega) and detected as above. YFP was excited at 470 nm (Polychrome 
IV) with an acqu is it ion/ i l lum inat ion t ime of 100 ms and fluorescence 
light was directed by a 505DRLPXR dichroic m ir ro r  (Omega) through a 
565ALP emission filter. No bleed-through was detected. A l l  hardware 
was controlled using Metaf luor 6.0 so ftware  (Mo lecu la r Devices Corpo­
ration, Downingtown, PA). Images were analyzed using Metamorph 6.2 
software for mean fluorescence in tensity of the mitochondr ia l area (149).
• Electron microscopy
Cells were fixed in 2% glu tara ldehyde in 0.1 M cacodylate buffer and 
post-fixed for 1 h in 1% osmium tetroxide and 1% potassium ferrocya- 
nide in 0.1 M cacodylate buffer. A f te r  washing in buffer, ce lls  were de­
hydrated in an ascending series of aqueous ethanol and t ransfe rred  via 
a m ix tu re  of e thanol and Epon to pure Epon 812 as embedding medium. 
U l trath in sections (60-80 nm) were cut, contrasted with aqueous 3% 
urany l acetate, rinsed, and counters tained with lead citrate, a ir  dried, 
and examined in a JEOL JEM1010 electron microscope (JEOL, Welwyn 
Garden City, UK) operating at 80 kV.
• Autophagosome quantification by LM and EM
Samples were fixed and embedded as described for EM analysis. 1% 
osmium tetroxide was included to increase v is ib i l i ty  of membranes (310). 
Sections of 0.5 pm were cut and stained w ith  tolu idine blue. Sections 
were mounted on a cover g lass using Euk i t t  (Sigma-Aldrich) and ana­
lyzed using light microscopy w ith  a Leica DM6000B/CTR6000 imaging 
system and Leica IM500 Image Manager acquisition software (Leica, 
Solms, Germany). The percentage of ce l ls  containing one or more sphe r­
oid autophagosome s t ruc tu res was quantified. Quantif ication on ult rath in 
sections by electron microscopy was done in a s im i la r  manner.
• Statistics
Data are expressed as mean ± s.e.m. Between group comparison was 
performed by two-tailed unpaired Student's t-test. Differences between 
groups were considered signif icant when P<0.05. * P<0.05, **  P<0.01, *** 
P<0.001. S ta t is t ica l analyses were performed with GraphPad Prism 4 
software. The number of rep licates and the number of ce l ls  counted per 














































































































































































































• The ta i l  region of hDMPK A is responsible for per inuclear mitochondrial 
clustering
Ear lier, we had observed that hDMPK A has the capacity to local ize 
to the MOM and affect m itochondr ia l d is tr ibution in a broad range of 
ce l l  lines (286). To analyze quantita t ive and qual i ta t ive aspects of this 
phenomenon in more detail, we used transfection of C2C12 myoblasts, a 
na tu ra l  host ce l l  line for DMPK proteins (215). Transfection of YFP- hD­
MPK A resulted in m itochondr ia l decoration in -60% of a l l  YFP-positive 
cells, whi le  for the remaining -40% a cytosolic f luorescence w ithout 
m itochondr ia l binding was observed. In contrast, m itochondr ia l YFP- 
fluorescence was found in v i r tu a l ly  a l l  ce l ls  that expressed YFP-hDMPK 
C. Classif ication of ce lls  with MOM-bound hDMPK A (see Fig. 1A for 
morpho log ica l classes) revealed that the major i ty  of cells contained 
mitochondr ia  w ith a clustered appearance (Fig. 1B). Approx imate ly  25% 
possessed fragmented mitochondria  and only few showed a network of 
normal,  elongated mitochondria. Frequencies in the d if ferent categories 
varied somewhat w ith exper imenta l conditions, including transfection 
dose and duration (data not shown). V i r tu a l ly  a l l  m itochondria  in cells 
w ith  cytosolic YFP-hDMPK A displayed a no rma l elongated appearance 
(Fig. 1A, lowest panel), s im i la r  to ce lls  with MOM-bound YFP-hDMPK C 
or mock-transfected cells. Taken together, these observations suggest 
that m itomorpholog ica l changes are only induced in ce lls  where hDMPK 
A proteins are associated to mitochondria.
To investigate whe ther the entire protein or only domains of hDMPK A 
are involved in this phenomenon, a series of YFP-fusion constructs was 
designed (Fig. 1C) and expressed in C2C12 myoblasts (Fig. 1D). Tagging 
w ith  monomeric L221K YFP va r ian t was incorporated to exclude invo lve­
ment of the dimerizing capacity of the YFP portion (259). Use of this 
monomeric  YFP tag did not affect hDMPK A's m itochondr ia l c luster ing 
behavior, demonstrat ing that this is indeed an in trinsic property of the 
DMPK moiety itse lf  (Fig. 1D). Importantly , m itochondr ia l cluster ing was 
s t i l l  observed when the kinase-dead K100A mutant was expressed (Fig. 
1D), consistent w ith the idea that enzymatic activ i ty  is not required. Since 
hDMPK C also anchors at mitochondr ia  but does not change m itochon­
d r ia l morphology, even though it differs from hDMPK A only in the C te r­
minus (286), we hypothesized that the ta i l  domain must be responsible 
for m itochondr ia l c luster ing. Indeed, expression of mutant YFP-hDMPK 
A®34-62® confirmed that cluster ing capacity was ent ire ly  contained within 
hDMPK A’s C-terminus (Fig. 1D).
It is w e l l  known that the 3'-UTR of a mRNA can determ ine gene prod - 
uct dis tr ibution and function in ce l ls  (53). The 3'-UTR of hDMPK mRNA,
Figure 1 • Perinuclear 
clustering of mitochondria 
is induced by the C-terminal 
domain of hDMPK A.
(A,B) C2C12 myoblasts 
trans ien tly  expressing YFP- 
hDMPK A or C fus io r 
proteins or mock-transfected 
ce lls  were stained w ith 
a cytochrome c oxidase 
antibody to v isua lize  m ito­
chondria. Typical examples 
of c lasses of m itochondria l 
m orphology are shown m 
(A). M itochondria l d is trib u­
tion was classified as 
fragmented, c lustered or 
elongated. Frequencies of 
appearance are listed as 
percentage of the to ta l 
num ber of ce lls  expressing 
MOM-associated hDMPK A 
(n = 3, ~50 ce lls  analyzed 
per experim ent). Arounc 
40% of YFP-hDMPK A- 
expressing ce lls  showed a 
cytosolic expression. These 
ce lls  contained m ito­
chondria w ith  a typ ica lly 
e longated shape, but were 
d isregarded in the analysis. 
(C) Schem atic representation 
of YFP constructs used for 
transfection expression w ith 
protein domains, mutations 
and 3'-UTR indicated. (D) 
C2C12 m yoblasts expressing 
YFP fusion proteins were 
stained w ith  a cytochrome c 
oxidase antibody to v is u a l­
ize the ir ab ility  to induce 
clustering of m itochondria. 
(E) Expression of constructs 
w ith  a ltered 3'-UTRs dem ­
onstrated that the hDMPK A 
3'-UTR was not involved in 
m itochondria l c lustering. (F) 
Co-expression of YFP-hDMPK 
A and hDMPK C-HA in N2A 
ce lls  resulted in m itochon­
d ria l clustering, whereas 
ce lls  only expressing hDMPK 
C-HA exhib ited normal, 
e longated m itochondria.
Bars, 10 pm.
when overexpressed, has been shown to be detr imenta l to ca rd iomyo­
cytes and myofibers (177). We therefore verif ied whether mitochondria l 
behavior differed between situations where hDMPK A  protein was ex­
pressed from constructs w ith or w ithout its no rma l 3'-UTR (Fig. 1C and 
E), but found no differences. Also, a contro l vector containing a YFP ORF 
fo llowed by the DMPK 3'-UTR gave the anticipated cytosolic and nuclear 
YFP distribution. Thus, our data indicate that the 3'-UTR is not involved 
in hDMPK A-induced m itochondr ia l cluster ing.
In most ce ll  types where the DMPK gene is na tu ra l ly  expressed, 
isoforms A and C are present in approx imate ly  equal amounts (95, 215, 
Mulders and Wansink, data not shown). To test whether presence of 
hDMPK C could prevent hDMPK A from inducing mitochondr ia l c luster ing, 
we used N2A cells, w e l l  known for the ir  high transfection efficiency, to 
generate suffic ient numbers of ce l ls  that coexpressed hDMPK A and C 
in a double transfection. Isoform hDMPK C fai led to modula te formation 
of m itochondr ia l c lusters in a l l  doubly transfected cells, indicating that 
hDMPK A effects are dominant (Fig. 1F).
I fragmented mito 
I  I clustered mito 
elongated mito
YFP- YFP- 
hDM PKA hDM PKC
YFP-hDMPKA
monoYFP-hDMPKA
YFP kinase coil tail 3-UTR
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• Microtubule depolymerization reduces mitochondrial clustering
The cytoskeleton controls  interactions in the m itochondr ia l network, 
facil i tated by a host of membrane fission/fusion proteins, motor and 
adaptor proteins. Mitochondria are transported along m icro tubules and 
actin m ic ro f i laments (39). Since hDMPK A appears to affect m itochondr ia l 
dynamics and is also believed to affect actomyosin behavior (135, 297), 
we reasoned that its role could be at the cytoske le ta l-m itochondr ia l 
interface.
Comparison of the actin and m ic rotubule cytoskeletons in ce lls  with 
YFP-hDMPK A or C expression did not revea l any overt effect on s t ruc­
tu ra l  in tegri ty  (Fig. 2A and B). We also examined what the absence of tu ­
bulin or actin f i laments would do to the per inuclear accumulat ion of m i­
tochondria (6, 307). DMPK KO mouse myoblasts (286) were reconstituted 
w ith hDMPK A or C isoforms by adenovira l transduction and immediate ly  
treated w ith cytochalasin D or nocodazole. F-actin depolymerization- 
disorganization by cytochalasin D did not a l te r clustered mitochondr ia l 
morphology as revealed by comparison between YFP-hDMPK decoration 
patterns in A and C isoform-transfected ce lls  (Fig. 2A). A lso the f re ­
quency of cluster ing was not a ltered by cytochalasin D trea tment (mea­
sured as the percentage of transfected ce lls that displayed clustered 
mitochondria; Fig. 2C). In contrast, in ce lls w ith a nocodazole-induced 
m ic ro tubu la r  disorganizat ion, the fraction of hDMPK A-expressing cells 
d isplaying per inuclear accumulat ion of m itochondr ia  was signif icantly  
reduced, even though the fragmented appearance of the m itochondr ia l
A  B
Figure 2 •. An intact microtu- 
bular cytoskeleton enhances 
hDMPK A-induced perinuclear 
mitochondrial clustering.
DMPK KO m yoblasts were 
transduced w ith  YFP- 
hDMPK A or C-expressing 
adenoviruses in the presence 
of cytochalasin D (A) or 
nocodazole (B). F-actin was 
v isua lized  by fluorescent 
phallo idin. The m ic ro tubu la r 
cytoskeleton was stained 
w ith  an anti- tubu lin  an ti­
body. D isruption of the actm 
cytoskeleton did not affect 
loca liza tion of m itochon­
dria. Depo lymerization of 
m icro tubu les decreased 
m itochond ria l c luste ring  m 
YFP-hDMPK A-expressing 
cells, but m itochondria s till 
appeared fragmented. The 
d istribution  of m itochondria 
in YFP-hDMPK C-transduced 
ce lls  was unaffected by 
nocodazole treatm ent. Bars, 
10 pm. (C) Quantification 
of m itochondria l clustering. 
The num ber of transduced 
ce lls  tha t contain clustered 
m itochondria are expressed 
as percentage of the to ta l 
am ount of ce lls  expressing 
hDMPK A at the MOM, w ith 
or w ithou t trea tm ent of cy­
tocha lasin D or nocodazole 
(images shown in A and B; 
n = 3, ~ 10 0 ce lls  per experi­
ment, P=0.01). (D) Effect of 
nocodazole wash-out. Quan­
tification of the percent­
age transduced ce lls  w ith 
c lustered m itochondria after 
a 12-16 hours trea tm ent 
w ith  nocodazole, followed 
by a 8 hours wash-out (n = 3, 
~30 ce lls  per experiment, 
P<0.05).
Figure 3 • Mitochondrial 
clustering is a rapid process 
and occurs already at low 
hDMPK A expression.
KO m yoblasts were trans­
duced w ith  YFP-hDMPK 
fusion proteins (top panels), 
w h ile  m itochondria stained 
w ith  M itoTracker Red 
(bottom panels). Images 
were collected every three 
minutes. The tim e of first 
appearance of YFP signal 
was set at t = 0; o ther tim e 
points are indicated in the 
top panels. (A) YFP-hDMPK 
A was firs t detected in the 
cytoplasm. Soon YFP- 
hDMPK-decorated m itochon­
dria appeared which the r 
started to cluster, eventu­
a lly  resu lting  in severe ly 
aggregated m itochondria 
surrounding the nucleus. 
(B) YFP-hDMPK C d irec tly 
appeared on m itochondria 
which maintained the ir 
elongated, re ticu la r structure. 
(C) In N2A cells, YFP-hDMPK 
A expression emerged m 
a s im ila r fashion as m 
KO myoblasts, except that 
m itochond ria l c lustering 
occurred a lm ost im m ed iate ly 
and cytosolic stain ing was 
less pronounced.
network  remained (Fig. 2B and C). When nocodazole was washed out 
at 12-16 hours af ter transduction and expression was continued for an 
addit ional 8 hours, the percentage of ce lls  with m ito-clusters was s ig­
nif icant ly  higher than among ce lls  that were continuously treated with 
nocodazole (Fig. 2D). Nocodazole had no overt effect on mitochondria l 
location or morphology in hDMPK C-expressing cells. To us, these obser­
vations suggest that hDMPK A-induced fragmentation and cluster ing are 
at least pa rt ly  uncoupled effects and that m ic ro tubu la r  in frastructure  
only affects the extent of clustering.
• Mitochondrial morphology changes soon after hDMPK A translocation
To obtain insight in spat io-tempora l aspects of m itochondr ia l morphology 
alterations, KO myoblasts were transduced with YFP-hDMPK isoforms 
a n d s ubje cted to live imaging. Mitochondria were visualized via Mito- 
Tracker Red staining and images were taken every three minutes. YFP- 
hDMPK A located in the cytosol at f i rs t  appearance, but t ranslocated
and concentrated at the MOM 
with in  four hours, a f ter which 
fragmentation and cluster ing 
of mitochondr ia  occurred (Fig. 
3A). YFP-hDMPK C appeared di­
rect ly  on mitochondria  without 
inducing mitochondr ia l c lus­
ters (Fig. 3B). In transfected 
N2A cells, in it ia l  YFP-hDMPK A 
stain ing in the cytosol was less 
evident and hDMPK A appeared 
at the MOM w ithout in te rmed i­
ate accumulation, directly afte r 
expression onset. Size changes 
and cluster ing of mitochondr ia  
could be detected as early  as 
six hours after transfection in 
these ce lls  (Fig. 3C). Combining 
these data with findings in other 
ce l l  lines (286) demonstrates 
that timing of expression and 
sort ing of DMPK isoforms may 
differ between ce l l  types, but 
the sequence of events that is 
induced once DMPK A is as­
sociated with mitochondr ia  is 
qua l i ta t ive ly  similar.
•Abno rm a l m itochondr ia l u l t ras t ruc tu redeve lops i jp  on hDMPK A expression
W e ee r fn rm e d e l r c t ro n  m ic toacopn (EM) on N2A ce l ls  expressing hDMPK 
A to mnes t lciate effects or  m i tocleonelna l u l t r a ot ruc ture  and ce l l  archi- 
tnnpnre. YFP-hDMPK A-trensfected oel ls  svoso e a s y  recognizable by the 
concent r c t i o N of m ltoneopMaa in t h e jo x ta nun le re  region (Fig. 4A)., whi le  
oth er puets cl f ne neU socio left nom°l.efdl.h vo i r l of mitochondr ia  (Fig. 4B). 
Clustered mitochondria  showed a rounded morphology, often with disor-
A OEPcODMPK A aeoUleoC
_  o n
•  ^  1





. '  i  ; UK
B OEP-hDMPK C aeoUleoC















































































































































































































ganized or absent cr is tae s t ruc ture  and a decrease of electron density 
in the matr ix  (Fig. 4A). Cells with this appearance were never seen in 
YFP-hDMPK C-transfected cultures. In control ce l ls  or ce l ls  expressing 
YFP-hDMPK C mitochondria  contained a normal, intact cr is tae s tructure, 
were more elongated and had a disperse localization (Fig. 4C).
Besides abnorma l mitochondria, we identified an increased number 
of autophagic s t ruc tu res  after hDMPK A expression (Fig. 4A). These au­
tophagosomes varied in size and were found near and w ithin areas of 
clustered mitochondria. In some cases, m itochondr ia l remnants could 
s t i l l  be recognized, indicat ive of mitophagy. The fraction of ce lls contain­
ing autophagic st ruc tu res was assessed by L M  and E M  and amounted 
to 12-14% after YFP-hDMPK A expression and 5-6% in ce lls  w ith YFP- 
hDMPK C.
As a second indicator of autophagy, we measured conversion of LC3b 
protein using western blotting (136). In transduced myoblasts signif icant 
conversion to the LC3b-II form was observed after 16-24 hours of ex­
pression of YFP-hDMPK A, but not C (Fig. 4D). These observat ions were 
confirmed in N2A  ce lls  (data not shown). On blot, we repeatedly observed 
a reduced hDMPK A  level w ith in the 16-24 h period of expression. We 
attr ibute  this finding to a selective loss of ce lls  w ith highest DMPK A 
expression (see below). A lthough this may have influenced our picture
o f ki n etic s of au toph ag y in d u ctio n i n the en tire p ool of cells, o ur d ata 
co llect ive ly  point to a g radua l v iab i l i ty  loss in the major i ty  of ce lls in 
th e t r a ns fected pool.
• Cluste r ing of m itochondr ia eesults in los;:; of function
Aga ins t t h i s backg tound, kn owiug th a tm i to c h o nd t ia l  integcity an M fenc- 
t ion are  dyna m iucfly tinkud and tiklsUy cou^ed  to t h e c k l t'r phkaiol.ogical
Figure 4 • Mitochondrial 
clustering is accompanied 
by aberrant ultrastructural 
morphology.
N2A ce lls  were transfectec 
w ith  YFP-hDMPK A or C 
isoforms and u ltras truc tu re  
was analyzed by electron 
microscopy. (A) YFP-hDMPK 
A-expressing ce lls  contained 
fragmented, c lustered m ito­
chondria near the nucleus. 
Cristae structure was often 
partly lost together w ith 
e lectron density of the 
m atrix (arrowhead) and 
m itophagy was observed 
(arrow). In contrast, other 
areas of the ce ll were com ­
p lete ly devoid of m itochon­
dria (B). (C) M itochondria l 
m orphology was normal 
in hDMPK C-expressing 
cells. A fragm ent of the 
nucleus is included here for 
orientation. Note the proper 
cristae structure and loose 
d istribution  of m itochondria 
and endoplasm ic reticulum . 
Bars, 1 pm. (D) Lysates 
from  m yoblasts expressing 
YFP-hDMPK A or C fo r 8,
16 or 24 hours were used 
for western b lotting w ith  a 
LC3b antibody and showed 
an increased LC3b conver­
sion fo llow ing  YFP-hDMPK 
A expression. Cells cultured 
under no rm a l conditions 
and nutrient-starved cells, 
cultu red in Earle's Balanced 
Sa lt Solution (EBSS) for 2 
hours, were used as nega­
tive  and positive controls, 
respectively. DMPK expres­
sion was verified using a 
DMPK antibody. Tubulin (T) 
antibody stain ing was used 
as loading control.
Figure 5 • Human DMPK A 
expression affects mito­
chondrial function and cell 
viability.
(A) C2C12 m yoblasts were 
grown under different 
cu ltu re  conditions and 
transfected w ith  YFP-hDMPK 
A or C. The fraction of 
v iab le  YFP positive cells 
was determ ined after 2C 
hours. When supplied with 
galactose and pyruvate, YFP- 
hDMPK A-expressing ce lls  
showed a s ign ifican tly lower 
v iab ility  than YFP-hDMPK 
C-expressing ce lls  (P<0.01, 
n = 3, >100 ce lls  analyzed 
per experiment). (B) The 
MMP was determ ined ir 
HeLa ce lls  expressing YFP- 
hDMPK A or C. YFP-hDMPK 
A-expressing ce lls  w ithout 
c lustered m itochondria 
showed a c lear MMP s ignal 
(upper panels). No TMRM 
s ignal was found in YFP- 
hDMPK A-expressing ce lls  
w ith  c lustered m itochondria 
(m idd le  panels, asterisks). 
YFP-hDMPK C-expressing 
ce lls  demonstrated a clear 
m itochond ria l s igna l (lower 
panels). Bars, 10 pm. (C) 
The MMP in YFP-hDMPK 
A-expressing ce lls  was 
alm ost com plete ly abolishec 
and s ign ifican tly lower 
than in YFP-hDMPK C and 
non-transfected (NT) ce lls  
(P<0.001, n = 3, >35 ce lls  per 
experiment).
state (12, 38), we invest igated hDMPK A effects on ce l l v iab i l i ty  further. 
To force util ization of re levant metabolic energy pathways, C2C12 myo­
blasts were kept in media of dif fe rent composition, including high or low 
oxygen supply, and monitored after t ransfect ion w ith YFP-hDMPK A or 
C. Cell s u rv iva l  was s im i la r  for YFP-hDMPK A-expressing ce lls growing 
under no rma l conditions or high glucose conditions w ith low oxygen plus 
use of m itochondr ia l uncoupler FCCP (to m ax im a l ly  prevent m itochon­
dr ia l OXPHOS activi ty; Fig. 5A). This outcome can be explained because 
no rma l growth of ce lls  in cu ltu re a lready s trongly  re lies on glycolytic 
metabo l ism (238) and therefore cannot be fu r the r promoted. In glucose- 
deprived medium supplemented w ith galactose, forcing ce lls to re ly  on 
m itochondr ia l oxidat ive phosphory la t ion (186), hardly  any YFP-hDMPK A- 
expressing ce ll  surv ived (Fig. 5A). This suggests that cluster ing of m ito­
chondria is detr imenta l for ce ll  viabi li ty, especia lly in aerobically-poised 
s ituations when ce lls are  forced to use mitochondr ia l TCA/OXPHOS ac t iv­
ity. As a control, YFP-hDMPK C-expressing ce l ls  showed no dif ferences 
in ce l l s u rv iva l  under these cultu re  conditions (Fig. 5A).
YFP- h DMPK A
»
■ -  ' | | |
DMEM + + + + + +
glucose + -
FCCP - -
2% O2 - -
gal actose - +
pyruvate + +






Formatiow of an electrochemicaL proton gradient across the inner mi- 
tochendria l membrane drives ATP production bn OXPHOS (242). Tn com­
pare pos siti le effe cts of D Is! P K isoforms en this c oupling , w e used stain- 
inw of YFP-hDMPK A and C-expressinn HeLa ceUs w ith the fluorescent 
dne TMRM, which provides a readoet for tlte m itochondr ia l membraee 
potentia l UMMP). HeLa ce lls were chosen because thnse have deen esed 
before for MMP determinat ion and gave suffic ient TMRM signal strength 
for quant itat ive analys is  (59). Before measurement, depolarization with 
FCCP as described by D is te lmaier et al. (60) was used to contro l that 
TMRM accumulat ion did not involve quenching, becoming a confounding 
factor in MMP measurement. For many other ce ll  lines the 100 nM TMRM 
concentration appeared toxic or TMRM did not accumula te w e l l  enough in 









































































































































































































A-expressing HeLa ce lls  showed a s ignif icant ly  lower MMP than cells 
that expressed YFP-hDMPK C (Fig. 5B and C). Interest ingly, YFP-hDMPK 
A-positive ce lls w ith no or only mild m itochondr ia l c luster ing showed 
a norma l MMP (Fig. 5B, upper panels). The lack of s ignal in clustered 
mitochondr ia  could not be due to an inab i l i ty  to take up TMRM, since they 
were able to internalize the related compound MitoTracker Red (data not 
shown). The MMP in YFP-hDMPK C-expressing ce lls was not signif icantly  
d if fe rent from that in untransfected ce l ls  (Fig. 5C).
• Cells with clustered mitochondria undergo apoptosis
We observed that YFP-hDMPK A-expressing KO myoblasts -but not 
YFP-hDMPK C expressing cel ls- died rapid ly after prolonged periods of 
t ransfect ion-complementation and wondered whe ther this loss could be 
expla ined by an apoptosis-based mechanism. One finding support ing this 
conjecture was that t rea tmen t with apoptosis inhib itor z-vad-fmk imme­
diately after transfect ion s ignif icant ly  increased the number of surv iv ing 
hDMPK A-expressing cells, whereas no effect was seen on the v iab i l i ty  
of ce lls expressing hDMPK C (Fig. 6A). Fu rther support was obtained by 
the observat ion that l i t t le  or no staining of cytochrome c, a mitochondr ia l 
in termembrane protein, w as present in clustered mitochondr ia  in YFP- 
hDMPK A-expressing KO myoblasts 
chondria that were only f ragment­
ed did contain cytochrome c (Fig.
6B, m iddle  panels). To us th is  sug­
gests that re lease of cytochrome c, 
a w e l l  known apoptosis-triggering 
event (168), probably occurs after 
the onset of m itochondr ia l c lus­
tering. No cyt o chrome c re lease 
was observed for YFP-hDMPK C- 
expressing ce lls  (Fig. 6B, lower
pane ls). YFP-hDMPK A YFP-hDMPK C
B
(Fig. 6B, upper panels), wh i le  mito
16 24 48 16 24 48 16 24 48 16 24 48 








Figure 6 • Expression of 
hDMPK A induces apoptosis.
(A) The effect of apoptosis- 
inh ib ito r z-vad-fmk was 
tested on ce ll su rv iva l of 
DMPK KO m yoblasts tra n s ­
duced w ith  YFP-hDMPK A 
or C-expressing adenovi­
ruses. YFP-positive ce lls  
were counted after 16, 24 
and 48 hours. Z-vad-fmk 
g rea tly reduced ce ll death 
of YFP-hDMPK A-expressing 
cells, but had no effect 
when YFP-hDMPK C was 
expressed. Z-vad-fmk was 
applied im m ed ia te ly  after 
transduction and maintained 
present for the rem ain­
ing tim e of the experiment. 
Values at 16 hours were 
set at 100%  (P<0.05, n = 3, 
>90 ce lls  counted per 
experiment). (B) YFP-hDMPK 
A and C-expressing cells 
were stained fo r cytochrome 
c (cyt c). Cells expressing 
YFP-hDMPK A displayed a 
diffuse, cytosolic cytochrome 
c stain ing when m itochon­
dria were clustered (upper 
panels). A c lear m itochon­
d ria l sta in ing was present 
tohsn m itochondria appeared 
fragmented (m idd le  panels). 
A discrete, m itochondria l 
cytochrome c staining was 
also observed in YFP-hDMPK 
C expressing cells. Bars,
1 0 pm.
• DISCUSSION
We demonstrate here that expression of MOM-anchored hDMPK A resu l ts 
in fragmentation of the mitochondr ia l ne twork  and per inuc lear cluster ing 
of morphologica l ly-a ltered mitochondria. In addition to these morphome- 
chanica l changes, physiolog ical changes like loss of MMP, increased 
autophagosomal ac t iv i ty  and leakage of cytochrome c accompanied by 
apoptosis were induced. It is d if f icult  to bring h ie ra rch ica l ordering in 
these events, but we propose that the fate of mitochondria  in cells 
w ith hDMPK A is specified as follows: based on our observat ions with 
l ive-ce l l  imaging and the finding that m icro tubule disruption attenuated 
cluster ing, we suppose that induction of morpho log ica l change is the in i­
tiating step that m arks  mitochondr ia  for subsequent anomalous transport  
and cluster ing. Upregulation of autophagy may be an in termediate phase 
to rescue defective energy and c lear m itochondr ia l waste (140).
The fact that the same sequence of events in m itochondria l f ragm en­
tation and per inuc lear cluster ing w ith g lobally s im i la r  f ina l outcome oc­
curred in a l l  mouse and human ce l l  types examined is important. S l ight 
varia t ion in the speed and magnitude of events was observed between 
ce l l  types, but this can most easily be expla ined by dif ferences in cytoar- 
ch itectura l arrangement, pathophysio logical th resholds or stress-coping 
abil ity. Toxicity of hDMPK A was also observed in KO myoblasts in which 
DMPK was reconstituted to apparent ly  no rma l expression leve ls by com­
plementation. We observed mitochondr ia l c luster ing a lready after severa l 
hours of hDMPK A expression when ectopic protein levels  were s t i l l  
re la t ive ly  moderate. Therefore, we postu late that induction of abnormal 
m itochondr ia l behavior is an in trinsic capacity of hDMPK A and cannot 
be s imply  expla ined as a resu l t  of overexpression. Mutationa l analysis  
demonstra ted that hDMPK A's ta i l  region was sufficient to induce m ito­
chondria l f ragmentation and cluster ing. The conclusion that this is the 
only segment with detr imenta l effects was corroborated by the observa­
tion that MOM-binding of hDMPK C, which dif fers from hDMPK A only in 
its C-terminus, had no effect on mitochondria l physiology and trafficking.
Interesting pa ra l le ls  can be drawn to the morphophysio log ical ef­
fects induced by ectopic or overexpression of other MOM proteins, like 
TA proteins h Fi s (123, 311), Miro GTPases (80, 82) and Mfn 1 and 2 
proteins (115, 234, 241). A l l  these enzymes are involved in m itochondria l 
dynamics. Although s im i la r  in nature, changes evoked by these MOM 
proteins cannot be s imply  lumped together, since it is unclear how m i­
tochondria l cluster ing occurs, and c lear mechanis t ic dif ferences can be 
noted. For example, enzymatic ac tiv i ty  appears i r re levant for Mfn 1 and
2 (1 15, 234, 241) and hDMPK A (this paper), but is necessary for hFis 













































































































































































































not require coiled-coi l interactions between proteins, but Mfn 1 and 2 
effects c lear ly  re ly  on these associations (151). The s tatus of the cyto­
skele ton does not determ ine Mfn 2 effects (234), yet hDMPK A cluster ing
part ly  depends on in tegri ty of micro tubules. It is tempting to speculate 
that every dist inct TA-containing MOM protein has its own role in crea t­
ing an appropria te m ic roenv ironment for m itochondr ia l interactions with 
other ce l l  structures. Reactions mediated by these proteins may involve 
dist inct areas in the MOM and also the complex and diverse machinery 
that l inks mitochondr ia  to motor proteins may be d if fe rent ia l ly  involved 
(34, 80, 82, 271). Disbalance in any of these systems may create overt ly 
s im i la r  effects, w ith  fragmentation and cluster ing of mitochondr ia  as 
main outcome.
M itochondria l f ragmentation and cluster ing is probably an in trinsic 
property of the hDMPK A membrane anchor itself. There is mounting ev i­
dence indicating that certain hydrophobic regions in membrane proteins 
are able to induce membrane curvature  and remodeling. Our EM data 
demonstrate that hDMPK A-decorated mitochondria  are sm a l l  and round 
-i.e., not one la rge continuum- suggesting that lipid-protein or lipid-l ipid 
interactions become abno rma l ly  affected in presence of the ta i l  anchor 
of hDMPK A. Direct effects of membrane anchors that resu l t  in distort ion 
of protein-protein interaction and cluster ing fo llowed by formation of 
abno rma l membrane curvature, vesic le formation or f ragmentation have 
been described (45, 231). Coupling to abno rma l fusogenic propert ies of 
hDMPK A's anchor could also be involved. It has been shown that Leu/ 
Val residues and Gly/Pro or Pro/Gly pairs in peptides in t ransmembrane 
domains add to a high fusogenic index (112, 214). Exactly  these amino 
acids are highly abundant in the ta i l  region of hDMPK A, but not hDMPK 
C. Further knowledge about involvement of lipid interactions w ith  specific 
peptide sequences in hDMPK A's ta i l  can be obtained by permutation 
analyses and biophysical in teraction studies. At this moment we can only 
remain speculative about the importance of the amino acid composit ion 
of the membrane anchor.
Many studies have shown that the physiolog ical state of mitochondria 
is rec ip roca l ly  coupled to morphologica l appearance (115, 172). Recently, 
even a re la t ionship  between mitochondr ia l form and ce l l  cycle con­
tro l  has been reported (196). Although mitochondr ia l fragmentation has 
been observed frequently in ce lls  undergoing apoptosis, its active role in 
apoptosis is s t i l l  unclear (123, 163). We observed that hDMPK A-induced 
morpho log ica l effects u lt imate ly  lead to ce l l  death and provide evidence 
that cytochrome c leak did not occur and MMP was s t i l l  la rge ly  intact in 
hDMPK A-decorated mitochondr ia  that were s t i l l  in the fragmented state. 
Loss of cytochrome c and disappearance of MMP was observed when 
mitochondr ia  became clustered. We take these observat ions to indicate 
that events that occur during or jus t  before m itochondr ia l c luster ing 
must contr ibute to the onset of apoptosis.
Aber ran t  m itochondr ia l morphology is linked to mult ip le  disease 
manifestat ions caused by mutat ions in genes involved in fission and 
fusion, like Charcot-Marie-Tooth subtype 2A and dominant optic a t ro ­
phy (38, 148). A lso in DM1 pat ient muscle, m itochondr ia l i r regu la r i t ies  
have been found, although the cause of these malfo rmations has not yet 
been identif ied (258, 284). Studies on Tg26-hDMPK mice, overexpressing
ta il-anchored hDMPK isoforms especia lly in heart and ske le ta l  muscle, 
showed disorganized cristae st ruc tu re  and symptoms like reduced w o rk ­
load tolerance, atrophy, hypert rophic cardiomyopathy, myotonic myopathy 
and hypotension, remin iscent of DM1 symptoms (211).
We do not expect that the no rma l physiolog ical function of hDMPK 
is directly related to regulation of m itochondr ia l cluster ing. Like hDMPK 
C, hDMPK A is p redominant ly  expressed in ske le ta l  muscle myofibers 
(95, 215), a ce l l  type w ith a rigidly compartmenta l ized cy toarch itectura l 
in frastruc tu re  and well-defined mitochondr ia l d is tr ibution across intra- 
m yo f ib r i l la r  and subsa rco lem m a l areas. This typ ica l robust cytoarchitec- 
tu ra l  organization may render muscle  ce lls  more res is tant to f luctuations 
in hDMPK A expression, but based on our findings we speculate that also 
for myotubes it is of paramount importance that hDMPK A protein leve ls  
are t ight ly regulated and s t r ic t ly  kept with in  the no rma l physiological 
range. Expression leve ls of comple te ly  other proteins, for example VEGF, 
also require t ight regula tion as both reduced and increased expression 
can resu l t  in pathogenesis, manifesting itse lf  in embryonic le tha l i ty  or 
cancer, respective ly  (76). Changes in DMPK mRNA synthesis  or pre-mRNA 
splic ing induced by the presence of expanded (CUG)n transcr ip ts, when 
resu l t ing in only a s l ight d isbalance in hDMPK A expression level, could 
thus be a contr ibuting factor in the pathophysio logy of DM and explain 
m itochondr ia l abnormal i t ies. In more extreme situations like congeni­
ta l DM with very la rge (CTG)n expansions, where abno rma l chromatin 
modif icat ion and defect ive b id irectional t ransc r ip t iona l control across 
the DM locus may directly  couple to unbalanced DMPK production, the 
toxic effects of DMPK A may even directly contr ibute to special disease 
features (44, 77). Fu rther research into the role of hDMPK A in health 
and disease is thus warran ted  and also needed to va l idate this model 
and its predictions. A more precise study of the balance in DMPK splice 
isoforms in dif ferent categories of DM1 patients is a necessary f i rst step.
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Myotonic Dystrophy type 1 (DM1) is caused by a (CTG)n repeat expansion 
in the myotonic dystrophy protein kinase (DMPK) gene. Different products 
encoded by this gene have been implicated in a va r ie ty  of ce l lu la r  events, 
including the regulation of ce l lu la r  ion homeostasis, actin-based cyto- 
ske le ta l  dynamics and ce l l  v iab i l i ty  control. Most studies up to now ad­
dressed bio logical signif icance by study of na tu ra l  m ix tu res  of truncated 
and C-terminally extended DMPK isoforms, as expressed in dif ferent cell  
types. Here, we report on the role of indiv idual DMPKs in Ca2* handling in 
muscle  cells, using adenovirus-mediated transduction-complementat ion 
of DMPK-deficient myoblasts-myotubes w ith single DMPK variants, as our 
study system. We found the mitochondr ia l-outer-membrane-associated 
mDMPK C isoform to affect the mobilization of Ca2* from the in t race l lu la r  
calcium stores af ter exposure of the myotubes to e ither acety lchol ine 
or ionomycin. Variat ion in m ax im a l  peak [Ca2+]c and [Ca2+]c decay rate 
correlated w ith absence or presence of enzymat ica l ly  active mDMPK C, 
but not w ith  absence or presence of any of the other DMPK isoforms. 
Likewise, t ransduction-media ted expression of the mDMPK A variant, an 
SR-bound DMPK isoform, affected mitochondr ia l Ca2+ uptake, causing 
a decrease in m ax im a l [Ca2+]m upon acety lchol ine stimula tion. DMPK- 
complemented and mock-complemented ce l ls  behaved s im i la r ly  during 
myogenesis, w ithout overt d if ferences in energy balance or cytoarchitec- 
tu ra l  make-up. We conclude that the role of DMPK isoforms A and C in 
Ca2+ handling is ra ther direct, and not exerted via effects on ce l l  state. 
Fu rther studies into a possible ro le of DMPK disbalance in DM1 patho­
genesis are warranted.
• INTRODUCTION
Myotonic dystrophy protein kinase (DMPK) is the protein product of the 
gene involved in myotonic dystrophy type 1 (DM1), a frequently occur­
ring autosomally-inherited, mult isys tem ic disorder which affects ske le ta l 
muscle, heart, brain, eyes and the gastro in test ina l t rac t (101). Disease 
manifestat ion in DM1 is caused by (CTG)n repeat expansion in exon 15 of 
the 3'-UTR of the DMPK gene (26, 86, 94), the length of which is re la ted 
to disease severity. Evidence has been provided that expression of DMPK 
t ranscr ip ts  with long expanded (CUG)n repeats plays an important role 
in DM1 disease induction. Presence of DMPK transcr ip ts  from the mutant 
a l le le  thereby causes abno rma l in t ranuc lea r t i t ra t ion or mis location of 
splice and t ranscr ip tion factors, w ith dominant trans-effects on the ex­
pression of products of many other genes (300).
Up to now, the direct involvement of abno rma l DMPK protein expres­
sion, which may expla in DM1 features like muscle  wasting, neurological 
p roblems or loss of endocrine function, has not received a lot of a t ten­
tion. As a resu l t  of a l te rna t ive  splicing, DMPK is expressed as a sm a l l  
set of protein isoforms. These isoforms a l l  have serine/threon ine protein 
kinase activity, but they differ in the absence/presence of an in ternal 
VSGGG-motif and in the length and sequence content of the C-terminus. 
In human and mouse, the DMPK C-terminal ta i l  exists as three variants, 
the longest of which can serve as ta i l  anchor for binding DMPK to either 
the mitochondr ia l outer membrane (MOM) or the ER membrane (95, 286). 
Moreover, a l l  DMPK isoforms contain a coiled-coi l segment involved in 
dimerization and association to other ce l lu la r  s t ruc tu res  (286, 287).
Based on the l inea r sequence charac te r is t ics of the ir  kinase domain, 
DMPKs are  c lassif ied as members of the AGC (cAMP-dependent, cGMP- 
dependent and protein kinase C) subfam ily  of protein kinases. Structure- 
function homology analys is revealed that DMPK displays highest homol­
ogy with myotonic dystrophy k inase-re la ted Cdc42-binding k inases a, ß, 
and y, Rho kinase a and ß, and citron kinase (297). Since these kinases 
a l l  are involved in remodeling of the actin-myosin cytoskeleton (130, 170, 
255), this suggests that also DMPK could play a ro le in ce l l  dynamics 
and ce l l  shape plast icity.
Interest ingly, DMPK appears to play an important ro le in ce l lu la r  
ion homeostasis  as well,  because two sm a l l  t ransmembrane  proteins 
that in teract with ion-pumping P-type ATPases, phospholamban (PLN; 
(134)) and phospholemman (PLM or FXYD1; (200)), have been ident i­
fied as targets. Moreover, DMPK may also phosphory late the ß-subunit 
of the dihydropyridine receptor (DHPR) Ca2+ channel, which modulates 
Ca2+-release from the sarcop lasm ic re t icu lum (SR) upon ske le ta l  muscle 





































































































































































human DMPK in mouse ske le ta l  muscle  t r iggers sarcop lasm ic Ca2+ over­
load leading to ce l lu la r  hyperexcitab i l i ty  (211). A role for DMPK in ion 
homeostasis, and in pa r t icu la r  Ca2+ homeostasis, is also compatib le with 
the observation that resting muscle  fibers and cultured ske le ta l  muscle  
ce lls  from DM1 patients exhib it  a depolarized p lasma membrane (PM) 
potentia l and elevated sarcop lasm ic Na+ and Ca2+ concentration (13, 121). 
Finally, analys is of DMPK knock out (KO) mice, which display mild s ke l­
etal myopathy and card iac conduction abno rma l i t ies  (227, 298), revealed 
abno rma l Ca2+ currents and Na+ channel openings in myotube cu ltu res 
(13, 226, 298), again pointing to the same direction.
Here, we focus on the question whether indiv idual long DMPK iso­
forms (DMPK A and C) d if fe rent ia l ly  affect Ca2+ handling in mature myo­
tubes. Interest in this question was tr iggered because mDMPK's anchor­
ing to e ither SR or m itochondria l membranes (286) p laces its kinase 
activ i ty  in immediate v ic in ity of the cell's most important calcium stores. 
Ea r l ie r  we reported that ectopic overexpression of hDMPK A affects 
both mitochondria l d is tr ibution fate and ce l l  v iab i l i ty  and is coupled to 
init iation of autophagy, processes that appear coupled to cytosolic ca l­
cium [Ca2+]c mobil ization and signaling (216). E laborate studies of other 
groups provided evidence that SR and mitochondr ia  can be closely ju x ­
taposed by s t ruc tu ra l  tethers, a l low ing eff icient Ca2+ exchange between 
these organel les (98). In muscle, this s t ruc tu ra l  and funct ional ER-mi- 
tochondria l coupling is important because it adds another dimension to 
reg ional [Ca2+]c control (81). Conversely, Ca2+-stimulated m itochondr ia l 
ATP production is required for shaping sarcop lasm ic Ca2+ t rans ien ts  and 
the rew ith  forms another leve l of contro l over muscle exc itab i l i ty  and 
re laxat ion (56, 150).
Here, we confirm the suggested re la t ionship between presence of 
ca ta ly t ica l ly  active DMPK isoforms and aspects of in t race l lu la r  Ca2+ d is­
tribution by demonstrat ing a d if fe rent ia l regu la to ry  influence of DMPK C 
on the magnitude of Ca2+ re lease and kinetics of re/uptake in in t race l­
lu la r  stores and of DMPK A on the Ca2+ loading of mitochondria.
• MATERIALS AND METHODS
• Cell culture
Norma l and DMPK-deficient immorta l ized myogenic ce l l  lines were de­
rived from the calf muscle complex of mice (postnata l day 10) that 
harbored one H-2Kb-tsA58 a l le le  and carr ied e ither two DMPK wild type 
(WT) or two DMPK KO a l le les, fo llowing procedures as described (56, 
197). Myoblasts were ring cloned and selected for myotube formation 
abil ity. Myoblasts were propagated at 33°C in gelatin-coated 6-wells  
pla tes in DMEM (GibcoBRL, Gaithersburg, MD) supplemented w ith 20% 
(v/v) FCS, 50 pg/m l gentamycin and 20 un its IFN-y/ml. Term ina l d if­
ferentiat ion w ith myotube formation was induced by placing a confluent 
myoblast cu lture grown on Matr ige l (BD Biosciences, the Netherlands) 
at 37°C in DMEM supplemented with 5% horse serum (HS) and 50 pg/ 
m l gentamycin and by main tain ing these conditions for up to five days.
• Plasmids and vectors
E1/E3-deleted serotype 5 adenovira l vectors encoding YFP-mDMPK A, C, 
E and kinase dead mutants (K100A mutation (298)) under the control of 
a CMV IE-promoter were generated using the AdEasy Vector System (106), 
as described (41). In short, fu ll- length cDNAs (including ORF and 3'-UTR) 
encoding EYFP-mDMPK A, C, E or kinase-dead mutant proteins were 
cloned as restr ic t ion fragments into the pShutt le-CMV transfe r  vector. In 
a second step, pShutt le-YFP-mDMPK p lasm ids were recombined with the 
v i r a l  DNA plasmid pAdEasy-1 in E. coli stra in BJ5183. Next, v i r a l  p a r­
t ic les were generated in N52.E6 (249) v i ra l  packaging ce lls  (93). Finally, 
adenovira l vectors were purified using CsCl gradient puri fication and 
stored at -80 °C. The v i ra l  t i te r and plaque forming units were determined 
(41) prior to use in transduction experiments.
• Adenoviral transduction of immortalized myotubes
For t rans ient expression of YFP-mDMPK A, C and E, and kinase-dead m u­
tants, myotubes dif ferentiated for 3 days, were transduced w ith adenovi- 
ra l-vectors in DMEM for 3 hours at 37 °C as described previously  (286). 
Three hours afte r addition of recombinant virus, medium was replaced 
w ith fresh DMEM supplemented with 2% HS and 50 pg/m l gentamycin 
and cu ltu res were main tained for an addit ional 48 hours (tota l of five 
days of differentiation).
• Cytosolic and mitochondrial calcium measurements
Myoblasts were seeded on Matr igel-coated g lass coverslips. Termina l 
diffe rentia t ion into myotubes was induced by placing them at 37°C on 





































































































































































of five days including transduction. To monitor changes in sarcop lasm ic 
free [Ca2+] ([Ca2+]c) and mitochondr ia l calcium concentration ([Ca2+]m), 
myotubes were exposed to 3 pM Fura-2 AM (Fura-2 acetoxymethy l ester; 
Invi trogen, Eugene, USA) or 5 pM Rhod-2 AM (Rhodamine-2 acetoxy­
methy l ester; Invit rogen) respectively, in the presence of 0.025% (w/v) 
Pluronic-F127 (Invitrogen) for 30 min at 37°C in cu ltu re medium. Afte r 
loading, adherent myotubes were washed w ith a co lo r less HEPES-Tris 
(HT) solution (125 mM NaCl, 10 mM NaHCO3, 1 mM NaH2PO4, 5 mM KCl,
2 mM MgSO4, 1.8 mM CaCl2, 10 mM HEPES, and 10 mM glucose, pH 7.4) 
and placed in a closed POC-R Cell Cult ivation System (Carl Zeiss, Jena, 
Germany). The la t ter was placed on the stage of an Ax iove r t  200 M in­
verted microscope (Carl Zeiss, Jena, Germany) equipped w ith a 40x, 1.3 
NA F F luar objective. To t r igger sarcop lasm ic Ca2+ release, the cu lture 
was superfused with HT solution containing 20 pM acety lchol ine (AC h; 
Invitrogen). Sarcoplasm ic Ca2+ content was invest igated by application 
of 1 pM of the Ca2+ ionophore ionomycin ( Invitrogen) in the absence 
of e x t race l lu la r  Ca2+ (i.e., HT medium w ithout CaCl2 and added 0.5 mM 
EGTA). Excitation light was provided by a monochromator (Polychrome 
IV; T ILL Photonics, Gräfelfing, Germany). Fura-2 was a l te rna te ly  excited 
using 340 nm (Ca2+-bound form) and 380 nm (Ca2+-unbound form) light 
and emission was directed via a 430DCLP dichroic m ir ro r  (Omega Optical, 
Bratt leboro, USA) and a 510WB40 emission f i l te r (Omega) onto a CCD 
camera (Roper Scientific, Vianen, The Nether lands) using an exposure/ 
integration time of 200 ms and a sampling in terva l of 1 s. Rhod-2 was 
visualized s im i la r l y  using 540 nm excitation, a 560DRLP dichroic m i r ­
ror (Omega) and a 565ALP emission f i l te r (Omega). Both Fura-2 and 
Rhod-2 emission s ignals were background corrected by subtraction of 
the f luorescence at a position on the covers l ip  w ithou t cells. YFP was 
excited using a monochromator (Polychrome IV; T ILL Photonics, Gräfelf­
ing, Germany), a 505DRLPXR dichroic and a 535AF26 emission filter. A l l  
microscopy hardware was controlled with Metaf luor 6.0 so ftware  (Mo­
lecu la r  Devices, Sunnyvale, USA).
• Immunofluorescence microscopy
Myotubes were grown and transfected on 24 m i l l im e te r  g lass cover­
slips coated w ith  Matr ige l (BD Biosciences, the Netherlands), washed 
once w ith phosphate-buffered sa l ine (PBS) and fixed in PBS containing 
2% (w/v) formaldehyde 48 hours af ter transduction. Cells were per- 
meabil ized in PBS containing 0.5% (w/v) Nonidet P-40 and processed 
for immunofluorescence microscopy using standard procedures. A rabbit  
anti-tit in antibody (88) was used to v isualize sarcomeric banding pat­
tern. Phallo id in-conjugated TexasRed (Invitrogen) was used to v isualize 
F-actin m ic ro f i laments and the mouse monoclonal ß-tubulin antibody 
E7 (Deve lopmenta l Studies Hybridoma Bank, Univers ity of Iowa) was 
used for detection of microtubul i.  Images were obtained w ith a Bio­
rad MRC1024 confocal laser-scanning microscope (Biorad Laboratories, 
Veenendaal, The Nether lands) equipped w ith an argon/krypton laser, us­
ing a 60x 1.4 NA oil object ive and LaserSharp2000 acquisition software. 
YFP was excited using a 488 nm laser, T1/T2A dichroic and 522DF35 
emission filter. TexasRed was excited using a 568 nm laser, T1/T2A di­
chroic and 585LP emission filter. Far-red was excited using a 647 nm
lase rs  T1/T2A dichroic and 680DF32 emission filter. To determ ine m ito ­
chondria l colocalizat ion, myotubes were stained w ith 1 pM M itotracker 
Red CM-XH2ROS (Invitrogen) for 30 min at 37°C and imaged at 37°C 
using the temperature-contro l led stage of a Zeiss LSM510-Meta confo- 
cal microscope (Carl Zeiss) using the appropria te argon laser lines and 
a Plan Neofluor 40X/1.3 oil DIC objective. YFP was excited using a 488 
nm laser, 545NFT dichroic and a BP500-530 emission filter. M itotracker 
Red was excited using a 568 nm laser, 545NFT dichroic and LP560 nm 
emission f i l te r
• Cell lysates, SDS-PAGE and Western blotting
Myotubes were lysed on ice in NP40 lysis buffer containing 1% NP40, 
50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 25 mM NaF, 1 mM sodium pyro­
phosphate, 0.1 mM vanadate, 1 mM PMSF, 1x protease inhibitor cocktai l 
(Roche, Mannheim, Germany) and 1 mM EDTA. Lysates were cleared by 
centr ifugation for 10 min (14,000g) at 4°C. The obtained supernatant 
fract ions were mixed with SDS sample buffer, separated on 8% SDS- 
PAGE gels and t ransfe rred  to PVDF membrane (Mill ipore, USA). For im­
munodetection, DMPK-specific po lyva lent an tise rum B79 (95) was used 
as a p r im a ry  antibody. HRP-conjugated goat anti-rabbit  I g G was used as 
a secondary antibody (Jackson ImmunoResearch Laboratories, UK). For 
v isualizat ion of ECL signals were detected using a Kodak X-OMAT AR film.
• Electron microscopy
For EM analysis, ce lls  were fixed in 2% (w/v) g lu ta ra ldehyde in 0.1 M 
cacodylate buffer and postfixed for 1 h in 1% osmium tetroxide and 1% 
potassium ferrocyanide in 0.1 M cacodylate buffer. A f te r  being washed in 
buffer, cells were dehydrated in an ascending series of aqueous ethanol 
and subsequent ly  t ransfe rred  via a m ix tu re  of e thanol and Epon to pure 
Epon 812 embedding medium. Ultrath in  gray sections (60-80 nm) were 
cut, contrasted with aqueous 3% u rany l acetate, rinsed, and counter­
stained w ith  lead citrate, a ir dried and examined in a JEOL JEM1010 
electron microscope (JEOL, Welwyn Garden City, UK) operating at 80 kV.
• HPLC analysis
Samp les were prepared using a perchloric  acid extraction method de­
scribed previous ly  (14). Briefly, myotubes and myoblasts (in t r ip licate) 
were washed three t imes in PBS and lysed in 1.4 m l of perchlor ic  acid 
(Fluka, Germany). Suspensions were homogenized on ice, centr ifuged at 
1,200g at 4°C and supernatants were t ransfe rred  to new Eppendorf tubes. 
Pe llets were used for protein analys is with the Mico BCATM Protein Assay 
Kit (Pierce, USA) to corre late data to protein input. Supernatants were 
neutra l ized using KOH to reduce metaboli te  oxidation and remove ClO4- 
ions from the solut ion. A f te r spinning down the potassium perchlorate 
crystals , supernatants were freeze-dried in a Speed Vac Concentrator 
(Savant, USA). Pel le ts were dissolved in milli-Q, fi ltered over a Millex-HV 
0.45 pm f i l te r and 50 pl of each sample was used for the HPLC ana ly­
sis as described previous ly  (267) using a Shimadzu LC20 HPLC system 
(Shimadzu, Japan) with a Supelcosi l LC-18-T, 15 cm x 4.6 mm (3 pm 





































































































































































• Data analysis and stat istics
Numerica l data was analyzed using GraphPad Prism 5.1 (GraphPad Soft­
ware, La Jo l la , CA, USA) and OriginPro 6.1 (Microcal, Northampton, MA). 
As a measure of the rest ing free sarcop lasm ic [Ca2+] ([Ca2+]c), the res t­
ing average fura-2 ratio s ignal was calcula ted for each ce l l  from 10 p re­
st im u la to ry  data points. The m ax im a l ACh-induced fura-2 ratio s ignal 
was calcula ted for each ce l l  and used as a measure of m ax im a l sa rco­
p lasmic [Ca2+]c. The rate of ACh-induced increase in fura-2 ratio s ignal 
was calcula ted for each ce l l  and used as a measure of the rate of in­
crease in sarcop lasm ic [Ca2+]c. The rate of decrease of the ACh-induced 
fura-2 ratio s ignal was used as a measure of the rate of decrease in s a r ­
coplasmic [Ca2+]c. In myotubes this decrease is adequate ly described by 
a mono-exponentia l function (56, 150), R(t) = R(P)+R(t=0)e(-A/t), where 
R(t) is the fura-2 ratio s ignal at timepoint t, R(P) is the post-st imulatory 
leve l to which R declines, R(t=0) is the m ax im a l ACh/ionomycin-induced 
fura-2 signal, t is the time (in s) and A is the t ime constant (in s). From 
A the decay t ime constant (K) was calcula ted using the equation: K = 
1/A (290). Unless stated otherwise, data from mult ip le  exper iments are 
expressed as averages ± s.e.m. S ta t is t ica l analys is was performed by 
means of an unpaired two-tailed Student's T-test using a signif icance 
leve l of P<0.05. * P<0.05; **  P<0.01.
• RESULTS
• DMPK isoforms localize to different ce l lu la r compartments in myotubes
To study how distinct long DMPK isoforms (A-D) affect sarcop lasm ic 
Ca2+ handling we applied adenovira l transduction (i.e., complementation) 
of DMPK-knockout (KO) myoblasts/myotubes w ith  indiv idual YFP-tagged 
mouse DMPKs (mDMPKs). We chose DMPK KO ce lls  because these pro­
vide a na tu ra l  ce l lu la r  context and lack the complex mixed background 
of endogenous DMPK isoforms (215). To a l low  proper in terpretation of 
complementation experiments, mDMPKs were introduced into ce lls  either 
as kinase active (no rmal)  or inactive (Kd, kinase dead) variants.
Both mDMPK A and A Kd displayed a re t icu la r  localization that did 
not overlap w ith mitochondria  (Fig. 1A; top panels). In contrast, mDMPK 
C and C Kd showed a mitochondria l pattern in addition to cytosolic 
staining (Fig. 1A; middle panels). DMPK var ian ts  w ithout the long C- 
te rm ina l ta i l  (mDMPK E and E Kd) displayed a cytosolic localization (Fig. 
1 A; bottom panels). Thus, in complemented matu re  DMPK KO myotubes, 
mDMPKs with dif ferent C-termini display a dif ferent subce l lu la r  loca l iza­
tion, confirming findings in other ce l l  types w ith a less highly organized 
in frastruc tu re  (215, 286). Of note, the mDMPK localization pattern did not 
depend on whether the protein was enzymat ica l ly  active or inactive. SDS- 
PAGE analys is of complemented ce lls  revealed that a l l  mDMPK variants 
were expressed to s im i la r  levels  and migrated at the ir  expected size (~ 
100 kDa; Fig. 1B and data not shown). Production of fusion proteins with 
an abe rran t  st ruc tu re  due to pro teolyt ic  processing was therefore not a 
concern in our experiments.
• Effects of mDMPK expression on cytosolic calcium handling and store 
filling
In an ea r l ie r  study, we analyzed myotubes that were formed by in vitro 
diffe rentia t ion of p r imary  myoblasts from WT or DMPK KO mice (13) and 
found that kinetics of ACh-induced sarcop lasm ic Ca2+ ([Ca2+]c) trans ients  
differed between WT and KO myotubes. Here, with myotubes generated 
from immorta l ized myoblasts derived from WT/SV40Tagts or DMPK KO/ 
SV40Tagts doubly-transgenic mice, we corroborate these findings. DMPK 
absence or presence affected kinetics of ACh- or ionomycin (Iono)-in- 
duced Ca2+ t rans ien ts  d if fe rent ia l ly  (Fig. 2). ACh was used to induce 
calcium re lease from the in t race l lu la r  SR Ca2+ stores via the activation of 
voltage-gated Ca2+ channels, imita ting muscle  st imu la t ion (in vitro). Use 
of Iono in Ca2+ free medium with EGTA enabled us to monitor effects of 
DMPK isoforms on the f i l l ing state of in t race l lu la r  SR Ca2+ stores.
Basa l [Ca2+]c in KO myotubes was consistent ly, but not significant ly, 
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Figure 1 • DMPK isoform 
expression and localization in 
myotubes.
Confocal images were ac­
quired 48 hrs after adenovi­
ra l transduction of DMPK KC 
myotubes (at d ifferentia tion 
day three) w ith  YFP-tagged 
mDMPK A/C/E isoforms.
Cells were co-stained for 
m itochond ria l m arke r M ito­
tracke r Red. (A) YFP-mDMPK 
A did not co localize with 
M ito tracke r Red and showec 
a re ticu la r pattern, s im ila r 
to YFP-mDMPK A Kd.Bo th 
YFP-mDMPK C and its Kd 
m utant localized at m ito­
chondria, but showed also 
some cytosolic and nuclear 
staining. A rrow s indicate 
c lear co loca lization betweer 
YFP-mDMPK C/C Kd and 
M ito tracke r Red. A cytosolic 
loca liza tion was adopted 
by YFP-mDMPK E and Kd 
fusion proteins. Bar, 25 pm. 
(B) Western blot ana lysis  of 
YFP-mDMPK fusion proteins 
expressed in DMPK KC myo­
tubes using an anti-DMPK 
antibody. Fusion proteins run 
at the appropriate m o lecu lar 
we igh t of about 100 kDa. 
Note tha t YFP-mDMPK Kd 
isoforms do not show the 
extra band associated w ith 
autophosphorylation ( in d i­
cated by as terisks) (296).
Figure 2 -Effects of DMPK 
expression on cytosolic 
calcium handling and store 
filling in myotubes.
Fura-2 AM-loaded WT 
and DMPK-KC myotubes 
d ifferentia ted fo r five days 
were s tim ula ted  w ith  20 pM 
acetylcho line (ACh) (A) or 
1 pM ionomycin (lono) (B) 
for about 60 s (b lack bar).
[Ca2+]c was monitored by 
d ig ita l imaging microscopy 
under constant s u p e rfu s o  
using Ca2+-containing (A) 
or Ca2+-free m edium  w ith 
0.5 mM EGTA (B). Typical 
trans ien ts  are shown. WT 
and KC myotubes showed an 
altered [Ca2+]c hand ling w ith 
s lig h t ly  elevated basal [Ca2+] 
c leve ls  for KC myotubes (A), 
which was more pronounced 
in Ca2+-free m edium  (B). 
DMPK-KC myotubes were 
transduced w ith  adenovira l 
vectors encoding active 
or inactive YFP-mDMPK 
isoforms and then subjected 
to ACh (C, E, G) or lone 
(D, F, H) s tim ula tion. The 
obtained curves were ana­
lyzed and effects induced 
by the expression of DMPK 
isoforms were quantified. 
The m ax im a l peak am plitude 
(C, D), Ca2+ decay time 
constant (E, F) and basal 
[Ca2+]c before stim ula tion 
together w ith  res idua l [Ca2+] 
c Y0 (G, H) were determ ined
for ACh-stimulated (C, 
E, G) or lono-stimulated 
(D, F, H) myotubes. The 
num ber of ce lls  used for 
a ll param eters is shown 
at the bottom of each bar 
in C and D. mA/C denotes 
ce lls  expressing both YFP- 
mDMPK A and C. WT indicate 
significance w ith  respect to 
WT myotubes.
B 0.60- lono
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be caused by either phosphory la t ion modif icat ion or by a mere s t ruc tu ra l  
association to protein targets. From these observations, we can draw 
one tentative conclusion: a lthough expression of certain isoforms mild ly  
affects the sett ing of balance between basal Ca2+ influx and extrusion, 
none of the DMPKs permanent ly  compromises the ab i l i ty  of myotubes to 
restore this balance to the ir  own resting-state value, af ter one round of 
st imula tion.
The m ax im a l  Ca2+ amp litude upon t rea tmen t with e ither ACh or lono 
did not marked ly  differ between cohorts of WT and KO myotubes and KO 
myotubes complemented w ith  dif ferent isoforms. Differences in compar i­
son to WT tubes appeared only m arg ina l ly  signif icant in two cases, for 
mDMPK A Kd-expressing myotubes w ith  ACh st imu la t ion and mDMPK A- 




































































































































































Conspicuously, corre lat ion analys is revealed that Ca2* responses in 
mDMPK C singly complemented, mDMPK A/C doubly-complemented and
WT myotubes showed clustered s im i la r i t y  in that these were the cells 
that showed the highest Fura-2 ratio peak heights upon ACh st imu lation 
and lowest peak heights upon lono st imula tion. (Fig. 2C and D and Fig. 
3C). Cluster ing resu l ts  for mDMPK C, A/C and WT myotubes were also 
found when decay ra tes of the Ca2* t rans ien ts  after ACh and lono t re a t­
ment were plotted (Fig. 3D), suggest ing that re la t ive ly  fast decay rates 
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Figure 3 • Correlation 
analysis of ACh- and Iono- 
stimulated myotubes.
Experim enta l data of the 
Fura-2 loaded ce lls  s tim u­
lated w ith  e ithe r ACh or lono 
were used in a co rre la­
tion ana lysis to determ ine 
linea r re la tionsh ips between 
parameters. (A, B) The linear 
re la tionsh ip  was determ ined 
between basal [Ca2+]c and 
fina l [Ca2+]c Y0 fo r ACh- and 
Iono-treated myotubes: ACh: 
R2 = 0.77, P=0.015; lono:
R2 = 0.89, P=0.017. (C) The 
linea r re la tionsh ip  between 
ACh-induced and lono-in- 
duced m ax im a l peak values: 
R2 = 0.91, P=0.011. (D) The 
linea r re la tionsh ip  between 
ACh-induced and lono- 
induced decay constants:
R2 = 0.90, P=0.015. (E) The 
linea r re la tionsh ip  between 
ACh-induced m ax im a l peak 
va lue  and decay constant:
R2 = 0.91, P=0.0008. (F) The 
linea r re la tionsh ip  between 
lono-induced m ax im a l peak 
va lue  and decay constant:
R2 = 0.79, P=0.06. A clear 
c luste ring  of mDMPK C, mD­







cells that express mDMPK C (Fig. 2E and F). Finally, ana lys is  of peak 
va lues versus decay ra tes of the Fura-2 s ignal ra t ios revealed that Ca2* 
re lease and Ca2* sequestrat ion were correlated and occurred to highest 
va lues and fastest ra tes in the group of ACh-stimula ted mDMPK C, A/C 
and WT myotubes (Fig. 3E). Ana lys is of lono st imu la t ion also placed 
mDMPK C, A/C and WT myotubes into one cluster. However, here the re la ­
tionship was reversed, as lowest m ax im a l peak va lues appear correlated 
w ith s lowest decay for this t rea tment (Fig. 3F).
• DMPK A expression alters mitochondrial calcium uptake
To study whether the effects described above indeed could in part be 
explained by influence of single DMPK isoforms on mitochondr ia l Ca2*
handling, [Ca2+]m was monitored using rhodamine-2 AM (Rhod-2) s ta in­
ing in WT, KO and complemented myotubes. A f te r  ACh st imu la tion, the
[Ca2+]m increased at a s im i la r  rate for KO and WT myotubes, reaching a 
s im i la r  fluorescent s ignal A inc rease  (Fig. 4A). In KO myotubes with m- 
DMPK A - but not A Kd or any of the other mDMPK isoforms - the m ax im a l 
peak height in the Rhod-2 s ignal tracing was sign if icant ly  lower than for 
a l l  other myotubes types analyzed (Fig. 4B). The shape of the [Ca2+]m 
t rans ient in ce l ls  that co-expressed mDMPK A and C had a s im i la r  ap­
pearance, again with s ignif icant ly  reduced peak height in comparison to 
WT myotubes (Fig. 4A and B). For c la r i ty  reasons, the spreading in traces 
for isoforms mDMPK C, C Kd, E and E Kd were not included in Fig. 4A
Figure 4 • DMPK isoform ex­
pression alters mitochondrial 
Ca2+ transients.
(A) Rhod-2-loaded WT and 
KO myotubes, d ifferentiated 
for five days, were s tim u­
lated w ith  20 pM ACh for 
60 s. [Ca2+]m was momtorec 
by d ig ita l imaging m i­
croscopy under constant 
superfusion. [Ca2+]m was 
calcu lated as the signal 
A increase compared tc 
basa l level. DMPK KO 
myotubes transduced w ith 
adenovira l vectors encoding 
d ifferent active and inactive 
YFP-mDMPK isoforms were 
also used. Traces show 
average [Ca2+]m after super­
imposing a ll appropriate ex­
periments. (B) The A increase 
m ax im a l peak is displayed 
showing [Ca2+]m uptake. 
For myotubes transduced 
w ith  DMPK A vector or for 
myotubes transduced w ith 
a m ixture  of DMPK A and C 
vectors, the m ax im a l peak 
of [Ca2+]m is s ign ificantly 
reduced (comparison to WT). 
The num ber of ce lls  tested 













































































































































































but are shown in Supp lementary Fig. 1, since no signif icant variat ion in 
m ax im a l  peak height was found for these isoforms. Comparison of k ine t­
ics of [Ca2+]m accumulat ion (i.e., rate of Rhod-2 s ignal increase during 
the brief period of high [Ca2*]c-induced mitochondria l ca lcium uptake 
(81), revealed no signif icant differences between the d if ferent myotubes 
(data not shown). Comparison of the rate of [Ca2+]m decay did also not 
revea l conspicuous differences. However, here the record ings should be 
considered unre l iab le  as the rendering of l inear trac ings for the decay 
phase of t rans ien ts  appeared notoriously difficult, due to sh ift ing of o r­
ganelle position caused by contract ile  movements of myotubes, directly 
fo llowing ACh st imu la t ion (Supplementary Fig. 2).
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Figure 5 • Myotube morphol­
ogy is not affected by DMPK 
expression.
(a ) WT myotubes and KO 
myotubes transduced with 
YFP-mDMPK isoforms at day 
three of d ifferentia tion were 
investigated afte r five days 
of d ifferentia tion for a lte ra ­
tions in m orphology using 
confocal microscopy. Myo­
tubes were co-stained for 
F-actin and titin  to v isua lize  
sarcom eric structures. Bar,
10 pm. (B-D) U ltras truc tu ra l 
ana lys is  by electron m icros­
copy. No obvious differences 
between WT, KO and YFP- 
mDMPK C-transduced myo­
tubes were found. Z-bands 
of sarcom eric s tructures are 
were found in a ll myotubes. 
Z-bands indicated by arrows. 
Bars, 1 pm.
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• Myotube development is not influenced by the absence or expression of 
individual DMPK isoforms
Calc ium is an important regu la to r of muscle  fate, but, reciprocally, 
muscle  in f ra s t ruc tu ra l  development (e.g., as in the development of the 
excita t ion-contractile system) is also an important parameter in the 
shaping of Ca2* transients. Since it has been proposed that DMPK plays a 
role in muscle maturat ion (30, 87), we set out to investigate whe ther the 
development of organization and maturat ion of the myotube in f ras t ruc­
ture and charac teris t ic changes in Ca2+ handling could be correlated and 
under coordinate regula tion in maturing myotubes. Using the typ ica l titin 
and F-actin banding pattern as indicator of maturat ion of sarcomeric 
structures, which usua l ly  occurs between day 4-7 of d if ferentiat ion in 
v it ro (48, 160, 250), we did not observe any abno rma l i t ies  in the cross­
str iated sarcomeric  s t ruc tu res  of any of the myotube-types analyzed 
(Fig. 5A). Phallo id in staining also revealed a no rma l cytoarch itectura l 
s t ruc tu re  with dist inct sarcomeric  organization, independent of p res­
ence or absence of DMPK isoforms. Ant i- tubul in  stain ing gave an overa l l  
staining of the myotubes with no obvious dif ferences between cu ltu res 
(Supp lementary Fig. 3). Fu rther analyses at the u l t ra s t ruc tu ra l  leve l with 
TEM confirmed formation of sarcomeric  s t ruc tu res at regu la r  appearance, 
w ith  no apparent malformations, s im i la r l y  for KO, DMPK transduced, and 
WT myotubes (Fig. 5B-D and Supp lementary Fig. 4). Actin-myosin fibers 
appeared w ith  electron dense Z-lines, next to c lear ly  v is ib le o rganelles 
like mitochondria. These data support that WT, KO and mDMPK A, C and 
E-expressing myotubes a l l  show a s im i la r  u l t ra s t ruc tu ra l  organization. 
Furthermore, v i r tu a l ly  a l l  myotubes measured were capable to respond 
to ACh treatment, indicating an intact excitat ion-contraction machinery. 
Hence, this suggests that any differences in calc ium handling observed 
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Figure 6 • DMPK expression 
does not influence nucleotide 
concentrations in myotubes.
Metabo lites of WT and KC 
myotubes transduced with 
YFP-mDMPK isoforms were 
investigated. (A, B) HPLC 
ana lys is  was used to deter­
m ine ATP, ADP, GTP and GDP 
concentrations in myotubes 
d ifferentia ted for five days. 
Means ± sem (n = 2, 3-4 








• Influence of DMPK expression on metabolic state
In m¡t2 chondr¡a, [Ca2*]m in directly controls ATP generation by OXPHOS 
through st imu la t ion of TCA dehydrogenases (131). Conversely, proper ATP 
fuel ing of Ca2+-ATPases is essentia l for t ight control over [Ca2+]c dynam­
ics in myotubes (133, 263). Since the profi les of both [Ca2+]c and [Ca2+] 
m trans ients  varied with presence of active DMPK C and A, respectively, 
we invest igated whether these isoforms had d if fe rent ia l effects on the 
global energetic state of myotubes. Using HPLC for the analys is of GTP, 
GDP, ATP, and ADP content we found no signif icant dif fe rences in metabo­
lite content between WT, KO myotubes and myotubes transduced w ith the
112
dif ferent DMPK isoforms (Fig. 6). Undifferentiated WT and KO myoblasts 






































































































































































DMPK proteins have a putative role in the a rrangement of the cytoskel- 
etal, ce l lu la r  and o rgane l la r  membrane arch itecture  and the control of 
ion distribution. As DMPKs with d if ferent C-termini target to dif ferent 
compartments -ER, MOM and cytosol- (286), we invest igated the physi­
ological signif icance of indiv idual DMPK isoforms. We focused on one 
aspect of this role, namely  Ca2+ handling in myotubes. Myotubes are cells 
in which products of the DMPK gene are most p rominently  expressed 
(215, 244). Fu rthermore its cy toarch itec tu ra l design is of paramount 
importance for proper functioning of the Ca2+-driven excitat ion contrac­
tion apparatus (62). We adopted use of SV40TAgts immorta l ized DMPK KO 
myoblasts, capable of d if ferentiat ing into myotubes, as our model system.
Due to lack of isoform-specific DMPK antibodies, no good data on 
DMPK isoform dis tr ibution in myotubes are ava i lab le  unti l now. Using 
t rans ient expression of DMPK isoforms, we found that the part it ioning 
behavior of single DMPK var ian ts  over ER (mDMPK A), mitochondria 
(mDMPK C) and cytosol (mDMPK E) in myotubes was as anticipated on 
the basis of findings in other ce l l  types (215, 286). We therefore assume 
that these patterns ref lect the locations of na tu ra l  preference of the 
three majo r DMPK isoforms. Besides concerns about ectopic location, we 
also considered it important to circumvent effects of local overexpres­
sion (211). We adapted a protocol where myotubes undergo three days of 
undisturbed differentiat ion, before adenovira l transduction is carr ied out. 
Under this regime myotubes express the YFP-mDMPK isoforms for only 
48 hours, keeping protein expression levels  around the t ime of analysis  
to w ith in a max imum of four-fold of that of endogenous protein (data not 
shown). Thus, we expect to avoid oversaturat ion at si tes at which DMPK 
proteins would no rma l ly  reside. We consider near-normal leve ls of DMPK 
pa r t icu la r ly  important because the protein has been implicated in the 
programming of myogenesis (30, 87) and, in turn, calcium handling ab i l­
ity in myotubes is coupled to dif ferentiat ion state.
Our s t ruc tu ra l  analyses confirmed that myotubes reached a s im i­
la r  degree of maturation. Myofib r il logenesis and costamerogenesis, with 
formation of str iated t it in and F-actin appeared to proceed s im ilar ly, 
leading to a comparab le  degree of maturat ion for immorta l ized  WT, KO 
and KO-complemented myotubes. We also noted s im i la r i t y  between the 
number and frequency of spontaneous contractions elic ited in acquis i­
tion medium (with or w ithout Ca2+; data not shown). To us these findings 
indicate that development of a funct ional excitat ion-contraction coupling 
(EC-coupling) system (171) -at least to the m ax im a l state of matu r i ty  
that can be achieved upon dif ferentiat ion in vit ro- is near no rma l in 
our transduced myotubes. Earlie r, also no apparent maturat ion d if fe r­
ences were observed between p r im ary  WT and KO myotubes (13) and an 
absence of gross morpho log ica l or s t ruc tu ra l  a lte ra t ions was reported 
for muscle  of KO mice (227). Taken combined, we consider this strong 
evidence against a major ro le of DMPK isoforms in sarcomere assembly, 
muscle  development and dif ferent iation. Interference by DMPK isoforms 
w ith cytoarch itec tu ra l a rrangement in myotubes is therefore only a minor 
concern for this study.
Our observat ions w ith regard to increased basal [Ca2+]c and altered 
m ax im a l  [Ca2+]c peaks and decay constant of calc ium trans ients  in KO 
myotubes compared to WT contro l ce lls  are large ly remin iscent of f ind­
ings with myotubes derived from p r imary  WT and KO myoblasts (13), 
a lbe it  that d if ferences upon st imu lation with ACh appeared somewhat 
less pronounced. The quantitat ive, but not qua l i ta t ive  nature of these dif­
ferences can be most easi ly expla ined by cel l- l ineage and mouse-stra in 
background differences. Comparison cannot be drawn to other findings 
for singly expressed DMPKs, because the exper iments and methods used 
for correlat ion analys is presented here are unique to this study.
In genera l,  th ree types of phenotypic effects on ca lc ium mobilization 
-i.e., se lective effects on basal and induced cytosolic concentration, ER 
store f i l l ing, and in tra-mitochondria l concentration- should be d is t in­
guished for ind iv idual DMPK isoforms. Presence of the ca ta ly t ica l ly  active 
DMPK C isoform, which is a common feature of mDMPK C, mDMPK A/C 
and WT myotubes, rendered the re lease of Ca2+ from, and sequestering 
into, ACh-responsive stores more efficient. For Iono-released Ca 2+, active 
DMPK C seemed to have opposite effects, coupled to lower peak values 
at cytosolic entry and s lower reuptake. Presence of DMPK A, as in DMPK 
A or DMPK A/C complemented cells, se lect ive ly  affected peak uptake 
of Ca2+ in mitochondr ia  af ter ACh stimula tion. What could explain these 
findings and the d if fe rent ia l effects of ACh and lono thereon? Various 
studies have indicated that the movement of Ca2+ among dif ferent com­
partments -cytosol, ER, mitochondr ia  and ex t race l lu la r  space- depends 
on the nature of the agent used to deplete the stores, and on the ce l l  type 
and manner in which stores are s t ruc tu ra l ly  arranged. ACh st imu la t ion of 
myotubes with a fu lly-developed excitat ion-contraction coupling occurs 
via the na tu ra l  way of tr iggering of voltage-gated Ca2+ channels, with 
subsequent calc ium re lease at specia l calc ium re lease sites in which SR, 
T-tubules and mitochondria  are in close apposition (237). The process of 
lono-induced re lease of calcium in myotubes is much less w e l l  under­
stood, but the ab i l i ty  of this ionophore to induce genera l membrane per­
foration and s t imu la te  the hydro lysis of phophoinositides evidently  plays 
a role. For ER stores, even special ized subcompartments w ith dist inctly 
regula ted depletion and entry of calc ium have been proposed (291).
Our findings are thus best expla ined if we assume that presence of 
DMPK C -or DMPK A- has a select ive modula ting effect on the spat ia l a r ­
rangement of these ER subcompartments, on the mitochondr ia l o r ien ta­
tion w ith  respect to the landscape of calc ium re lease and uptake events, 
and/or the eff iciency or positioning of re lease channels and Ca2+-ATPases 
in ER and mitochondr ia l membranes. What remains puzzling, however, is 
that DMPK C, which is anchored to the mitochondr ia l outer membrane 
(MOM), seems to exert its main effects on the kinetics of exit and (re)en- 





































































































































































our [Ca2+]m findings indicate that mDMPK A, which is anchored in the ER 
membrane has its main se lective effects on events that play a ro le in 
Ca2+ entry in mitochondria. Ca2+ is no rma l ly  re leased into the cytosol at 
s ites of close contact between SR and mitochondria, before it is taken up 
by the mitochondr ia  (98). We reported before that ER-location may be a 
pecul ia r property of the mouse DMPK A isoform, because human DMPK A 
binds to the MOM, jus t like DMPK C. From an evolutionary point of view, 
we may therefore have to assume that the mitochondr ia l localization of 
DMPK is dominant in Ca2+ handling (286) and DMPK A effects via the SR 
are only important in mice. Furthermore, we cannot easi ly  explain why 
single complementation w ith DMPK A, or double complementation with 
DMPK A and C, does not m im ic [Ca2+]m mobilization as seen in WT or 
in KO myotubes, but resu l ts  in dist inct behavior. It is s t i l l  possible that 
ectopic overexpression of DMPK A, a lthough only s l igh tly  beyond the 
na tu ra l  range, may dominate effects on [Ca2+]m. Ea r l ie r  we have shown 
that expression of the human DMPK A isoform may have dramatic ef­
fects on mitochondr ia l behavior. More work needs to be done to c la r ify  
whe ther the si tuation in mice represents a "side-step in evolution” and 
how DMPK A homologues in other species are located and involved in 
cytosolic calc ium handling.
Further studies on the apparent t rans-o rgane l la r  effects of DMPKs 
A and C -and the spat io tempora l aspects thereof- are needed. In any 
future study special attention should be on the possib il ity of se lective 
modula tion of activ i ty  of the ER- or p lasma-membrane resident pumps 
and channels, l ike the SERCA pump, the DHPR (ß-subunit), voltage- 
gated Ca2+ and/or Na+ channels, or associating partne r proteins like PLM 
(pa r tne r of SERCA) or PLN (pa r tne r of Na+ channel), proteins in the ca l­
cium-handling network that have been identified as potentia l ta rgets for 
DMPK-mediated phosphory la tion in v it ro (297). Proper analys is of regu­
lation of ion pumps and channels  by phosphory la tion in vivo, certa in ly  in 
highly dynamic ce lls  w ith a dense and highly ordered in frastructure  like 
myotubes, remains a complicated technica l challenge w ith the current ly  
ava i lab le  approaches.
• SUPPLEMENTARY FIGURES
Supplementary Figure 1 • 
DMPK expression alters mito­
chondrial Ca2+ transients.
(A,B) Rhod-2-loaded WT 
and KO myotubes, d iffe ren ti­
ated fo r 5 days, were s tim u­
lated w ith  20 pM ACh for 
60 s. [Ca2+]m was monitorec 
by d ig ita l imaging m i­
croscopy under constant 
superfusion. [Ca2+]m was 
calcu lated as the signal 
D increase compared tc 
basa l level. DMPK KO 
myotubes transduced w ith 
adenovira l vectors encoding 
d ifferent active and inactive 
YFP-mDMPK were also 
examined. Traces show the 
average [Ca2+]m ± sem after 
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Supplementary Figure 2 • 
Myotube movement upon 
acetylcholine stimulation.
Exam ple of myotube move­
ment affecting 
[Ca2+]m measurements. Im ­
ages at five d ifferent tim e 
points are shown. The reg ior 
were fluorescence intensity 
is measured is indicated m 
red. Myotubes move when 
s tim u la ted  w ith  ACh, thereby 
ham pering fluorescence 
in tensity determ ination.
Bar, 10 pm.
Supplementary Figure 3 • 
Actin and tubulin localiza­
tion in myotubes upon DMPK 
isoform expression.
WT myotubes and KO 
myotubes transduced with 
YFP-mDMPK isoforms were 
investigated fo r a lte ra ­
tions in m orphology using 
confocal microscopy. Cells 
were co-stained for F-actin 
and tubu lin  to visua lize  
cytoske le ta l organization 
and sarcom eric structure.
No apparent m orphological 
a lte ra tions  were found for 
d ifferent myotube cultures. 
Bar, 10 pm.
118
Supplementary Figure 4 • 
Myotube morphology is not 
affected by DMPK expression.
(A-C) U ltras truc tua l ana lysis 
of myotubes using electron 
microscopy. No obvious 
d ifferences between YFP- 
mDMPK A, C and A/C-trans­
duced myotubes were found.
Z-bands of sarcomeric 
struc tu res were found in a ll 
myotubes. Z-bands indicated 
by arrows. Bars, 1 pm.
Supplementary Figure 5 • 
Nucleotide levels in WT and 
DMPK KO myoblasts.
The energy-metabolite 
content of WT and KO 
m yoblasts was determ ined.
(a , B) HPLC ana lysis  was 
used to determ ine ATP, ADP, 
GTP and GDP concentrations 
in myoblasts. Means ± sem 
(n = 2, 3-4 sam ples per 
experiment).

























































































Myotonic dystrophy type 1 (DM1) is caused by the expansion of a (CTG) 
n t r ip le t  repeat in exon 15 of the DMPK gene (175). Since the repeat 
sequence is not situated in the protein-coding region of the gene, the 
length increase of the t ransc r ip t  does not resu l t  in production of a m u­
tant protein. Rather unconventional mechanisms must thus be involved in 
disease manifestation of DM1. Nowadays it has been commonly accepted 
that a dominant RNA pathogenesis mechanism -a process by which ab­
no rma l t ranscr ip ts  induce pathology- may be the main cause of the m a­
jo r i ty  of symptoms (129, 300). The RNA toxicity mechanism has received 
increased attention since the discovery that a second form of myotonic 
dystrophy, DM type 2 (DM2), is caused by a (CCTG)n repeat expansion in 
intron 1 of the ZNF9 gene (225). Transcrip ts bearing an expanded (C/CTG) 
n repeat capture proteins involved in splicing, t ranscr ip t ion or mRNA ex­
port and thereby induce misregu lation of seve ra l  genes in t rans (65, 181).
So is there no need to invoke DMPK protein products in our theo­
ry about the complex c l in ica l manifestat ion of DM1? Based on current 
knowledge, we feel this possib il ity can s t i l l  not be excluded. For example, 
expansion of the (CTG)n repeat may affect the rate of DMPK transcr ip tion 
or the mode and act iv i ty  of a l te rna t ive  splic ing or t ranspor t  of DMPK 
t ranscr ip ts  in cis and thus directly  influence the leve l of expression or 
the composition of the DMPK isoform repertoire. Any aberrancy in the 
expression of DMPK protein isoforms could have an addit ive ro le in one 
or more of the symptoms in the mult isys tem ic pattern of DM1 patho l­
ogy. Only very few well-contro l led in-depth studies have ac tua l ly  dealt 
w ith this matte r (135, 297). A lso s t i l l  re la t ive ly  l i t t le  is known about the 
expression and bio logical function of a l te rna t ive  protein va r ian ts  of the 
DMPK gene. This PhD study aimed to improve our leve l of knowledge on 
DMPK protein st ruc tu re  and function by investigating the localization and 
funct ional propert ies of d if ferent DMPK splice isoforms in more detail.
• DMPK splicing and isoform expression
P r imary  transcr ip ts  of the DMPK gene in both man and mouse are subject 
to a lte rna t ive  splicing. Most DMPK splice modes are evo lu t ionar i ly  con­
served and resu l t  in the expression of mult ip le  isoforms, six of which are 
considered majo r isoforms (95). One of the dif ferences between isoforms 
is the presence or absence of a five-amino-acid VSGGG motif C-terminal 
of the kinase domain. The re la t ive  expression of VSGGG-encoding t ra n ­
scrip ts s l igh tly  increases during myogenic diffe rentia t ion (S. Mulders, 
PhD Thesis, Radboud Univers ity  Nijmegen). For our studies, we decided 
to concentrate on the protein products encoded by these most abundant 











































activ i ty  (296).
A l te rna t ive  splicing, by which dif ferent C-termini are generated, con­
fers dif ferent membrane association propert ies to DMPK A, C and E, in 
that DMPK A and C typ ica l ly  bind to in t race l lu la r  membranes and DMPK 
E remains in the cytosol. Species-specif ic membrane targeting occurs for 
the DMPK A isoform. DMPK A from mouse localizes at the ER membrane 
and DMPK A from human localizes at the MOM (286). DMPK C proteins 
from human and mouse both bind to the MOM.
Because of the typ ica l C-terminal association to membranes, long 
DMPK isoforms A-D belong to the group of tail-anchored (TA) prote ins 
(18). TA proteins charac te r is t ica l ly  expose the ir  N-terminal protein do­
main into the cytosol and contain a segment of hydrophobic amino acids 
in the C term inus, which inserts in a membrane. Various in t race l lu la r  
membranes including the nuc lear membrane and p lasma membrane are 
potent ia l ta rgets for TA prote ins (21, 223). DMPK is the f i rs t and only TA 
kinase reported in l i te ra tu re  to date.
Study of the organelle-se lect ive membrane behavior of DMPKs with 
na tu ra l  and a r t i f ic ia l  sequence variat ion in the ir  C-terminal domain im ­
proved our unders tanding of targeting requirements and specif ic ity for 
membrane binding (Chapter 3; see below).
• DMPK expression profile
In order to identify a contr ibut ion of a ltered DMPK expression to DMl's 
complex pathology, it is important to obtain detailed knowledge on the 
DMPK expression pattern in dif ferent ce l l  types and tissues. A contro­
versy about DMPK expression in no rma l and DM1 patient t issues has 
existed ever since the DMPK gene was fi rst described about two decades 
ago, pa rt ly  because appropria te tools and well-matched t issue samples 
were lacking. Antibodies used in early  studies often recognized protein 
products ranging in size from 42-54 kDa, whereas DMPK has a predicted 
mo lecu la r  weight of 68-72 kDa (297). Unfortunately, antibodies against 
protein domains se lect ive ly  present in some DMPK isoforms are difficult 
to make (Wansink et al. unpublished resul ts) and therefore s t i l l  not exist.
In situ hybridization analys is on mouse tissues demonstrated DMPK 
RNA expression in a range of t issues that show pathology in DM1 (244), 
but pattern ing in the DMPK splice isoform profi les or ac tua l protein le v­
els were not w e l l  studied. Here, we chose a Western blott ing approach 
using a high-affin ity polyc lonal an t ise rum specific for the DMPK protein 
core to obtain a re l iab le  picture of the ra tios of expression and t is ­
sue d is tr ibution of long (A-D) and short (E-F) DMPK isoforms. Although 
w ith  this technique information on cell-type specificity, in trat issue and 
in t race l lu la r  pattern ing is lost, Western blotting is quant ita t ive ly  more 
re l iab le  and enables easy d iscrim inat ion between membrane-associa ted 
(long) and cytosolic  (short) isoforms. We found that the ratio between 
steady state concentra tions of long and short DMPK isoforms var ies be­
tween t issues and changes during myogenesis (Chapter 2). This suggests 
dif ferent funct ional requ irements for DMPK protein during development 
in d if ferent t issues, because the long and short DMPK isoforms probably 
display d if fe rent ia l substra te specif ic ity at the d if ferent locations in the 
ce l l  (296).
Cardiac involvement in DM1 has been correlated with both (CTG)
n repeat expansion and DMPK gene product dosage (16, 101, 211). We 
found that long and short isoforms exist in about equal concentra tions 
in card iac t issue and HL-1 heart ce lls  in culture. If this suggests that 
t ight regula t ion has card io-physio logica l relevance, aberran t expression 
leve ls  of splice isoforms as may occur in DM1, could possibly contr ibute 
to cardio pathology.
Weakness and wast ing of d is ta l ske le ta l  musc les and myotonia are 
other ha l lm a rk s  of DM1 (101), where most ly  type I (slow twitch) fibers 
are affected (289). Seve ra l of these disease features are also found in 
DMPK KO mice and Tg overexpressor mice, again suggest ing that tight 
contro l of DMPK protein expression may be necessary to prevent disease 
development (126, 211). We found that in ske le ta l  muscle t issue long 
DMPK isoforms predominate, being expressed about three-fold more than 
short isoforms. Strik ingly, DMPK protein was expressed at comparable 
leve ls  in both type I and II muscles: in so leus muscle (predominant ly  
type I) only s l igh t ly  higher amounts of DMPK were found than in t ib ia l is 
an te r ior (main ly  type II) and gastrocnemius (mixed type I and II muscle). 
These observat ions corroborate findings reported in an ISH study (244). 
Comparison of expression leve ls of DMPK protein or RNA between muscle 
types, therefore, gives not a s imple  explanation for the predisposit ion to 
type I muscle pathology in DM1.
Gastro in test ina l d is turbances might be related to DMPK expression 
leve ls  in smooth musc le  tissue, a lthough no direct evidence for DMPK 
protein involvement exists up to now, as no apparent smooth muscle 
abno rma l i t ies  have been reported in KO mice (298). Smooth muscle 
involvement in DM1 is main ly  characterized by malfunctioning of the 
gastro in test ina l tract, inducing symptoms like abdominal pain, vomiting, 
nausea and d ia rrhea (101, 198). DMPK is also expressed in layers of the 
i leum (244), in stomach and bladder (215). Other than vacuolization in 
bladder, no obvious ce l lu la r  pathology has been found in smooth muscle  
t issue of DM1 patients (101). DMPK protein in stomach and bladder was 
predominant ly  made up of short DMPK isoforms, pointing to a dist inct 
smooth muscle  ce l l  type-specific ro le of these cytosolic isoforms.
Short DMPK isoforms E and F can be regarded as truncated re la t ives 
of MRCK and ROCK (297), proteins involved in ce l l  motil ity. Therefore, se­
lective knockdown or overexpression of DMPK E-F in smooth muscle  cel l 
l ines in ce l l  migration- or ce l l  spreading assays could help increasing 
our understanding of the ir  no rma l ro le in smooth muscle  biology.
Pathology of the centra l nervous system in DM1 includes symp­
toms like menta l retardation, character changes, apathy, cognitive and 
emotional d is turbances and hypersomnia (101, 193, 235). Bra in-related 
symptoms are most severe in patients with the congenita l form of DM1 
and can lay a great burden on fam ily  and carers. At a s t ruc tu ra l  level, 
brain abno rma l i t ies  like progressive white matte r loss, co r t ica l brain 
atrophy and ven t r icu la r  dilation have been described in DM1 patients 
(193). In one study using DMPK KO mice, absence of DMPK was linked 
to neuronal p last ic ity  defects (252). In a second, however, no cognitive 
and behavio ra l abno rma l i t ies  could be detected in DMPK-deficient mice 
(190). Using t ransgenic  mice expressing mu lt ip le  copies of the human 
DMPK gene (211), we were able to demonstrate expression of both long 











































factory bulb and str ia tum. Due to the low expression, sensit ive methods 
l ike immunoprecip itat ion had to be used to study DMPK isoforms in WT 
mice. DMPK expression increased during development, confirming RT- 
PCR resu l ts  that showed higher expression in adult mouse brain cortex 
and cerebellum compared to neonatal t issue (72). The question whether 
this implies a more important role for DMPK at la te r stages of brain 
development therefore now needs fu r the r study.
A highly important finding is that DMPK protein is more abundant in 
astrocytes than in neurons, at least in semi-pure ce l l  populations kept 
in culture. However, as was a lready c lear from previous studies (129), 
DMPK expression is not comple te ly  si lenced in neurons and we could de­
tect low leve ls  of DMPK transcr ip ts  by RT-PCR. Stil l , our findings on p r i­
m ary  ce l ls  indicate that a more detailed invest igation of the role of DMPK 
gene products -both RNA and protein- in a l l  ce l l  types of neura l origin 
is fu l ly  justified. Astrocytes are increasingly seen as ce lls  with a dist inct 
ro le in the enormous complexity of brain functioning, and not anymore 
considered as ce l ls  with jus t  a support ive neuroanatom ica l scaffolding 
role. Until now, presence of r ibonuc lear foci, containing (CUG)n-repeat 
bound splice factors like MBNL1, has only been reported for neurons. No 
studies have appeared that show presence of abno rma l RNP aggregates 
in astrocytes in postmortem brain t issue of patients. However, on the 
basis of our findings reported here we highly recommend comparative 
study of fate of no rma l and mutant DMPK transcr ip ts  in a l l  majo r types 
of brain ce lls  of DM1 patients. As certa in populations of astrocytes are 
involved in brain diseases like Parkinson's and A lzhe imer's  disease (194) 
a ro le of astrocytes in the bra in-re la ted symptoms in DM1 can no longer 
be excluded.
• DMPK subcellu la r localization and membrane anchoring
The mo lecu la r  principles that govern membrane insert ion and organelle 
se lect iv i ty  of TA proteins are s t i l l  ra the r poorly understood. Like in other 
TA proteins, the hydrophobic sequence in the C-terminus of long DMPK
isoforms serves both as a membrane anchor and targeting s ignal (18, 
286). We used in terspecies dif ferences and isoform variat ion of the ta i l  
domain in DMPKs to investigate membrane se lect iv i ty  and mode of m em ­
brane anchoring in more detai l (Chapter 3).
We found that the membrane location of TA DMPK isoforms is not 
determined or affected by cell-type dependent dif ferences in cytoarchi- 
tecture or anticipated dif ferences membrane lipid composition. For DMPK 
C, we observed a Nout-Cout topology. To our best knowledge, DMPK C is 
the f i rs t  MOM-localized TA protein described to display th is  orientation. 
Ear lier, we reported that anchoring of DMPK C is dependent on p res­
ence of a coiled-coi l domain (296). This region may bind d irec tly  to the 
lipid membrane (236), induce the formation of homo-oligomers (298) or 
in teract with other membrane proteins. Besides the contr ibution of the 
coil domain, basic residues flanking the hydrophobic region can play an 
important ro le in ta i l  anchoring. Furthermore, pro line residues in the 
membrane anchor can cause breaks in the regu la r  st ruc tu re  of a-hel ica l 
s tre tches and decrease eff iciency of membrane insert ion (109). These 
residues can a lte r the orientation of a membrane anchor (97, 288) re su l t­
ing in embedding of the membrane anchor in the lipid b ilayer rather than
spanning it. Current ly, we think that it is the combination of the above 
sequence features that determines the topology of DMPK C binding. To 
know a l l  details, more biophysical work on this topic is necessary.
We invest igated specific requirements for ER and MOM anchoring by 
analyzing effects of sequence dif ferences between the mouse and hu­
man form of DMPK A. We found that the length of the hydrophobic region 
was more important than the presence of posit ive ly charged residues 
C-term inal of the hydrophobic region. Indeed, it has been reported that 
membrane width can influence localization of TA proteins in the secre­
tory pathway, suggest ing that the length of the hydrophobic region may 
become important in selecting the preferred membrane site for anchor­
ing (236). Based on this idea, we were somewhat surpr ised to find that 
extending the hydrophobic region of mDMPK A did not resu l t  in altered 
organelle  localizat ion.
A lthough both the mouse and human DMPK A isoforms display an 
Nout-Cin topology, we can only speculate about the exact membrane as­
sociation of the ta i l  anchor of the human DMPK A isoform. Based on 
the length of the hydrophobic e lements in the C term inus, hydrophobic 
region 2 (HR2) would  be ab le  to span the MOM lipid bilayer. As HR1 is 
probably too short to act as a t ransmembrane  domain (302), it may be 
embedded in the outer leafle t of the MOM (292). Increased MOM as­
sociation of mutant hDMPK A (L593R) suggests that HR1 is able to bind to 
negative ly  charged lipids in the MOM. Introduction of a basic residue in 
the membrane anchor is probably tolerated because there are sufficient 
hydrophobic residues surrounding it (109).
The curvature  of membranes can recru it  amphipath ic helices present 
in the ta i l  anchor of TA proteins (104). It has been postu lated that protein 
complexes at the MOM can induce membrane curvature  by the t ransfer 
of specific lip ids (e.g., phosphatidylserine, phosphotidy le thanolamine). In 
turn, these events can contr ibute to the recru itment of TA proteins, like 
h Fis, for in itiat ion of autophagosome formation (97) or possibly p ro­
motion of m itochondria l fission or fusion. Curved membranes can thus 
operate as scaffolds for the recru itment of specific proteins. Whether 
membrane curvature  is important in DMPK membrane anchoring remains 
to be determined.
Translocation of TA proteins to the ir  target membrane can occur un­
assisted or assisted and is mediated by special ized protein complexes, 
being e ither ATP dependent or independent. Proteins ass is t ing in MOM 
targeting have not yet been described, however it is known that an­
choring of seve ra l  MOM-targeted TA prote ins is independent of the TOM 
machinery (18). Insert ion of TA proteins into the ER membrane has been 
studied more e laborate ly  and resulted in the discovery of seve ra l fac­
tors that may be involved, like the s ignal recognition part ic le  (SRP), the 
Hsp40-Hsc70 complex, the Asna-1/TRC40 polypeptide (223) and the Bat3 
complex (185). It has been postu lated that TA proteins with a highly 
hydrophobic membrane anchor are more prone to aggregate and thus 
require fast chaperone-regulated translocation. For example, increasing 
the hydrophobicity of the cytochrome b5 membrane anchor rendered 
the protein unable to independently insert into its target membrane (18). 
Since ta i l  1 of DMPK A is very hydrophobic, we specula te that it indeed 











































ther invest igation of the possible in teraction of this and other DMPK iso­
forms with known or newly  to be discovered chaperones would therefore 
be of great interest.
• Membrane clustering behavior by DMPK A expression
In this thesis  (Chapter 4) we have demonstra ted that the expression of 
hDMPK A leads to cluster ing of mitochondr ia  (216). The membrane c lu s­
tering capacity is localized in the ta i l  domain itself, as expression of ta il
1 alone is suffic ient to induce this phenomenon, even after only severa l 
hours of t rans ient expression. There is mounting evidence indicating that 
certa in hydrophobic regions in membrane proteins are able to induce 
membrane curvature  and remodeling (45, 231). Our EM data demonstra te 
that hDMPK A decorates sm a l l  and round mitochondria, indicating abe r­
ra t ions in lipid-protein or lipid-lipid interactions. At the MOM, sites of 
membrane curvature  can be in itiat ion sites of specific processes like 
autophagy (97). As we find an increase in the leve l of autophagy after 
hDMPK A expression, we like to specula te that ectopic expression of 
hDMPK A might induce membrane cu rva tu re  and subsequent formation 
of autophagosomes at the MOM. This idea is supported by the fact that 
expression of hDMPK A also resu l ts  in loss of m itochondr ia l membrane 
potential, a known in it ia tor of mitophagy (42).
Mitochondria s tarted to round up and c luste r around the nucleus 
upon expression of hDMPK A ta i l  1. S im i la r  m itochondr ia l c luster ing ef­
fects have been reported for overexpression of other MOM proteins like 
the TA proteins hFis (123), Miro GTPases (80), and Mfn 1 and 2 (234). 
It is not c lear how these TA proteins are able to induce mitochondr ia l 
cluster ing, as ne ither the presence of a coiled-coil domain, enzymatic 
activ i ty  of the protein nor the status of the cytoskele ton are determining 
factors. It appears as if a l l  MOM proteins are involved in separate pa th­
ways or m ic roenv ironments for m itochondr ia l in teractions w ith  other ce l­
lu la r  structures. Therefore it could be speculated that these proteins are 
involved in forging links between dist inct areas of the mitochondria  and 
dist inct ce l lu la r  s t ruc tu res  or machineries, possibly motor proteins (80). 
Any disbalance in this coupling may resu l t  in s im i la r  effects, resu lt ing in 
m itochondr ia l fragmentation and cluster ing. In the case of hDMPK A, the 
high hydrophobic ity of the membrane anchor is the main dete rm inant of 
m itochondr ia l c luster ing as expression of mutant hDMPK A (L593R) gave rise 
to reduced cluster ing (Chapter 3).
The physiological state of mitochondr ia  is coupled to morpho log i­
cal appearance (172). Even with in  a single cell, m itochondr ia  can be 
morpho log ica l ly  and funct ional ly  heterogeneous and change appearance 
during dif ferent stages of ce l l  cycle (196). Abno rm a l m itochondr ia l m o r­
phology, like cluster ing of mitochondria, is linked to human diseases 
l ike Dominant Optic A trophy and Charcot-Marie-Tooth subtype 2A (CMT) 
(38, 148). The c l in ica l symptoms of CMT resemb le  DM1 symptoms and 
even has a history of m isdiagnosis w ith DM1 (101). A lso A lzhe imer's 
disease has been associated with m itochondria l ma lfo rmations induced 
by amylo id p recursor protein via modif icat ion of Drp1, a known mediator 
of m itochondr ia l morphology (294). Since astrocytes are l inked to brain 
pathology in A lzhe imer's and because these ce l ls  express substant ia l 
amounts of DMPK, one might specula te that -as a cause of a ltered DMPK
expression- astrocyte m itochondr ia l morphology or function could be­
come aberran t in DM1, possibly leading to astrocyte ce l l  death and white 
matte r abnorma l i t ies in patients.
Perhaps s im i la r  arguments can be used for muscle  pathology, as 
long DMPKs like the A and C isoforms are main ly  expressed in this tissue. 
Muscle ce lls  have a highly organized cytoarchitecture, which may render 
them vu lnerab le  to s t ruc tu ra l-o rgane l la r  disorganizat ion. Thus, we an­
tic ipate that also in muscle the concentration and the ratio of expression 
of long hDMPK A and C isoforms must be main tained with in  a st r ic t  range. 
Speculative arguments in favor of a ro le for m itochondr ia l abnorma l i t ies 
in connection to DMPK misexpression are even fu r the r strengthened by 
findings in the TG mouse that ca rr ies  mult ip le  copies of the hDMPK gene. 
Tissue analys is of this model showed an aberran t m itochondria l m o r­
phology w ith disorganized cr is tae st ruc tu re  and symptoms like reduced 
work load tolerance, atrophy and cardiomyopathy (211). Whethe r the role 
of DMPK misexpression, in pa r t icu la r  hDMPK A overexpression, is indeed 
special for DM is a topic for fu r the r  study in this mouse model. Ultimately, 
we w i l l  also need studies of DMPK isoform leve ls  and ra tios in DM pa­
tients with dif ferent repeat lengths and comparison to healthy controls  
to shed more light on the contr ibution of the DMPK mitochondr ia l axis 
to DM1 pathogenesis.
• DMPK function
S t i l l  not much is known about the physiological ro le of DMPK. Especially 
the role of the separate isoforms remains to be investigated. Severa l 
studies have shown that DMPK is localized at the neuromuscu la r junction 
or the intercala ted disk and gap junct ions (135). Furthermore, a ltered Ca2* 
handling was found in mytubes derived from DMPK KO mice, compared 
to WT myotubes, resembling Ca2* handling in myotubes derived from DM1 
patients (13), indicating a role in ion homeostasis in muscle. We have in­
vest igated the contr ibution of indiv idual DMPK isoforms on Ca2* handling 
in myotubes (Chapter 5). S im i la r  resu l ts  were found for myotubes with 
(the MOM-local ized) enzymat ica l ly  active DMPK C isoform (WT, mDMPK C, 
coexpression of mDMPK A and C). Upon acety lcho l ine st imu la t ion these 
myotubes were able to re lease Ca2* from - and sequester Ca2* into - ACh- 
responsive stores most efficiently. The opposite effect was found for han­
dling of Ca2* released by ionomycin st imula tion. Myotubes expressing the 
mDMPK A isoform (mDMPK A, coexpression of mDMPK A and C) showed 
a decreased ab i l i ty  to take up Ca2* into mitochondria. Remarkably, WT 
myotubes and DMPK KO myotubes, showed s im i la r  behavior in m itochon­
d r ia l Ca2* handling, so mDMPK A expression must be apparent ly  ca re­
fu l ly  dosed to avoid dominant effects with reduced mitochondr ia l uptake. 
Another unexplained and somewhat surpr is ing finding was that mDMPK 
C (located at the MOM) appears most important in the regula tion of Ca2* 
re lease and uptake from the sarcop lasm ic re t icu lum (SR; a special type 
of ER in muscle  cells), whereas mDMPK A (located at the SR) has its 
most dominant effects on mitochondria l Ca2* uptake.
The cy toarch i tec tu ra l a rrangement of the excitat ion-contraction ap­
paratus and the positioning of organe l les in myotubes is of great im ­
portance regard ing myotube functioning. As Ca2* is no rma l ly  re leased 











































location of mDMPK C would enable it to exert its activ i ty  on proteins at 
both the MOM or SR. Seve ra l potentia l substra tes have been proposed for 
DMPK, like phospholamban an inhibitor of the SR Ca2* ATPase (SERCA) 
or the ß-subunit of the dihydropyridine receptor (DHPR). Furthermore, in 
a previous study performed in our lab DMPK consensus phosphoacceptor 
sequences were identified in VDAC-1, the b3-subunit of the DHPR and 
the card iac ryanodine receptor, a l l  proteins involved in Ca2* homeostasis 
(297). Since VDAC also has been proposed to in itiate SR-MOM contact 
formation (51), a ltered phosphory la t ion of VDAC by mDMPK C could con­
tro l  the t ightness of contact sites between SR and MOM and contr ibute to 
variat ion in Ca2* handling. Finally, DMPK phosphory la t ion of phospholem- 
man (PLN) could a lte r the depolarization state of myotubes via in terac­
tion w ith Na* channels, thereby increasing the influx of Ca2* ions through 
the DHPR (297). In order to fu l ly  understand the ro le  of DMPK in musc le  
ce l ls  addit ional exper iments are required addressing the phosphory la tion 
state of these potentia l DMPK targets.
Next to phosphory lat ion, regula t ion of Ca2* handling, behavior of Ca2* 
trans ients  can also be affected via the redox state of the cell. Reactive 
oxygen species (ROS) are able to increase or decrease the ac tiv i ty  of 
certain proteins involved in Ca2* homeostasis  by reacting w ith  avai lab le 
cysteine residues. Both SERCA and the ryanodine receptor have been 
described to be susceptible to ROS (51). Interest ingly, oxidant-stress 
dependent regulation of the ER-resident protein STIM1 (105) controls 
m itochondr ia l Ca2* handling. Although involvement of oxidant-stress m e­
diated control of Ca2* t rans ien ts  was not invest igated in this PhD study, 
elevated ROS leve ls have been reported in DM1 patients (281). Future 
work  should thus also include a possible direct or indirect ro le of DMPK 
isoforms on mitochondria l-mediated oxidant s t ress control.
• Concluding remarks
DM1 is caused by expansion of a (CTG)n repeat leading to mis regu la tion 
of gene expression of seve ra l  genes, including possibly the DMPK gene
itself. Could this cis-acting mechanism, potentia l ly result ing in haploin- 
sufficiency or DMPK isoform ratio aberrancies, contr ibute to DM1 patho l­
ogy? In this PhD study, I provide evidence that the ro le of indiv idual long 
DMPK isoforms -depending on the ir  membrane anchoring behavior- may 
be linked to ER and mitochondr ia l biology, to Ca2* handling and to cell 
v iab i l i ty  control. This new knowledge increases ra the r than decreases 
the probabi l i ty  of involvement of a disbalance in DMPK protein activ ity 
in aspects of DM1 pathology. As a consequence, any mo lecu la r  the ra ­
peutic strategy for DM1 based on breakdown of expanded DMPK mRNA 
(202, 212, 293) should be developed w ith care and not contr ibute to a 
d isbalance in the expression of DMPK protein products. Only then, safe 
and effective t rea tmen t w i l l  become ava i lab le  and a patient's experience 
w ith  DM1 may improve.
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Myotone dystrofie type 1 (DM1) wordt ve roorzaakt door de expansie van 
een (CTG)n-tripLet repeat -een DNA sequentie bestaande uit vele CTG- 
nucleotide-tr ip letten in tandem- in het Laatste exon van het DMPK-gen. 
W aar in gezonde mensen een repeatlengte van 5 tot 35 (CTG)n-tripletten 
voorkomt, worden bij aangedane personen repeatexpansies gevonden die 
kunnen oplopen tot enke le duizenden repeats. De repeatsequentie is ge­
situeerd buiten het e iw itcoderende deel van het DMPK-gen en resu l tee r t  
daardoor niet in de expressie van een mutant eiwit. Inmiddels  is a l ­
gemeen geaccepteerd dat een dominant-RNA-pathogenese-mechanisme, 
een proces waarb ij  een ziektebeeld wordt geïnduceerd door een abnor­
m aa l t ranscr ip t, ten grondslag ligt aan het merendeel van de symptomen 
van DM1. Transcripten afkomstig van een mutant DMPK-gen met een 
geëxpandeerde repeat zijn in staat bepaalde splice- en transcr ip tie- 
factoren af te vangen hetgeen leidt tot m is regu la t ie  van de expressie van 
een grote verscheidenheid aan andere genen. Mogeli jk heeft abnormale  
expressie van het DMPK-gen zelf ook een pathobiologische rol. Expansie 
van de (CTG)n-repeat in het DMPK-gen kan nameli jk  -direct of indirect- 
leiden tot veranderde transcr ip tie, splicing, of t ranspor t  van DMPK mRNA 
transcr ip ten en daarmee u ite indeli jk  ook de expressie  van DMPK eiwit- 
producten beïnvloeden. Slechts weinig studies hebben aandacht besteed 
aan deze mogeli jkheid. Over de expressie en functie van individuele ei- 
w itproducten van het DMPK-gen is tevens nog maar weinig bekend.
P r ima ire  DMPK transcr ip ten zijn onderhevig aan uitgebreide a l te rna­
tieve splicing, wat resu l tee r t  in de expressie van een zesta l hoofdeiwi- 
t isovormen. Deze isovormen bevatten al len een leucine-ri jke N-terminus, 
een ser ine/threonine k inasedomein en een coiled-coil-domein. In de helf t 
van de isovormen bevindt zich een VSGGG-sequentie aan het einde van 
het kinase domein. De uiterste C-terminus van DMPK is het meest bepa­
lend voor loka l isa t ie  en functie en komt voor in drie varianten. Isovormen 
A en B bevatten een hydrofobe C-terminus die in het ER membraan anker t  
(NB: bij de mens aan mitochondriën). Een m inder hydrofobe C-terminus 
wordt gevonden bij isovormen C en D, die bindt aan het mitochondrië le  
bu itenmembraan (MOM). Een cytosolische lo ka l isa t ie  wordt gevonden 
voor isovormen E en F, die een C-terminus van slechts twee aminozuren 
bezitten. Vanwege de typische wijze van binding van isovormen A-D aan 
in t race l lu la i re  membranen worden de DMPK's A-D ingedeeld in de groep 
van zogenaamd C-terminaal verankerde eiwitten.
In dit p roefschrift  zijn de loka l isa t ie  en functionele eigenschappen van 
versch i l lende splice-isovormen van het DMPK-eiwit in meer detai l bestu­
deerd. Om te bepalen of het DMPK-eiwit mogeli jk  een ro l kan spelen bij
de DM1-pathogenese is het belangrijk te weten in welke weefse ls van het 
lichaam en in welke re lat ieve hoeveelheden het e iw it  voorkomt. In Hoofd - 
stuk 2 is de expressie van het DMPK-eiwit onderzocht en in het bi jzonder 
aandacht besteed aan de verhouding van de lange (A-D) en korte (E, F) 
isovormen. Het onderzoek heeft aangetoond dat de ratio van de DMPK- 
isvormen in versch i l lende sp ie rweefse ls va r iabe l is en dat de verhouding 
gevonden in ske letsp ie ren overeenkomt met die in p r imaire  spiercel l ijnen. 
Daarnaast is gekeken naar de DMPK-expressie in verscheidene brein- 
regio's. Lange DMPK-isovormen komen in brein het meest tot expressie 
en nemen in hoeveelheid toe t ijdens breinontw ikkel ing. Express iestudies 
in p r imaire  neura le  cell i jnen lieten zien dat DMPK voorname li jk  voor­
komt in cort ica le astrocyten. Nogal verrassend was de observat ie  dat 
p r imaire  hippocampale  neuronen slechts een zeer lage DMPK-expressie 
lieten zien. Deze vinding imp l iceer t  dat de bre insymptomen gevonden in 
DM1 gerela teerd zouden kunnen zijn aan veranderde DMPK-expressie of 
processing in tenminste beide celtypes of zelfs in astrocyten a l leen en 
niet in neuronen.
In een studie van YFP-DMPK fusie-eiw it ten in p r imaire  spier- en 
breincellen werden geen ve rsch i l len in subce l lu la i re  loka l isa t ie  gevon­
den tussen DMPK isovormen. Dit suggereert dat de bij DMPK-binding 
betrokken membraaneigenschappen en targeting machiner ie  -en daa r­
mee de subce l lu la i re  lo ka l isa t ie  van DMPK's- niet celtype of celsoort 
a fhanke l i jk  zijn.
De subce l lu la i re  targeting van DMPK is verder onderzocht in Hoofd­
stuk 3 aan de hand van t ransduct ie-expressiestudies met muize- en 
humane DMPK-isovormen. Voor de humane DMPK C isovorm werd lo ka l i­
satie op het MOM gevonden. Binding bleek bepaald te worden door zowel 
het coiled-coi l domein als  ook door de C-terminus. Eenzelfde loka l isa t ie  
was ook gevonden voor muis DMPK C en is dus niet soortafhanke l i jk .  Voor 
lo ka l isa t ie  van de humane DMPK A isovorm op het MOM is s lechts de 
C-terminus vereist. Deze eigenschap w i jk t  af van die van de ortholoog 
van DMPK A van de muis, welke loka l isee r t  op het ER. Analyse w ijs t 
uit dat op aminozuurposit ie  600 van de humane DMPK A-sequentie een 
arg in ine (R) aanwezig is in p laats van een a lanine (A) residu in DMPK A 
van de muis. Dit zorgt ervoor dat het hydrofobe domein in de C-terminus 
van hDMPK A onderbroken wordt, waardoor twee gespl itste hydrofobe 
regios aanwezig zijn. Kennelijk zorgt dit voor een MOM-lokalisatie. Na­
dere analyse van de C-termini van de muize- en humane DMPK A liet 
zien dat een lange hydrofobe regio leidt tot ER-lokalisatie. Het opbreken 
of verkorten van de hydrofobe regio resu l tee r t  in een loka l isa t ie  op het 
MOM of in het cytosol. Het grote belang van indiv iduele aminozuurposi- 
ties in C-ankers is hiermee nogmaals  aangetoond. In een topologiestudie 
waarb i j  DMPK gemerk t werd met fluorescente anti l ichamen na se lectieve 
permeab i l isa t ie  van het ce lmembraan hebben we aangetoond dat zowel 
bij de muize- a ls  de humane DMPK C isovorm het uiterste deel van het 
C-terminale  uiteinde zich in het cytosol bevindt. Voor de muize- en de 
humane DMPK A-isovorm is het uiteinde van de C-terminus in het ER- 
lumen (muis) of de mitochondr ië le  in termembrane space (IMS; mens) 
gelokaliseerd. De expressie van de humane DMPK A isovorm op het MOM 
kan daarb ij specifiek aggregatie van mitochondriën induceren. In cellen 

















































A zich in het cytosol te bevinden. Waarsch i jn l i jk  heeft dit te maken met 
het ve r l ies  van mitochondr ië le  in tegrite it  na aggregatie.
Het fenomeen van mitochondr ië le  aggregatie is nader onderzocht in 
Hoofdstuk 4. Expressie  van hDMPK A b l i jk t  eerst te leiden tot f ragm en­
tatie van mitochondriën en dit proces wordt gevolgd door mitochondrië le 
aggregatie en u ite inde li jk  celdood. M.b.v. t runcat ie-analyse konden we 
aantonen dat de C-terminus van hDMPK A zelf ve ran twoorde l i jk  is voor 
deze mitochondrië le aggregatie en dat een afwijkende s truc tuu r van de 
mRNA waa rvan  het eiw itdomein vertaa ld  wordt, met a l  dan niet een 
(CUG)n-repeat daarin, hierbij  geen ro l speelt. Ook het coiled-coi l do­
mein, we lke  dimeriserende eigenschappen bezit, bleek niet van belang 
voor m itochondrië le  aggregatie. Aggregatie t reedt a l na enkele uren na 
aanvang van hDMPK A expressie op en wordt gefaci li teerd door een in­
tact m ic rotubul i netwerk. Verstoring van de s t ruc tuu r van dit m ic ro tubu­
la i re ne twerk  ve r t raag t  de mitochondr ië le  aggregatie m aa r kan deze niet 
voorkomen. Ook de fysio logische gevolgen van mitochondrië le aggregat ie 
zijn bestudeerd. Dit werk  liet een ver l ies van mitochondr ië le  functie 
zien, onder andere het ve r l ies  van de mitochondr ië le  membraanpotenti- 
aa l (MMP). Opvallend was het fei t dat wanneer de mitochondriën slechts 
gefragmenteerd waren deze nog we l een norma le  MMP bezitten en deze 
pas verl iezen na aggregatie, iets wat ook gevonden werd voor het v r i jko ­
men van cytochroom c uit de IMS, hetgeen een m arke r  is voor apoptose. 
Een verhoogde expressie van hDMPK A leidt dus tot apoptose en heeft 
u ite indeli jk  celdood tot gevolg. Verder nam autofagie toe t ijdens mito- 
chondrië le aggregatie. Waa rsch i jn l i jk  betreft het hier een reactie waarb ij  
de cel t racht te compenseren voor een ve r l ies  aan energieproductie. Ook 
kan autofagie betrokken zijn bij het opruimen van niet langer functionele 
mitochondriën. Deze resultaten geven aan dat regulat ie  van de expres- 
sieniveau's en ook de ratio van de versch i l lende DMPK isovormen erg 
belangri jk  zijn voor het opt imaa l functioneren van de cel.
Uit studies uit het ver leden is bekend dat de ca lc iumregu la t ie  is 
veranderd in sp ie rce llen zonder DMPK. In Hoofdstuk 5 gaan wij op dit 
thema verder en wordt een studie beschreven naar de betrokkenheid van 
individuele DMPK isovormen bij de calc iumresponse. Prima ire  DMPK KO 
myotubes en WT myotubes werden daarvoor afgeleid van transgene m u i­
zen met een gen welke codeert voor een temperatuur-sens it ie f SV40TAg 
eiwit. In aanwezigheid van dit e iw it  bij re la t ie f lage tempera tuu r groeien 
deze van muizen afgeleide myoblasten ongelimiteerd. Bij hoge tempe ra­
tuur wordt het TAg eiw it geinactiveerd en kri jgen de cellen hun vermogen 
tot te rm ina le  dif ferent ia t ie terug. Gebruik van dit celsysteem m aak t  het 
voor het eerst mogeli jk  om langetermijneffecten van aan of afwezigheid 
van afzonderl ijke mDMPK A, C en E isovormen op de cytosola ire en mi- 
tochondriële  ca lc iumhuishouding gedeta i l lee rd te bestuderen. In de door 
ons gebru ik te ge ïmmorta l iseerde myotubes werden dezelfde kwal i ta t ieve 
ve rsch i l len  tussen DMPK KO en WT gevonden a ls  vroeger geobserveerd 
voor p r imaire  myotubes. Voor a l le  mDMPK C-expresserende myotubes 
(mDMPK C, mDMPK A en C dubbel t ransfectie, en WT) werden opvallend 
identieke responsen waargenomen, waarb i j  na acety lchol ine-s timu la t ie  
een verhoogde max ima le  Ca2* piek en een versne lde verw ijdering van 
cytosolisch Ca2* optrad. Bij s t imu la t ie  met ionomycine werd een tegen­
overgeste lde cluster ing van effecten gevonden, met ver laagde max ima le
cytosolische calcium en vert raagde verw ijdering, weer uniek voor cellen 
met mDMPK C. Verder werd voor de mDMPK A isovorm een verandering 
geconstateerd wat betreft m itochondrië le Ca2*-regulatie in de vorm van 
een lagere max ima le  piek na acety lchol ine-stimula t ie . Wij concluderen 
dat de gevonden effecten te maken hebben met de lokaa l membraan-ge- 
bonden enzymatische ac tiv i te i t  van DMPK, en dat deze niet het indirecte 
gevolg zijn van een door DMPK-isovormen geïnduceerd ve rsch i l  in dif- 
fe rentiat iegraad of globale energ iestatus. Onze resultaten zijn ve rrassend 
omdat (i) de MOM-gelokaliseerde DMPK C isovorm zijn effect so rtee rt  op 
de snelheid van vr i jkomen en opname terug in de SR Ca2* stores van Ca2* 
en ( ii)  de SR-gelokal iseerde DMPK A isovorm ju is t  een effect heeft op 
de max ima le  mitochondrië le Ca2* opname. Het vr i jkomen van calc ium in 
het cytosol en opname van calcium in het ER vindt voorname li jk  p laats 
in gebieden w aa r ER en mitochondriën zich dicht bij e lkaa r bevinden. We 
moeten dus aannemen dat de effecten van mDMPK C activ i te i t  tussen 
deze organellen kan worden uitgewisseld. Ook moet in onze ve rk la r ing  
rekening gehouden worden met de mogeli jkheid dat lichte overexpressie  
van de DMPK isovormen -wat onverm i jdbaar is in onze exper imentele  
opzet- de vindingen heeft beïnvloed. Verder kunnen er d ie rsoortverschil- 
len zijn in de ro l van DMPK, waarb i j  de ER-lokalisat ie  van de DMPK A 
van muis kan duiden op een specifieke ro l voor deze isovorm a lleen in 
dit zoogdier.
Samenvattend; in dit p roefschrift  tonen we aan dat DMPK isovormen 
specifiek tot expressie komen in een groot aan ta l  sp ie rweefse ls en brein- 
regio's. Deze isovormen bevinden zich op versch i l lende locaties in de cel, 
gekoppeld via gedefinieerde membraanankers. Dit maak t  DMPK tot een 
aan trekke l i jk  modelsysteem voor het bestuderen van de (patho)biolo- 
gische ro l en wijze van membraanbinding van C-terminaal verankerde 
eiwitten. De ve rsch i l len  in lo ka l isa t ie  van de zeer homologe muis- en 
humaan DMPK A-isovormen maken dit nog extra  interessant. De cel- en 
weefse l-afhanke l i jke expressie van isovormen imp l iceer t  een a l te rna­
tieve functie voor DMPK op versch i l lende locaties. Mogeli jk modificeert 
DMPK op de diverse locaties a lte rna t ieve substra ten en is een juiste 
verdeling over in t race l lu la i re  membranen belangri jk. Mogelijk heeft een 
d isbalans in de expressie  van DMPK isovormen daardoor aanzienli jke 
consequenties voor de fysio logische in tegrite it  van bepaalde cellen. 
Voortgezet onderzoek naar DMPK-expressieniveaus en spliceproducten in 
DM1 -patiënten zal voor de toekomst waardevo l le  informatie  kunnen op­
leveren betreffende de mogeli jke betrokkenheid van een DMPK-disbalans 







































AGC cAMP-dependent protein kinase/protein kinase 
G/protein kinase C
[Ca2*]c Sarcoplasm ic free [Ca2*]
[Ca2*]m Mitochondria l [Ca2*]
CELF1 CUG-BP and ETR3-like
CMT Charcot-Marie-Tooth subtype 2A
ClC-1 Chloride Channel 1
CRAC Ca2* re lease-activated Ca2* influx
CRIK Citron Kinase
CUGBP1 CUG-binding protein 1
DHPR Dihydropir id ine Receptor
DM1 Myotonic Dystrophy type 1
DM2 Myotonic Dystrophy type 2
DMPK Myotonic Dystrophy Protein Kinase
EBSS Ear le's Balanced Salt  Solut ion
EC-coupling Excitat ion-Contraction coupling
EM Electron Microscopy
ER Endoplasmic Reticulum
hDMPK human Myotonic Dystrophy Protein Kinase
HR Hydrophobic Region
HS Horse Serum
HSP Heat Shock Protein
HT Hepes Tris





LATS Large Tumor Suppressor
MBNL Muscleblind
mDMPK mouse Myotonic Dystrophy Protein Kinase
Mfn Mitofusin
MKBP DMPK Binding Protein
MMP Mitochondria l Membrane Potentia l
MOM Mitochondria l Outer Membrane
MRCK Myotonic Dystrophy Kinase-Related Cdc42-Binding 
Kinase
MRLC Myosin Regula tory Light Chain
MYPT Myosin Phosphatase Targeting Subunit
NDR kinase Nuclear Dbf2-Related kinase
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ORF Open Reading Frame





PMCA Plasma membrane Ca2*-ATPase
Rhod-2 AM Rhodamine-2 acetoxymethy l ester
RNP Ribonucleoprotein
ROCK Rho-associated Coiled-coi l Containing Kinase
ROS Reactive Oxygen Species
SERCA Sarco/endoplasmic re t icu lum Ca2*-ATPase
SP1 Specific Protein 1
SR Sarcoplasm ic Reticulum
SRF Serum Response Factor
SRP Signal Recognition Part ic le
































Na de nodige ja ren hard werken is dan eindeli jk een ha l le lu ja-t je  op zijn 
plaats, het 'boekje' is dan toch afgekomen. Een moment w aa r zolang 
tegenaan gehikt is, is plots gekomen en ineens definitief. Naast vele 
wetenschappel i jke vragen heeft de vraag: "Gaat het dan ooit afkomen?” 
zeker ook door mijn hoofd gespookt. Nu eindeli jk een vraag die met een 
'ja' beantwoord kan worden. Het is een leuke, interessante en af en toe 
zware tijd geweest. Een tijd waar in  ik menig maa l in de spiegel heb moe­
ten kijken, m aa r w aa r ik veel van heb geleerd en met plezier op terug 
kijk. Nu tijd dus om het laatste (en b l i jkbaar meest gelezen) stukje van 
het boekje te schri jven: het dankwoord.
Het tot stand komen van dit werk je  is na tuu r l i jk  niet he lemaa l zonder de 
nodige hulp gebeurd. A l le re e rs t  w i l  ik graag Bé bedanken voor de mo­
gel ijkheid om bij Celbiologie mijn promotieproject te beginnen. Bedankt
voor de vri jheid die ik heb gekregen t ijdens mijn promotieonderzoek en 
je geduld. Je raad en inzicht hebben ervoor gezorgd dat dit boekje een 
samenhangend geheel is geworden. Verder w i l  ik Rick na tuu r l i jk  heel erg 
bedanken. Rick: van jouw begeleiding, gedrevenheid en je pragmatische 
man ie r van experimenten doen, heb ik veel geleerd. Ook de spiegel die je 
me enkele malen voorgehouden heb, is erg leerzaam geweest. Daarnaast 
was het al t ijd erg gezellig in het u-tje, menig onderwerp is de revue 
gepasseerd, met tussenti jds zelfs tijd voor een exper imentje  hier en daar. 
Ook Jack w i l  ik graag bedanken. Door jou ben ik fan geworden van m i­
croscopie, een voorliefde die niet meer ver lo ren zal gaan. Bedankt voor 
je begeleiding en enthousiasme.
Ik heb het al t ijd erg naar mijn zin gehad op de 6e verdieping, de 
gezelligste verdieping van de toren! Susan, je bent een van de drijvende 
krachten achter deze goede sfeer, bedankt voor je initiatief. Verder had ik 
zeker een stuk minder experimenten gedaan wanneer je niet in het week­
end 'effe' wat voor mij gedaan hebt. Ook bedankt voor de samenwerk ing 
bij het M&N verhaal.  Ik ben blij dat je paran imf w i l t  zijn. Veel succes bij 
Prosensa en the cure for DM1! Verder w i l  ik graag Rinske bedanken voor 
a l le  prakt ische hulp bij het M&N verhaa l, voor mij echt een milestone 
omdat mijn eerste gepubliceerde hoofdstuk is. Bedankt ook voor menig 
geze llige tre in re is richting het zuiden. Leuk dat je paran imf w i l  zijn.
Daarnaast w i l  ik ook graag Mietske heel erg bedanken voor de vele 
uurt jes EM en autofagosomen tellen. Heel wat keren kwam ik weer aan­
dragen met nog maar eens wat myotubes of cellen met geclusterde 
mitochondriën. Het resu l taa t  is we l dat bijna ieder hoofdstuk we l een EM 
plaatje bevat. Ook w i l  ik graag de rest van de DM groep bedanken voor de 
hulp en gezell igheid (een bbq-tje op zijn tijd is a lt ijd  goed, ook a l  regent
het). Walther, ik wacht op een volgende productie met jou in de hoofdrol 
en Lieke, veel succes met de afronding van jouw boekje. René, ik heb 
het onderzoek van je overgenomen. Bedankt voor die basis, het wegwi js  
maken op het lab en je samenwerk ing, oa. bij het M&N verhaal.
De sfeer op het lab is alt ijd erg goed geweest, daar hebben de nodige 
labdagen, paaslunches, kerstd iners en fi lmavonden zeker aan bijgedra­
gen. Ook tijdens de lunch en v r i jdagm iddagborre l heb ik veel gelachen. 
Dit heeft er in ieder geval voor gezorgd dat ik me meteen heb thuis ge­
voeld op de 6e. Ik w i l  iedereen van Celbiologie, nog present of inmiddels 
verkast, bedanken voor een goede tijd. Marieke, Mirthe, Magda, Irene, Ad, 
Edwin, Mariska, Yvet, Marloes, Lieke vdB, Femke, Helma, Shari ta, Gönöl, 
Gerda, Jan S. en Remco bedankt! W i lma, ons helaas veel te vroeg ontva l­
len. Je gezelligheid zal ik nooit vergeten. Huipie, bedankt voor de hulp 
tijdens het microscopen, wanneer er weer eens een schuif je of zo ve r­
keerd stond en er niks te zien was. Op naar de zeven min ;-). Daarnaast, 
Frank bedankt voor de HPLC metingen op de myoblasten en myotubes, 
en de hulp bij het bijbehorende bepalen van ce lvo lumes met jazeker, een 
schuifmaat. Basic celbiologie dacht ik zo! Wiljan, je commentaren tijdens 
werkbesprek ingen hebben zeker geholpen en mocht je nog een art ike l t je  
nodig hebben, ik hoor het wel :-). Jan K. en Bas, erg fijn dat ik bij een 
van ju l l ie  kon pitten na weer een kerstd iner of labstapavond wanneer ik 
niet he lemaa l meer capabel was om nog naar Wageningen of la te r Den 
Bosch terug te keren. Mijn tijd op de f lex-plek t ijdens het schri jven van 
dit p roefschrift  is ook erg gezellig geweest. Gert-Jan, Linda, Monique, 
Ineke en Mich ie l bedankt voor de goede sfeer. Ook de 'de Boertjes' Alwin, 
Godfried, Marieke en Peter bedankt. De Mold ieren w i l  ik na tuu r l i jk  ook 
niet vergeten. J u l l ie  hebben er a l lem aa l  aan bijgedragen dat de 6e ve r­
dieping de beste verdieping van de toren is. Jess ica nog bedankt voor het 
carpoolen vanuit Wageningen, het reizen was erg gezellig zelfs met de 
onvermi jdeli jke fi les voor de Waalbrug.
Ook mijn studenten Daan en Lisette w i l  ik bedanken voor hun inspan­
ningen zodat hoofdstuk 3 is geworden tot wat het nu is. Ik vond het erg 
gezellig om met ju l l ie  samen te werken en ju l l ie  te begeleiden, hier heb ik 
een hoop van geleerd. Daan, veel succes nu met jouw promotie. Lisette, ik 
heb weinig studenten rond zien lopen met meer motivatie  en arbeidsethos 
dan jij. Houd ook tijd over voor leuke dingen :-).
Verder w i l  ik nog Fons en Miranda bedanken voor hun samenwerk ing 
met het ontw ikkelen voor de DMPK adenovirussen. Deze zijn zeer veel 
gebru ik t voor dit werkje. Daarnaast ook Werner heel erg bedankt voor 
de input bij hoofdstuk 5. Je hebt ervoor gezorgd dat het max ima le  uit de 
data gehaald kon worden.
Ook vr ienden en fam il ie  hebben na tuu r l i jk  een belangrijke ro l gespeeld. 
J u l l i e  hebben ervoor gezorgd dat er naast de al t ijd aanwezige druk van 
het p roefschrift  ook de mogeli jkheid is geweest om er even niet aan te 
denken en gewoon lo l te hebben. Ook a l waren de ontmoetingen niet 
alt ijd met even grote rege lmaat is het toch alt ijd erg gezellig en w i l  ik 
graag iedereen bedanken. De club uit Rooi w i l  ik bedanken voor a l le  jaren 
vriendschap, lol en gezel ligheid. Joost en Maureen, Bart en Birgit, Ruud 
en Aukje, Roel en Marlou, Danny en Kim en Mathieu en Margot, na de hele 























feestje. Ook de stud ievr ienden uit Wageningen w i l  ik bedanken, waarvan 
sommigen a l  hebben voorgedaan hoe je moet promoveren. Nu moet ik het 
dan maar eens gaan waarmaken. Hans en Marieke, Frank en Inge, Robert 
en Annel ieke en Stijn en J in ji  bedankt voor a l le  gezelligheid ti jdens ve r­
jaardagen, kroeg en vr i jgezellenfeest jes. Maurice en Annemieke: wanneer 
zullen we de volgende cu lina ire avond houden?
Hans, Froukje, Imke en Alw in, bedankt voor ju l l ie  belangste ll ing, ge­
zelligheid en steun. Ook tijdens de keren dat Hester en ik weer eens 
besloten hadden te gaan verhuizen en er geschilderd moest worden en 
lam inaa t worden gelegd. We zullen ons proberen een beetje in te houden.
Pappa, Henriette, Eefje, Joep en Ama, bedankt voor mijn tweede thuis, 
w aa r het alt ijd gezellig is. Voor ju l l ie  steun, interesse en oprechte vragen. 
Soms was het toch lastig om goed uit te leggen w aa r ik toch a l lem aa l  
mee bezig was en waarom het zolang duurde. Maar dat hoeft nu niet 
meer, 't is k laar!
Mam, dank je voor een solide basis, je onvoorwaarde l i jke  steun, l ie f­
de en geloof in mij. A ls  je duizend keer hoort dat je het kunt dan ga je er 
zelf ook een keer in geloven :-). Mede hierdoor heb ik volgehouden en ligt 
er toch een boekje. Was het nou opvoeding of toch genen?
Hester, lieverd, dank je voor a l je liefde, steun en enthousiasme de 
afgelopen jaren. Ook je hulp met het layouten van het boekje was onm is­
baar. Je geduld is aardig op de proef gesteld maar dan is het nu toch 
af. Eindel ijk is er weer tijd om leuke dingen te doen. Ik kijk uit naar de 
nieuwe fase in ons leven. Kus...
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